Posttraumatic stress disorder and chronic musculoskeletal pain : how are they related? by Peng, Xiaomei
 
 
 
 
 
POSTTRAUMATIC STRESS DISORDER AND CHRONIC 
MUSCULOSKELETAL PAIN: HOW ARE THEY RELATED? 
 
  
 
 
 
 
 
 
 
 
 
 
Xiaomei Peng 
 
 
 
 
 
 
 
Submitted to the faculty of the University Graduate School 
in partial fulfillment of the requirements 
for the degree 
Doctor of Philosophy 
in the School of Health and Rehabilitation Sciences, 
Indiana University 
 
December 2013 
ii 
 
Accepted by the Faculty of Indiana University, in partial 
fulfillment of the requirements for the degree of Doctor of Philosophy. 
 
 
 
 
 
 
      
 _______________________________ 
      Matthew J. Bair, MD, MS, Chair 
 
 
 
 
      
 _______________________________ 
       Kurt Kroenke, MD 
 
 
Doctoral Committee 
 
      
 _______________________________ 
      Douglas E. Faries, PhD 
 
 
May 8, 2013 
 
      
 _______________________________ 
       Joyce L. Mac Kinnon, EdD 
 
 
      
 
 
 
 
 
iii 
 
 
 
 
 
 
 
 
© (2013) 
Xiaomei Peng 
ALL RIGHTS RESERVED 
iv 
 
ACKNOWLEDGEMENTS  
 
First and foremost, I’d like to thank Dr. Bair, my advisor, for teaching me 
how to initiate good research through asking appropriate research questions, and 
for involving me in numerous discussions about ESCAPE study design and 
processes. Dr. Bair helped me finalize my research topic, and guided me to 
optimize my research questions based on extensive literature review. Dr Bair has 
always been an excellent mentor as well as a kind friend, who’s always there to 
listen and to help whenever I have a problem.  
Second, I’d like to thank Dr. Kroenke, who kindly agreed to serve on my 
dissertation committee and offered numerous suggestions and comments for my 
dissertation from the very beginning. His suggestions and comments inspired me 
to keep improving the quality of my research and my writing.   
Third, I’d like to thank Dr. Faries for his consultancy on important statistical 
issues of the research. For example, he cautioned me on the statistical impact of 
subsample choice, and helped me correctly interpret the results from my CART 
analysis. His comments and suggestions made my analyses more robust. 
In addition, I’d like to thank Dr. Mac Kinnon for her consistent efforts to 
keep the committee work together and ensure my dissertation work to move 
forward smoothly and on plan to finally reach a good conclusion.  
Last but not least, I have to thank my husband, Hui, for all of his 
encouragement and support over the past few years. Thank Hui for taking care of 
v 
 
most of our housework and encouraging me when I was struggling and pushing 
me when I needed to be pushed.  
  
vi 
 
ABSTRACT 
Xiaomei Peng 
POSTTRAUMATIC STRESS DISORDER AND CHRONIC 
MUSCULOSKELETAL PAIN: HOW ARE THEY RELATED? 
Symptoms of post-traumatic stress disorder (PTSD) are a common 
comorbidity in veterans seeking treatment of chronic musculoskeletal pain 
(CMP). However, little is known regarding the mutual influence of PTSD and 
CMP in this population. Using cross-sectional and longitudinal data from a 
randomized clinical trial evaluating a stepped care intervention for CMP in 
Iraq/Afghanistan veterans (ESCAPE), this dissertation examined the 
relationships between PTSD and CMP along with other factors including 
depression, anxiety, catastrophizing and health-related quality of life.  The 
Classification and Regression Tree (CART) analysis was conducted to identify 
key factors associated with baseline PTSD besides CMP severity. A series of 
statistical analyses including logistical regression analysis, mixed model repeated 
measure analysis, confirmatory factor analysis and cross-lagged panel analysis 
via structural equation modeling were conducted to test five competing models of 
PTSD symptom clusters, and to examine the mutual influences of PTSD 
symptom clusters and CMP outcomes. Results showed baseline pain intensity 
and pain disability predicted PTSD at 9 months. And baseline PTSD predicted 
improvement of pain disability at 9 months. Moreover, direct relationships were 
found between PTSD and the disability component of CMP, and indirect 
relationships were found between PTSD, CMP and CMP components (intensity 
vii 
 
and disability) mediated by depression, anxiety and pain catastrophizing. Finally, 
the coexistence of PTSD and more severe pain was associated with worse SF-
36 Physical Component Summary (PCS) and Mental Component Summary 
(MCS) scores. Together these findings provided empirical support for the mutual 
maintenance theory. 
 
      Matthew J. Bair, MD, MS, Chair 
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Chapter I: Introduction 
Overview 
Posttraumatic stress disorder (PTSD) and chronic pain often co-occur and 
patients with chronic  pain often report more severe PTSD symptoms (T. Moeller-
Bertrama April 2009). The high rate of comorbidity suggests that the two 
disorders are related (Otis, Keane et al. 2003). To explore the nature of this 
relationship between PTSD and chronic pain, a number of theories have been 
proposed. For example, the Mutual Maintenance model (Sharp and Harvey 
2001), one of the most influential theories, posits PTSD and chronic pain 
exacerbate and maintain each other through seven intermediate factors: (1) 
attentional and reasoning biases, (2) anxiety sensitivity, (3) reminders of the 
trauma, (4) avoidance of activities and sensations associated with pain and 
trauma, (5) depression and reduced activity levels, (6) anxiety and pain 
perception, (7) cognitive demand from symptoms that interfere with use of 
adaptive strategies. Another theory, the Shared Vulnerability Model (Asmundson, 
Coons et al. 2002) considers anxiety sensitivity as a predisposing risk factor for 
both PTSD and chronic pain. And the Perpetual Avoidance theory (Liedl and 
Knaevelsrud 2008) hypothesizes a PTSD and pain cycle in which each condition 
influences each other through avoidance/inactivity and hyperarousal; two of the 
primary symptoms shared by both PTSD and pain. 
This chapter and related study discusses several conceptual models 
related to PTSD and chronic pain and aims to examine these models empirically 
using data from a clinical trial evaluating a stepped care intervention for chronic 
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musculoskeletal pain in Iraq/Afghanistan veterans (ESCAPE). In particular, this 
study aims to analyze the relationship and mutual influence between PTSD 
symptoms, chronic musculoskeletal pain, and other intermediate factors and 
outcomes such as depression, anxiety sensitivity, disability and quality of life. To 
complete the study aims, factor analysis, structural equation modeling and other 
statistical methods will be used.  
This dissertation contains several chapters. First, Chapter 1 gives an 
overall introduction to the study objectives, rationale and methods. Next the 
chapter describes the study background including the diagnosis, prevalence, 
assessment instruments and conceptual models of posttraumatic stress disorder 
and chronic pain, as well as the empirical findings and theories about their 
comorbidity.  Finally, several key components of the study are highlighted, 
including the statement of the problem, study objectives, study methodologies, 
study rationale and significance, study assumptions, and a brief summary of this 
chapter. Chapter 2 reviews the literature on PTSD and chronic pain comorbidity 
and several studies examining their relationship. Chapter 3 details the study 
design, hypotheses, and analytical methods. 
 
Posttraumatic Stress Disorder 
According to the Diagnostic and Statistical Manual of Mental Disorders 
Fourth Edition (DSM-IV)(American Psychiatric Association. 2000), posttraumatic 
stress disorder (PTSD) is one of several anxiety disorders, and is characterized 
by “the re-experiencing of an extremely traumatic event, symptoms of increased 
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arousal and avoidance of stimuli associated with the trauma.” To meet the 
diagnostic criteria for PTSD, an individual must have been exposed to a 
traumatic event as a victim or witness, and must have 1) at least one re-
experiencing symptom; 2) at least three avoidance symptoms; 3) at least two 
arousal symptoms; and 4) those symptoms persisting for at least one month and 
causing significant distress to the patient (see Appendix A for detail of PTSD 
diagnostic criteria).   
According to the National Comorbidity Survey Replication (NCS-R), the 
lifetime prevalence of PTSD was 6.8% among the U.S. adult population (Kessler, 
Berglund et al. 2005). Current past year PTSD prevalence was estimated at 
3.5% (Kessler, Chiu et al. 2005). Both lifetime and 12-month prevalence rates 
were nearly three times as high among women as they were among men 
(Survey. 2005). Understandably studies of at-risk individuals (e.g., combat 
veterans, victims of vehicle accidents or criminal violence) have yielded higher 
prevalence rates. Depending on ascertainment methods and the population 
sampled, the prevalence rates reported by individual studies vary considerably. 
For example, a study reported 8.6% of patients seen in primary care clinics had 
PTSD (Kroenke, Spitzer et al. 2007). Of Iraq/Afghanistan War veterans,, 
approximately 13.8% have PTSD (Tanielian 2008), more than double the rate in 
the general population. In addition, PTSD is associated with other physical health 
problems including cardiovascular and respiratory diseases, chronic pain 
conditions, gastrointestinal illnesses, and cancer, as well as suicide attempts, 
poor quality of life, and short- and long-term disability (Sareen, Cox et al. 2007). 
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Psychological theories 
A number of psychological theories have been proposed to explain the 
causes of PTSD. 
• Behavior theory (OH 1960; Keane TM 1985): this theory proposes PTSD 
is caused by learned fear and avoidance behaviors that minimize the 
contact time with the conditioned cues to an extreme stressor such as a 
traumatic event. The avoidance behaviors thus prevent extinction of the 
learned fear.  
• Fear network theory (cognitive and information-processing models): 
According to this theory, a fear network is formed following a traumatic 
event storing information about what is threatening and what should be 
escaped or avoided (Foa 1989). Anxiety disorders develop when the fear 
network contains faulty connections such as distorted evaluations of 
external threats that do not truly represent the state of the world (Foa 
1989). When compared to other anxiety disorders, the size of the fear 
network in PTSD is larger, the networks are more easily activated, and 
the affective and physiological response elements of the network are 
more intense (Foa and Kozak 1986).  
• Social-cognitive theory: this theory emphasizes the meaning of the 
trauma and the content of cognitions, assuming trauma survivors have a 
“completion tendency’’ that involves cycling between intrusive images 
and nightmares about the meaning of the trauma and defense processes, 
such as numbing and denial (Horowitz 1986). The experience of trauma 
 
 
5 
 
shatters the individual’s assumptions about (1) personal invulnerability, 
(2) the world being meaningful, and (3) the self as positive or worthy 
(Janoff-Bulman 1992). 
Biologically, PTSD is thought to be associated with a series of physiologic 
changes within the brain (including prefrontal cortex, amygdala and 
hippocampus), the autonomic nervous system, and the endocrine system 
(Kulich, Mencher et al. 2000). For example, PTSD has been associated with low 
levels of urinary cortisol and high levels of catecholamines, with a 
norepinephrine/cortisol ratio consequently higher than comparable individuals 
without PTSD.  
 
Assessment instruments 
Several screening tools and diagnostic instruments are available to assist 
clinicians in making a PTSD diagnosis, documenting a traumatic event, and 
assessing symptom severity.  These include structured or semi-structured 
diagnostic interviews, such as the Clinician-Administered PTSD Scale (CAPS), 
the Structured Clinical Interview for DSM-IV (SCID), the Diagnostic Interview 
Schedule for DSM-IV (DIS-IV), and the Composite International Diagnostic 
Interview (CIDI), all of which might be used prior to or as a complement to the 
clinical interview; and non-diagnostic assessment and screening instruments 
such as the PTSD Checklist (PCL), the Posttraumatic Diagnostic Scale, the 
Davidson Trauma Scale, and the Keane PTSD Scale of the Minnesota 
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Multiphasic Personality Inventory (MMPI-PK), which assess DSM-IV symptoms 
of PTSD and symptom severity as well as associated features of PTSD.  
The ESCAPE study includes the PCL as one of the psychological distress 
outcome assessment tools. The PCL is a 17-item self-report measure of the 17 
DSM-IV symptoms of PTSD. Three validated versions (PCL-M for military, PCL-
C for civilian, and PCL-S for specific stressful experience) of the PCL are 
available and can be used to screen individuals for PTSD, diagnose PTSD, or 
monitor symptom change during and after treatment.  
The PCL is scored in the following  ways (VA National Center for PTSD 
June 2010): 
 A total symptom severity score (range = 17-85) can be obtained by 
summing the scores from each of the 17 items. Evidence suggests that a 
5-10 point change represents reliable change (i.e., change not due to 
chance) and a 10-20 point change represents clinically significant change. 
 A PTSD diagnosis can be made by:  
1. Determining whether an individual meets DSM-IV symptom criteria, 
i.e., at least 1 B item (symptoms of re-experiencing, see Appendix 
A), 3 C items (symptoms of avoidance, see Appendix A), and at 
least 2 D items (symptoms of arousal, see Appendix A). Symptoms 
rated as "Moderately" or above (responses 3 through 5) are 
counted as present.  
2. Determining whether the total severity score exceeds a given cut 
point. Some studies consider a score of 50 as a conservative PCL-
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17 cut point (Forbes, Creamer et al. 2001; Gerrity, Corson et al. 
2007). Other studies use a score of 44 as a cut point for PTSD 
diagnosis (Chossegros, Hours et al. 2011), or consider 41 as a 
valid cut point (Sherman, Carlson et al. 2005). 
3. Combining methods (1) and (2) to ensure that an individual has 
sufficient severity as well as the necessary pattern of symptoms 
required by the DSM.  
 All three methods above are acceptable for research purposes, although 
method #1 and #3 tend to be more consistent with formal clinical diagnosis made 
by clinicians using structured or semi-structured diagnostic interviews. 
 
Chronic pain 
Unlike chronic pain syndrome, which is one type of somatoform disorder 
classified by DSM-IV, chronic pain is not a formal diagnosis. Any type of pain that 
persists for 6 months or longer is typically referred to as “chronic” pain (Merskey 
H). According to an internet-based survey, about 30% of US adults suffer from 
chronic pain (Johannes, Le et al. 2010). Chronic pain costs the U.S. up to $635 
billion each year in medical treatment and lost productivity (Institute of Medicine 
Report from the Committee on Advancing Pain Research 2011). 
 Chronic pain can be categorized by its origin, such as cancer pain, 
musculoskeletal pain (including arthritis, back problems, repetitive stress injuries, 
and fibromyalgia), headache and migraine, and neuropathic pain (e.g., pain 
related to herpes zoster or diabetes). According to the 1999-2002 National 
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Health and Nutrition Examination Survey (NHANES), chronic pain condition 
prevalence estimates were 10.1% for back pain, 7.1% for pain in the legs/feet, 
4.1% for pain in the arms/hands, and 3.5% for headache (Hardt, Jacobsen et al. 
2008). The three most common types of chronic pain are back pain, headache, 
and joint pain, two of which are categorized as musculoskeletal pain. The 
prevalence of musculoskeletal pain ranges between 38% and 47% among 
Persian Gulf War and Operation Iraqi Freedom/Operation Enduring Freedom 
veterans (Gironda, Clark et al. 2006) (The Iowa Persian Gulf Study Group 1997). 
Musculoskeletal pain is the most common, disabling, and costly of all pain 
conditions (Badley, Rasooly et al. 1994; Elliott, Smith et al. 1999). 
Chronic pain is frequently comorbid with psychiatric disorders, the most 
common ones being affective disorders (depression and anxiety), substance-
related disorders, and personality disorders (Fishbain, Cutler et al. 1998). The 
following psychological theories have been proposed to explain the development 
and maintenance of chronic pain. 
 
Psychological theories 
• Behavior theory (operant theory): this theory focuses exclusively on ‘‘pain 
behaviors’’ and contingencies of reinforcement. According to this theory, 
pain behaviors, if negatively reinforced by, e.g. overprotection from work 
or household chores, could persist beyond the normal healing time 
expected for an injury (Fordyce 1996). 
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• Cognitive behavioral theory: this theory assumes unhelpful cognitive and 
behavioral reactions to pain such as catastrophizing, avoidance of pain-
elicit activities or hypervigilance to bodily sensations and can lead to 
prolonged duration of pain, and higher levels of distress, dysfunction and 
disability. 
 
Assessment instruments 
The Initiative on Methods, Measurement, and Pain Assessment in Clinical 
Trials (IMMPACT) recommended six core outcome domains for the assessment of 
pain: 1) pain severity/intensity, 2) physical functioning, 3) emotional functioning, 4) 
patient ratings of improvement and satisfaction with treatment, 5) associated 
symptoms, and 6) adverse effects. The IMMPACT group also recommended 
several outcome measures and instruments for these six domains including the 
Brief Pain Inventory, the Massachusetts General Hospital Pain Center’s Pain 
Assessment Form, and the Beck Depression Inventory, for example. 
The ESCAPE study measures pain-related disability and pain severity 
using the following instruments:   
 The Roland Disability Scale is a 23-item pain-specific measure of physical 
disability originally validated in patients with back pain and subsequently 
validated in patients with non-malignant pain problems. Scoring is simple 
and ranges from 0 (no disability) to 23 (severe disability).  
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 The Graded Chronic Pain Scale (GCPS) is a brief 7-item scale that rates 
global severity of chronic pain in two domains: intensity and disability. Rich 
normative data exists for the GCPS.  
 The SF-36 Bodily Pain scale contains two items which assess pain severity 
and interference. A large body of normative data available for this scale.  
 The BPI Interference scale has 7 items that rates the interference of pain 
with mood, physical activity, work, social activity, relations with others, 
sleep, and enjoyment of life.  
 
PTSD and chronic pain comorbidity 
A review of PTSD and chronic pain studies indicated that pain symptoms 
and chronic pain are prevalent in patients with PTSD. The converse is also true, 
PTSD symptoms are common in patients with chronic pain, particularly in those 
with more severe pain, greater interference with activities of daily living, and 
more negative affect (Asmundson, Coons et al. 2002).  
In particular,  compared with the general population, the prevalence of 
PTSD has been found in a number of studies to be elevated among individuals 
with the following nine types of chronic pain: fibromyalgia, headache, migraine, 
orofacial pain syndromes, accident related pain, back pain, pelvic pain, 
mastalgia, and complex regional pain syndrome (Tobias Moeller-Berrtram 2011).  
Another study found, however, patients with migraine did not experience PTSD 
symptoms more than the general population (Ifergane, Buskila et al. 2009). 
Evidence also shows that PTSD is most prevalent in patients with chronic 
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musculoskeletal pain who are classified as dysfunctional (i.e. those displaying 
higher pain severity, pain interference, elevated affective distress and fear, and 
lower activity), compared with those classified as interpersonally distressed (i.e. 
those displaying lower perceived social support) or adaptive copers (i.e. those 
displaying lower pain severity, pain interference, and affective distress) 
(Asmundson, Bonin et al. 2000). (Ifergane, Buskila et al. 2009) 
Furthermore, PTSD and PTSD symptoms are strongly associated with 
current pain, overall pain ratings, and pain-related disability (Beckham, Crawford 
et al. 1997). McGhee et al. found that PTSD severity and chronic pain severity 
are positively correlated (McGhee, Slater et al. 2011). Other studies have shown 
that patients experiencing both PTSD and chronic pain report greater disability 
and poorer quality of life, and are less likely to receive effective treatment than 
those experiencing only one of the two conditions (Ifergane, Buskila et al. 2009). 
PTSD may also mediate the relationship between pain severity and depression, 
functional adjustment, and satisfaction with life (Bryant, Marosszeky et al. 1999). 
The high comorbidity of PTSD and chronic pain suggests these two 
disorders are likely related. A number of theoretical models have been proposed 
to explain this relationship, which will be discussed in detail in the next chapter. 
 
Statement of the Problem 
The frequent co-occurrence of PTSD and chronic pain has been reported 
by many epidemiological studies. A limited number of studies have examined the 
relationship between PTSD and chronic musculoskeletal pain, resulting in 
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several testable conceptual models. Although these models seem to be 
supported by certain study results, there is still no consensus on the exact nature 
of the relationship between PTSD and chronic musculoskeletal pain due to its 
complexity. In particular, evidence is still lacking to answer the following 
questions:  
1) How strong is the relationship between PTSD and chronic musculoskeletal 
pain?  
2) Which factors mediate the relationship between PTSD and chronic 
musculoskeletal pain? 
3) Do different clusters of PTSD symptoms (e.g. re-experiencing vs. avoidance 
vs. arousal) affect chronic musculoskeletal pain outcomes differently? 
This study aims to answer the above questions using data from a 
longitudinal trial evaluating the effect of a stepped care intervention for 
Iraq/Afghanistan veterans with musculoskeletal pain. Various statistical methods 
will be used to explore and test the direct, indirect and possibly bi-directional 
relationships between PTSD symptoms, chronic musculoskeletal pain outcomes 
and other factors that may mediate or moderate the PTSD and chronic 
musculoskeletal pain relationship.  The strength of these relationships will also 
be examined. 
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Study Objectives 
In summary, this study’s objectives include: 
1. Examine the cross-sectional relationships between PTSD, depression, 
anxiety, chronic musculoskeletal pain severity, pain disability and 
quality of life. 
2. Examine the relationships between different PTSD symptom domains, 
pain outcomes (pain intensity and pain disability) and pain beliefs 
(pain-related catastrophizing). 
3.  Examine the longitudinal relationships between PTSD and chronic 
musculoskeletal pain. 
 This study will test a number of hypotheses that may be implicated by 
various theories. It is not, however, intended to test or validate any specific 
conceptual model or theory. 
 
Study Methodology 
This study uses data from the ESCAPE trial. To evaluate the effectiveness 
of the stepped care intervention, the ESCAPE trial measured a comprehensive 
set of relevant outcomes and key variables at baseline as well as 3-, 6-, and 9-
months after baseline. For our study,  we are most interested in those variables 
related to 1) pain severity; 2) pain disability; 3) PTSD symptoms; 4) pain beliefs 
(pain-related catastrophizing), each of which may play a role in helping us better 
understand the relationship between PTSD and pain and the underlying 
mechanisms that explain this relationship.  
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Various statistical methods, including factor analysis, structural equation 
modeling and multivariate regression models will be used to examine the 
relationships and mechanisms hypothesized by various conceptual models. 
 
Study Rationale and Significance 
PTSD and chronic musculoskeletal pain are very common among 
veterans and cost billions of dollars each year in medical treatment and lost 
productivity.  PTSD and chronic musculoskeletal pain frequently co-occur among 
veterans seeking treatment of either condition alone. Patients with both PTSD 
and chronic musculoskeletal pain are often more difficult to treat, utilize more 
heath services, and suffer more distress and lower quality of life. 
Despite the high comorbidity and negative impact of these two conditions, 
there have been relatively few studies investigating their longitudinal 
relationships. Several studies have attempted to examine the Mutual 
Maintenance model empirically. So far the results are incomplete and 
inconclusive due to 1) limited pain conditions studied: oral/facial pain e.g., no 
musculoskeletal pain; 2) limited trauma type: car accident, intimate partner 
violence, no combat injuries; 3) few longitudinal studies; 4) lack of control for 
confounding variables in most studies such as sleep quality, anxiety sensitivity, 
and attentional biases; 5) use of a single-factor rather than multi-factor model for 
PTSD symptoms ; 6) various competing and plausible models such as Shared 
Vulnerability model and Perpetual Avoidance model making it hard to determine 
which one represents the true relationships based on existing evidence. 
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This study will help improve our understanding of the relationship of PTSD 
and chronic pain, especially musculoskeletal pain, by analyzing a comprehensive 
set of data collected as part of a randomized controlled clinical trial. A better 
understanding of this relationship may help us develop a more effective 
assessments and treatment protocols when the two disorders co-occur. 
Clinically, a failure to appreciate the intricacies of co-occurring PTSD and chronic 
pain may result in reduced treatment efficacy and continuing negative outcomes 
(Asmundson, Coons et al. 2002). 
 
Study Assumptions 
This study is based on the assumption that PTSD symptoms are 
significantly associated with chronic musculoskeletal pain symptoms, including 
pain severity and life interference due to pain, and other psychiatric symptoms. 
The pain severity, interference, pain related disabilities, cognitive, physical and 
social functions and quality of life are worse among patients with  comorbid 
chronic musculoskeletal pain and PTSD than among patients with chronic 
musculoskeletal pain only. The pain severity and other related outcomes are 
positively correlated with the severity of PTSD symptoms. After 9 months of 
treatment, the baseline PTSD symptoms and other factors can predict pain 
severity.  
This study also assumes PTSD and chronic musculoskeletal pain may 
have a mutual maintenance relationship through various mechanisms. For 
example, the pain perception and catastrophic cognitions may be exacerbated by 
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PTSD symptoms such as hyperarousal or re-experiencing symptoms. 
Meanwhile, the sensation of pain may be a reminder of trauma experience for 
PTSD patients, resulting in increased PTSD symptoms. In addition, PTSD 
symptoms may exert their influence on chronic musculoskeletal pain severity 
through generalized anxiety or depression. 
 
Summary 
PTSD and chronic musculoskeletal pain frequently co-occur and may be 
related in some way. Several theories and models have been published to 
explain this relationship. This study aims to test a number of hypotheses 
empirically that may be implied by these models using data collected from a 
longitudinal study. A better understanding of the relationship between PTSD and 
chronic musculoskeletal pain may help us develop more effective assessments 
and treatment protocols when the two disorders co-occur.  
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Chapter II: Review of the Literature 
Overview 
According to the National Comorbidity Survey Replication (NCS-R) 
conducted between 2001 and 2003, PSTD is the 5th most common psychiatric 
disease in the United States with a lifetime prevalence of 6.8% among adults 
(Kessler, Berglund et al. 2005). In primary care clinics, prevalence of “current” 
PTSD is 8.6% (CI, 6.9% to 10.6%) (Kroenke, Spitzer et al. 2007). Of 
Iraq/Afghanistan War veterans, approximately 13.8% have PTSD (Tanielian 
2008), more than double the rate in the general adult population. In addition, 
PTSD is significantly associated with other physical health problems including 
chronic pain conditions, as well as suicide attempts, poor quality of life, and 
short- and long-term disability (Sareen, Cox et al. 2007).  
Chronic pain and PTSD frequently co-occur partly because several of the 
more common causes of chronic pain involve traumatic events such as motor 
vehicle accidents and work-related incidents (Sharp 2004). Besides, chronic pain 
especially musculoskeletal pain, and PTSD often share common symptoms, 
comorbidity, and risk factors (Asmundson, Coons et al. 2002). In fact, high 
comorbidity has been found among low back pain, fibromyalgia, and PTSD, 
which seems to suggest a common etiology (Schur, Afari et al. 2007).  
Several narrative reviews (Asmundson, Coons et al. 2002; Otis, Keane et 
al. 2003; Sharp 2004; Sharp and Keefe 2006; Asmundson and Katz 2009) and 
one systematic review (Tobias Moeller-Berrtram 2011) have discussed the 
comorbidity of PTSD and chronic pain.  These reviews support the following 
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general findings: 1) PTSD and chronic pain frequently co-occur (Asmundson, 
Coons et al. 2002; Otis, Keane et al. 2003; Asmundson and Katz 2009; Tobias 
Moeller-Berrtram 2011); 2) The prevalence of PTSD in the chronic pain 
population is higher than the general population (Asmundson, Coons et al. 2002; 
Otis, Keane et al. 2003; Sharp 2004; Sharp and Keefe 2006; Asmundson and 
Katz 2009; Tobias Moeller-Berrtram 2011); 3) The prevalence of chronic pain in 
the PTSD population, especially among veterans, is higher than the general 
population (Otis, Keane et al. 2003; Asmundson and Katz 2009; Tobias Moeller-
Berrtram 2011); 4) The comorbidity of PTSD and chronic pain often increase the 
symptom severity of either condition (Otis, Keane et al. 2003).  
The high comorbidity suggests PTSD and chronic pain are likely related. A 
number of theories have been proposed to explain this relationship, including the 
Mutual Maintenance Model (Sharp and Harvey 2001), the Shared Vulnerability 
Model (Asmundson, Coons et al. 2002), and the Perpetual Avoidance Model 
(Liedl and Knaevelsrud 2008), to name just a few. Meanwhile, a small but 
growing number of studies have examined the relationships of PTSD and chronic 
pain, and validated the above theoretical models.   
 This chapter will review the following topics: 1) prevalence of chronic pain 
in PTSD cohorts and vice versa; 2) influence of PTSD on chronic pain and vice 
versa; 3) conceptual models explaining the relationship between PTSD and 
chronic pain; 4) treatment of patients with both PTSD and chronic pain. Previous 
reviews will serve as the foundation of this dissertation research, which aims to 
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further examine the relationship between PTSD and chronic pain using empirical 
data collected from a randomized controlled clinical trial in a primary care setting. 
 
Prevalence of Chronic Pain in PTSD 
Pain is among the most commonly reported physical symptom in 
individuals with PTSD, especially among U.S. veterans (Tobias Moeller-Berrtram 
2011). Beckham et al. found the prevalence of chronic pain to be as high as 80% 
among 129 consecutive out-patient combat veterans with PTSD (Beckham, 
Crawford et al. 1997). Shipherd et al. reported that two-thirds (66%) of the 
Veteran Affairs (VA) patients with PTSD had a chronic pain diagnoses prior to 
mental health treatment for their PTSD (Shipherd, Keyes et al. 2007). In a 
sample of Croatian war veterans, headache was experienced by 63.8% of the 
subjects with PTSD, facial pain by 12.8%, and pain in the region of the jaw by 
10.6%, suggesting that PTSD patients are at increased risk for the development 
of temporomandibular disorder symptoms (Uhac, Kovac et al. 2006). White et al 
found that over a four-year period for 543 veteran inpatients treated for PTSD, 
25% developed some type of musculoskeletal problem frequently accompanied 
by pain (White and Faustman 1989). 
Compared to patients without PTSD,  patients with PTSD have 
significantly higher odds of pain (Odds ratio (OR) ranging from 2.1 to 9.7) (Lowe, 
Kroenke et al. 2011), psychiatric comorbidity such as depression, anxiety, panic 
disorder and substance abuse, as well as several physical health problems 
including cardiovascular, respiratory, musculoskeletal, neurological, 
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gastrointestinal symptoms and cancer (McFarlane, Atchison et al. 1994; 
McWilliams, Cox et al. 2003; Arguelles, Afari et al. 2006; Sareen, Cox et al. 2007; 
Sareen, Cox et al. 2007; Afari, Harder et al. 2009). One case-control study 
conducted among adolescent girls with a PTSD diagnosis showed that 
musculoskeletal disorders were significantly associated with both “simple” (no 
associated psychiatric disorders, OR=2.3) and “complex” (complicated by a 
dissociative disorder or borderline personality disorder, OR=5.6) PTSD, while 
fibromyalgia was only significantly associated with complex PTSD (OR=8.0). 
(Seng, Graham-Bermann et al. 2005). 
In addition, Arguelles et al. found PTSD symptoms were significantly 
linked to wide spread pain among a community-based sample of twins (OR=3.5). 
In a sample of care-seeking Gulf War veterans, patients with PTSD had the 
highest comorbid symptom count independent of demographic characteristics, 
veteran-reported environmental exposures, and comorbid medical conditions 
(Engel, Liu et al. 2000).  
The combination of pain with PTSD is often present in persons exposed to 
multiple war traumatic experiences and more psychosocial problems 
(Avdibegovic, Delic et al. 2010). Several studies suggest that depression, anxiety 
or substance abuse may either moderate or mediate the effect on the PTSD-
chronic pain relationship (Roy-Byrne, Smith et al. 2004; Jakupcak, Osborne et al. 
2006). 
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Prevalence of PTSD in Chronic Pain 
Over the last 25 years multiple studies have reported the high prevalence 
of PTSD in patients with chronic pain. Most data on PTSD and chronic pain co-
occurrence come from studies examining the prevalence of psychiatric disorders 
in samples that report chronic pain, e.g. community dwellers with chronic arthritic 
pain and low back pain. The prevalence of anxiety disorders including PTSD is 
higher than that of all types of mood disorders in the chronic pain population 
sampled (Sharp and Keefe 2006). 
Table 2.1 (Appendix B) lists 17 studies of patients with various types of 
chronic pain in various care settings. The prevalence rates for PTSD varied 
considerably depending on the sample studied and the nature of the pain 
complaint, ranging from 6.5% among patients with migraine to 64% among 
patients with general headache. Five studies examined patients with 
fibromyalgia, with a 28.6% average prevalence of PTSD.  
Table 2.2 (Appendix C) lists 5 studies that compared the prevalence of 
PTSD among patients with and without chronic pain. Three studies reported an 
odds ratio greater than 3. The other two studies found the prevalence of PTSD 
was significantly greater among patients with chronic pain than without. In 
particular, individuals with fibromyalgia were 5 times more likely to have PTSD 
than persons without fibromyalgia. Additional data from the National Comorbidity 
Study indicated that patients with musculoskeletal pain were 4 times more likely 
to develop PTSD than are those without musculoskeletal pain (Asmundson, 
Coons et al. 2002).  
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Relationship between pain and PTSD symptom severity 
Table 2.3 (Appendix D) lists several studies that examined the relationship 
between pain and PTSD symptom severity. These relationships can be 
summarized into the following findings.  
Higher pain severity correlates positively with higher PTSD symptom 
severity: Higher levels of pain severity are associated with higher levels of PTSD 
symptoms in cross-sectional studies (Humphreys, Cooper et al. 2010). Pain 
severity also predicts PTSD symptoms severity in longitudinal studies (Glynn, 
Shetty et al. 2007; Whitehead, Perkins-Porras et al. 2006; Sullivan, Thibault et al. 
2009).   
Pain persistence and relationship to PTSD severity: At least two 
prospective cohort studies concluded that chronic or persistent pain may predict 
more severe PTSD symptoms (Bonin, Norton et al. 2000; Chossegros, Hours et 
al. 2011). 
Pain related cognitions are associated with increased PTSD severity and 
persistence: pain catastrophizing and pain related anxiety are associated with 
more severe PTSD symptoms, and pain catastrophizing predicted the 
persistence of PTSD (Van Loey, Maas et al. 2003; Sullivan, Thibault et al. 2009).   
Greater pain and more severe PTSD symptoms are related to more 
disability: A study using structural equation modeling analytics examined the 
relationship between PTSD symptoms, pain severity, and perceived life control 
among people with motor vehicle accident caused pain.  The investigators found 
more severe PTSD symptoms and greater pain complaints were related to 
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psychosocial impairment. However, only pain, but not PTSD was significantly 
related to impairment in physical functioning (Palyo and Beck 2005). Another 
study found pain and PTSD symptoms were frequent and disabling factors after 
orthopedic trauma (Ponsford, Hill et al. 2008). Patients with fibromyalgia 
syndrome and PTSD reported greater pain, lower quality of life, higher functional 
impairment and suffered more psychological distress than patients with PTSD 
without fibromyalgia syndrome (Amir, Kaplan et al. 1997).  
 
Relationship between PTSD, pain severity, interference with activities, and 
disability 
 Several studies have identified PTSD as a risk factor for chronic pain 
(Miro, Nieto et al. 2008; Jenewein, Moergeli et al. 2009), for the transition from 
acute to chronic pain (Kongsted, Bendix et al. 2008; Shaw, Means-Christensen 
et al. 2010), and for the subsequent development of chronic widespread pain 
(Ang, Peloso et al. 2006).  
PTSD is associated with  increased pain severity (De Leeuw, Bertoli et al. 
2005; Williams, Newman et al. 2009) and pain disability (Katz, Asmundson et al. 
2009; Peterlin, Tietjen et al. 2009)(Burris, Cyders et al. 2009)(Corry, Klick et al. 
2010). Furthermore, PTSD increases the likelihood of transitioning from sub-
acute to chronic back pain (Shaw, Means-Christensen et al. 2010). Meanwhile, 
peritraumatic pain was found to increase the risk of PTSD (Norman, Stein et al. 
2008). 
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PTSD symptom severity mediates the relationships between chronic pain 
severity and the severity of both child abuse and assaultive intimate partner 
violence (Wuest, Ford-Gilboe et al. 2009). PTSD also mediates the relationship 
between chronic pain severity and depression, functional adjustment, and 
satisfaction with life (Bryant, Marosszeky et al. 1999).  
Several studies report  that PTSD symptoms exert their influence on pain 
severity through other factors such as depression, anxiety, substance abuse and 
sleep quality (Burris, Cyders et al. 2009) (Roy-Byrne, Smith et al. 2004); 
Jakupcak, Osborne et al. 2006). 
 
Conceptual models 
Despite a large body of research documenting elevated rates of PTSD in 
patients with chronic pain, elevated rates of chronic pain in patients with PTSD, 
and the frequent comorbidity of chronic pain and PTSD across different 
populations, it remains unclear whether there is a causal relationship between 
PTSD and chronic pain. As Asmundson et al noted (Asmundson, Coons et al. 
2002), for any 2 variables (or conditions), possible relations are as follows: 1) 
they co-occur but are unrelated, 2) one causes the other (that is, PTSD causes 
pain, or vice versa), 3) each influences the other in some way (for example, 
chronic pain exacerbates symptoms of PTSD, or vice versa), or 4) some third 
factor (for example, a genetic predisposition) causes both. Fishbain et al. 
(Fishbain, Cutler et al. 1997) discussed five major hypotheses concerning the 
relationship of depression and chronic pain, some of which may be applied to the 
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relationship of PTSD and chronic pain as well. These categories include 1) 
antecedent hypothesis—depression precedes the development of chronic pain 
(i.e. depression causes pain); 2) consequence hypothesis—depression is a 
consequence and follows the development of pain (i.e. pain causes depression); 
3) scar hypothesis—episodes of depression occurring before the onset of pain 
predispose an individual to a depressive episode after pain onset (i.e. pain and 
pre-pain depression causes post-pain depression); 4) cognitive behavioral 
mediation hypothesis—cognitions mediate the relationship between chronic pain 
and the development of depression (i.e. pain and depression co-occur but are 
not directly-related); and 5) common pathogenetic mechanisms hypothesis (i.e. 
some third factor causes both pain and depression). 
 Various hypothesis and conceptual models have also been proposed to 
explain the relationships between chronic pain and PTSD. These models can 
generally be classified into three classes: 1) mutual maintenance class (i.e. 
PTSD and chronic pain have a mutual maintenance relationship); 2) shared 
vulnerability class (i.e. PTSD and chronic pain share the same pre-existing risk 
factors); and 3) shared pathway class (i.e. PTSD and chronic pain share the 
same after-trauma pathway). Table 2.4 (Appendix F) lists the major points of 
seven of these models, along with their classifications and brief comments from 
the dissertation author.  
 In general, most of these models follow the cognitive behavioral mediation 
hypothesis (e.g. mutual maintenance model and fear-avoidance model), or 
common pathogenetic mechanisms hypothesis (e.g. shared vulnerability model 
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and triple vulnerability model). Some of these models were originally developed 
to explain the cause of chronic pain and were subsequently applied to explain the 
relationship between PTSD and chronic pain (e.g. fear-avoidance model and 
Diathesis-stress model).  
 The Fear Avoidance Model assumes activity or cognitive avoidance due to 
fear of pain or fear of traumatic experience is the common cause of prolonged 
PTSD and chronic pain. Two other models, the Shared Vulnerability and the 
Triple Vulnerability model, also focus on the common causes of PTSD and 
chronic pain, and assume there are pre-existing factors (e.g. the single anxiety 
sensitivity factor as stated in the Shared Vulnerability model, or multiple 
biological, generalized psychological and specific psychological factors as stated 
in the Triple Vulnerability model) that contribute to the development of both 
disorders. The pre-disposing vulnerability hypothesis is also an important part of 
the stress system dysregulation model and the diathesis-stress model. 
The Mutual Maintenance Model and the Perpetual Avoidance Model both focus 
on the interaction of PTSD symptoms and chronic pain symptoms, and 
hypothesize that PTSD and chronic pain have a mutual maintaining relationship 
either through seven identifiable psychological, cognitive and behavioral 
mechanisms as stated in the Mutual Maintenance Model (Figure 2.1), or through 
the interaction of the so-called PTSD (symptom) circle and chronic pain 
(symptom) circle as stated in the Perpetual Avoidance Model (Figure 2.2). The 
Mutual Maintenance Model is more comprehensive than the Perpetual 
Avoidance Model, as it involves not only the interaction of shared symptoms 
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between PTSD and chronic pain, but also the influence of possible depression 
and anxiety, two of the most common psychological disorders among PTSD and 
chronic pain patients, as well as the distress and disability factors, through which 
the seven mechanisms exert additional influence on both PTSD and chronic 
pain. As a result, the Mutual Maintenance Model has received significant 
attention and has been (partially) validated in several studies.  
Figure 2.1: The Mutual Maintenance Model (Sharp and Harvey 2001) 
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Figure 2.2: The Perpetual Avoidance Model (Liedl and Knaevelsrud 2008) 
 
 
The Stress System Dysregulation Model emphasizes the key role of a 
vulnerable human stress response system, a biological mechanism, to the 
development of both PTSD and chronic pain (Figure 2.3), and hypothesizes there 
is a causal relationship between abnormal stress response system and 
psychological and cognitive factors that exacerbate PTSD and chronic pain 
symptoms. Multiple mechanisms have been proposed by which abnormal stress 
system function during or after a stressor might increase the risk of both PTSD 
and chronic pain development by disrupting the neurobiological processes which 
orchestrate an adaptive stress response (McLean, Clauw et al. 2005). 
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Figure 2.3: The Stress System Dysregulation Model (McLean, Clauw et al. 
2005) 
 
 
 The Diathesis-Stress Model emphasizes the interaction of pre- and post-
traumatic cognitive behavioral factors and the exposure to a trauma (Figure 2.4). 
In particular, the following factors are included within the original model: anxiety 
sensitivity, anticipation of pain, catastrophizing, attributions about the causes of 
the symptoms, worries about the future, self-efficacy, fear-avoidance beliefs and 
operant conditioning (e.g. inactivity due to pain may be positively reinforced by 
attention from a spouse or health care provider). Martin A, Halket E, et al further 
extended this model by including posttraumatic stress symptoms (PTSS) within it 
and found pain intensity accounted for 15% of the variance in PTSS and PTSS 
had a large effect on pain disability, accounting for 45% of the variance.  
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Figure 2.4: The Diathesis-Stress Model (Turk 2002) 
 
 It is worth noting that disability is included in three of these models: mutual 
maintenance model, stress system dysregulation model and diathesis-stress 
model. In the mutual maintenance model, disability, together with distress and 
other cognitive behavioral factors, mediates the interaction between PTSD and 
chronic pain. In the stress system dysregulation model, disability lies within the 
circle of pain experience, pain catastrophizing, pain-related fear, behavioral and 
psychological avoidance, and disuse/depression/disability, and influences (and is 
influenced by) the stress response system, whose dysregulation  may be the 
cause of both chronic pain and PTSD. In the (extended) diathesis-stress model, 
there is a feedback loop between disability and fear of pain, through which PTSD 
symptoms may have an influence on chronic pain. 
 All of the above models are supported from empirical studies. Some of 
these studies are cross-sectional and thus cannot provide information on the 
relative timing of pain and PTSD symptoms onset. Some are longitudinal, which 
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are better designed to explore the causal relationships among PTSD, chronic 
pain and other cognitive behavioral factors. All of the above models have found 
support from empirical studies. For example, there are longitudinal studies that 
confirmed a mutual maintaining relationship between pain and PTSD 
(Ramchand, Marshall et al. 2008; Zatzick, Jurkovich et al. 2008; Jenewein, 
Wittmann et al. 2009; Liedl, O'Donnell et al. 2010), or a unidirectional impact of 
PTSD on pain (Tsao, Dobalian et al. 2004; Jenewein, Wittmann et al. 2009; Katz, 
Asmundson et al. 2009), or vice versa (McGhee, Slater et al. 2011).  A recent 
study by Sterling et al. (Sterling, Kenardy et al. 2003)found that PTSD symptoms 
after a motor vehicle collision (MVC) predicted whiplash severity at 6 months. 
Another study found vulnerability to develop PTSD after MVC may also predict 
the development of fibromyalgia (McLean, Clauw et al. 2005). 
 Several studies used structural equation modeling or cross panel analysis 
to investigate the longitudinal relationships (Schell, Marshall et al. 2004; 
Marshall, Schell et al. 2006; Ramchand, Marshall et al. 2008; Jenewein, 
Wittmann et al. 2009). One notable example is a recent study that found two 
four-factor models of PTSD symptom clusters that fitted the data reasonably well, 
and different PTSD symptom clusters predicted different components of pain 
(Cyders, Burris et al. 2010). One of the four-factor models contained the re-
experiencing, avoidance, numbing and hyperarousal factors. The other model 
contained the re-experiencing, avoidance, dysphoria and hyperarousal factors 
with different factor loadings in the third and fourth factors. Hierarchical 
regression models have also been used to examine the relationship between 
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PTSD symptom clusters and pain (Clapp, Beck et al. 2008). Yet no randomized 
controlled studies have been found to test the causal relationship of PTSD and 
chronic pain.  
In summary, available evidence tends to support that pain and PTSD are closely 
associated, PTSD contributes to increased pain severity, and increased pain 
severity contributes to increased PTSD prevalence or PTSD symptom (e.g. 
arousal and/or re-experiencing) severity. 
 Several studies demonstrate that pain impacts PTSD through increased 
arousal and re-experiencing symptoms, rather than avoidance. Meanwhile, 
hyperarousal is a potent predictor of subsequent re-experiencing, avoidance and 
hyperarousal (Schell, Marshall et al. 2004; Marshall, Schell et al. 2006). On the 
other hand, avoidance is not correlated with pain (Sterling, Kenardy et al. 2003). 
This seems to contradict major conceptual models such as the Mutual 
Maintenance Model, Perpetual Vulnerability Model, and Fear Avoidance Model, 
where avoidance plays an important role in the development and maintenance of 
both PTSD and pain.  
 In addition, Asmundson et al (Asmundson, Bonin et al. 2000) using the 
multiaxial assessment of pain, found chronic pain patients differ substantially in 
their propensity to become fearful and in their likelihood to develop PTSD. A 
substantial proportion of patients classified as dysfunctional (i.e. those displaying 
higher pain severity, pain interference, elevated affective distress and fear, and 
lower activity) and interpersonally distressed (i.e. those displaying lower 
perceived social support) meet diagnostic criteria for PTSD, much more than 
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patients who are classified as minimizers/adaptive copers (i.e. those displaying 
lower pain severity, pain interference, and affective distress).  
 
Biological Models 
 Some of the conceptual models dsicussed in previous section are based 
on biological models/assumptions on the causes of PTSD and chronic pain. For 
example, both the Triple Vulnerability Model and the Diathesis-Stress model are 
based on the assumption that biological vulnerability to develop certain 
psychopathological disorder exists. And the Stress Dysregulation Model is based 
on the biological theory that abnormal stress system function during or after a 
stressor might increase the risk of PTSD development by disrupting the 
neurobiological processes which orchestrate an adaptive stress response 
through multiple mechanisms. 
 Although multiple biological models have been proposed to explain how a 
traumatic event may cause PTSD (van der Kolk, Greenberg et al. 1985) or a 
combination of both PTSD and chronic pain (McLean, Clauw et al. 2005), no 
such model (biological pathway) has been developed to explain how PTSD and 
chronic pain may exacerbate each other in a similar way as the Mutual 
Maintenance and other conceptual models have suggested. On the contrary, a 
number of studies have confirmed the theory of stress-induced analgesia (SIA) 
among PTSD patients (Pitman, van der Kolk et al. 1990; Mickleborough, Daniels 
et al. 2011).  In these studies, reduced experimental pain response was 
observed among patients with PTSD compared to patients without. The SIA 
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theory and related evidence seem to contradict with the Mutual Maintenance and 
other conceptual models that implicate an increased pain response among PTSD 
patients. 
 A recent systematic review (Tobias Moeller-Berrtram 2011) identified six 
studies that used an experimental pain assessment approach to find out how 
PTSD affects pain sensation and pain processing. The evidence presented in the 
review is inconclusive as conflicting results were reported regarding whether 
PTSD reduced or increased pain sensitivity, pain rating, and pain threshold. The 
review also presented an exploratory meta-analysis of four studies that used 
functional magnetic resonance imaging to examine the effect of PTSD on the 
sensation of experimental pain. The study found PTSD was associated with 
reduced pain sensitivity through altered neural activation patterns (Geuze, 
Westenberg et al. 2007). Specifically, there was increased activation of right 
middle insula and right dorsolateral prefrontal cortext during initial painful 
simulation (Strigo, Simmons et al. 2010).  
 Although biological models may help us better understand the nature of 
the relationships between PTSD and chronic pain, they are not going to be 
further examined in our present study. 
 
Treatment of Patients with Both PTSD and Chronic Pain 
Muse reported pain treatment had little impact on PTSD symptoms 
improvement (Muse 1986). In contrast, Hickling noted (Hickling EJ 1992) treating 
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PTSD improved pain symptoms. Yet a growing number of studies have tested an 
integrated approach to treat patients with both PTSD and chronic pain. 
For example, an integrated approach designed for veterans with comorbid 
chronic pain and PTSD using components of cognitive processing therapy (CPT) 
and conitive behavioral therapy (CBT) proved to be feasible and demonstated 
clinical benefit (Otis, Keane et al. 2009). The innovative Integrative Health Clinic 
and Program (IHCP) designed by the Veterans Affairs Health Care System is 
another successful example of using integrated, non-pharmacologic 
biopsychosocial approaches to treat chronic non-malignant pain, stress-related 
depression, anxiety and symptoms of PTSD simultaneously (Smeeding, 
Bradshaw et al. 2010). Preliminary data were presented recently on the pattern 
of treatment response of combining interoceptive exposure (IE) with trauma-
related exposure therapy (TRE) in five female patients with posttraumatic stress 
disorder (PTSD) and comorbid chronic musculoskeletal pain originating from 
motor vehicle accidents (Wald, Taylor et al. 2010).  
Biofeedback supported cognitive behavioral therapy was also used to 
address both pain and PTSD among victims of war and toture in a pilot study 
(Knaevelsrud, Wagner et al. 2007). A randomized controlled study was published 
recently demonstrating the effectiveness of the above therapy (Liedl, Muller et al. 
2011). Another study indicated that pain rehabilitation programs which provide 
directed interventions for PTSD symptoms among chronic pain patients with 
accident-related pain improved pain treatment outcomes (Roth, Geisser et al. 
2008). 
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 Kulich et al reviewed treatment outcomes with comorbid pain and PTSD 
and noted that tailored cognitive or pharmacologic interventions based on 
individual differences in their symptoms and deficit areas were critical. It is often 
difficult to make decisions in terms of phamacologic choices due to complicatons 
of concurrent psychotherapeutic interventions, and the possibility of other 
comorbid diagnoses such as concurrent substance abuse and chronic pain 
(Kulich, Mencher et al. 2000).  
Challenges and strategies for treating polytrauma pain and associated 
cormorbid conditions such as PTSD were outlined in another publication 
(Gironda, Clark et al. 2009). One of the most important components in treating 
traumatized patients with chronic pain should be education about the relationship 
between chronic pain and PTSD (Liedl and Knaevelsrud 2008). In addition, 
PTSD symptoms may be an important determinant of selecting a treatment 
modality for patients experiencing pain subsequent to traumatic injury (Clapp, 
Masci et al. 2010). Additional  treatment research is needed that will eventually 
lead to guidelines for patients with co-morbid pain and PTSD (Liedl, Muller et al. 
2011). 
 
Summary 
Our review of epidemiologic studies found consistent evidence that the 
prevalence of chronic pain among patients with PTSD is significantly higher than 
that among general population. Likewise, the prevalence of PTSD is increased 
among patients with chronic pain. Moreover, higher pain severity correlates with 
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higher PTSD symptom severity, and the combination of pain and PTSD is 
associated with greater disability and complicates treatment (therefore an 
integrated treatment is needed).  The high comorbidity and positive correlation of 
chronic pain and PTSD suggest that PTSD and chronic pain are related in some 
way, and a number of conceptual models have been proposed to explain this 
relationship. More studies are needed to exam the nature of this relationship 
empirically, and to validate existing conceptual models and corresponding 
hypothesis of causal relationships between PTSD, chronic pain and other 
biopsychosocial mediating factors. 
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Chapter III: Methodology 
Introduction 
As stated in Chapter I, the current study aims to answer the following 
research questions using data collected in the ESCAPE study: 1) How strong is 
the relationship between PTSD and chronic musculoskeletal pain? 2) Which 
factors mediate the relationship between PTSD and chronic musculoskeletal 
pain? 3) Do different clusters of PTSD symptoms affect chronic musculoskeletal 
pain outcomes differently? In Chapter II, we have reviewed existing theories and 
previously published studies that helped generate our hypotheses for these 
questions. In addition, our review of the literature in Chapter II summarized a 
growing number of studies that used the Structural Equation Modeling technique 
to confirm the factor structure of PTSD, and to examine the differential 
relationships of PTSD symptom domains with chronic pain outcomes (Burris, 
Cyders et al. 2009; Jenewein, Wittmann et al. 2009; Cyders, Burris et al. 2010; 
Liedl, O'Donnell et al. 2010). To our knowledge, no studies have used the 
Decision Tree technique to examine the relationship between PTSD and chronic 
pain, although this technique has drawn increasing interest over the last twenty 
years in clinical research studies.  
 
Structural Equation Modeling 
 Structural equation modeling (SEM) is a methodology for representing, 
estimating, and testing a theoretical network of (mostly) linear relations between 
observed (measured) and unobserved (latent) variables (Rigdon 1998). SEM 
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enables researchers to readily develop, estimate, and test complex multivariable 
models, as well as to study both direct and indirect effects of variables involved in 
a given model (Raykov and Marcoulides 2000). SEM differs from classical linear 
modeling techniques such as regression analysis, analysis of variance, analysis 
of covariance, and a large part of multivariate statistical methods in different 
aspects. For example, SEM includes measured variables (manifest variables) as 
well as implied variables (latent variables), allowing for a simpler and better 
fitting. In addition, SEM handles measurement errors explicitly through 
measurement model, without the assumption of no measurement error as 
required by classical statistical modeling. Finally SEM allows for simultaneous 
evaluation of complex model construct relationships, making it an ideal tool for 
researchers to test various theoretical models in social and life sciences. 
Confirmatory factor analysis and path analysis are two of the most 
common SEM techniques used for cross-sectional data analysis, and have been 
used to examine the relationship between PTSD and chronic pain in several 
studies. For example, Cyder et al. used confirmatory factor analysis to compare 
five PTSD symptom domain models and concluded the two four-factor models fit 
their data best (Cyders, Burris et al. 2010). This result is consistent with a similar 
analysis by Asmundson et al (Asmundson, Coons et al. 2002). Asmundson et al 
found a 4-factor inter-correlated PTSD domain model fit the data significantly 
better than the hierarchical 2- or 3-factor model. Furthermore the factor loadings 
differed between groups of patients with and without chronic pain. Following the 
confirmatory analysis, a path analysis was conducted to examine the differential 
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relationships of those domains with chronic pain outcomes (Cyders, Burris et al. 
2010). The influence of PTSD symptoms on pain-related disability 
(Multidimensional Pain Inventory pain interference subscale), partially mediated 
through depression and general activity levels (MPI general activity level 
subscale), was found to be uniquely a function of avoidance, numbing, and 
dysphoria, not re-experiencing or hyperarousal symptoms. In particular, it was 
found avoidance influenced pain-related disability directly, and indirectly through 
the mediation of general activity levels, and numbing and dysphoria influenced 
disability indirectly only through the mediation of depression. Alternatively, the 
influence of PTSD symptoms on pain severity (MPI pain severity subscale), 
mediated through sleep quality, was found to be a function of only hyperarousal, 
not numbing, avoidance, dysphoria, or re-experiencing symptoms.  
 Cross-lagged panel analysis is one of the most popular SEM techniques 
for longitudinal data analysis, and has been used in several studies to examine 
the causal relationship between chronic pain and PTSD (Schell, Marshall et al. 
2004; Marshall, Schell et al. 2006; Ramchand, Marshall et al. 2008; Jenewein, 
Wittmann et al. 2009). Analysis of panel data has been recognized for its 
advantages in testing for causal effects because it can provide evidence 
regarding all three conditions of causality: covariation of the 2 variables, time 
precedence of the causal variable, and nonspuriousness (i.e., the association of 
the 2 variables must not be produced by a joint association with a third variable 
or set of variables) (Finkel 1995). It is worth noting that the cross-lagged 
approach investigates causality in the absence of a randomized experimental 
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design. Instead of addressing the traditional causal question of whether X causes 
Y", the cross-lagged analysis examines which is the predominant cause-effect 
direction. As such, it should be viewed as an indicator of temporal precedence, 
and not as proof of causation.(Anderson 1982). The minimal cross-lagged panel 
design involves two variables measured at two separate times. Multiple 
regression analyses in which the time two measures are regressed on the time 
one measures can also be used to analyze data.  However, SEM is better suited 
for simultaneous evaluation of causality among model constructs without 
imposing the strict assumptions (e.g. no measurement error) required by 
traditional regression analysis. 
Generally, the maximum likelihood estimation will be used in Structural 
equation modeling (SEM).  The overall fit of a model will be assessed by various 
indices. These indices can be categorized into three categories 1) absolute fit 
indices (a measure of how well the model fits in comparison to no model at all), 
including Chi-Squared test (χ2), root mean square error of approximation 
(RMSEA), goodness-of-fit statistic (GFI), adjusted goodness-of-fit statistic 
(AGFI), root mean square residual (RMR) and standardized root mean square 
residual (SRMR);  2) Incremental fit indices (a measure of how well the model fits 
in comparison with a baseline model where the null hypothesis is that all 
variables are uncorrelated), including normed-fit index (NFI) and comparative fit 
index (CFI); and 3) Parsimony fit indices (a measure of how much a model differs 
from a saturated, complex model that is tied to sample data only), including the 
parsimony goodness-of-fit index (PGFI) and the parsimonious normed fit index 
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(PNFI). The most commonly applied fit indices to date are NNFI and CFI (>0.90 
indicates good fit), RMSEA (<0.08 indicates acceptable fit), and relative χ2 
statistic (χ2 / d.f. ratio of 3 or less), which tend to meet the following criteria 
proposed by Marsh, Balla and McDonald (Marsh 1988): relative independence of 
sample size, accuracy and consistency to assess different models, and ease of 
interpretation aided by a well defined pre-set range.   
 
CART Analysis 
One of the most widely used nonparametric decision tree techniques is 
the classification and regression tree (CART) analysis. In CART analysis, a set of 
rules is developed for dividing a large heterogeneous population into smaller, 
more homogeneous groups with respect to a particular target variable. It is 
ideally suited to generate clinical decision rules, and also provides an effective 
way to reveal important data relationships that may remain hidden using 
traditional analytical tools. For example, CART analysis has been used in tailored 
therapy studies to identify subgroups of patients who may react more favorably to 
certain treatments (Foster, Taylor et al. 2011; Ruberg, Chen et al. 2011).   It has 
also been identified as a promising research tool to identify at-risk populations in 
public health research and outreach (Lemon, Roy et al. 2003; Louie, Tektonidou 
et al. 2011). Although CART analysis has not been used in studies on PTSD, it 
has been used in studies on chronic pain. For example, CART analysis was used 
to determine what level of early pain improvement best predicted later response 
to duloxetine treatment for fibromyalgia pain. (Fulton-Kehoe, Stover et al. 2008; 
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Wang, Ruberg et al. 2011). Using CART analysis, another study found pain 
interference and radiating leg pain comprised the best predictive model of work 
disability status 1 year after claim submission (Fulton-Kehoe, Stover et al. 2008). 
 
Design of the ESCAPE Study 
 The study population consists of 242 OEF/OIF (Operation Enduring 
Freedom/Operation Iraqi Freedom) veterans with moderate musculoskeletal pain 
of the spine and extremities. Participants were enrolled from the Roudebush 
Veterans Administration Medical Center (RVAMC) outpatient clinics. Willing 
patients underwent an eligibility interview and those who met entry criteria and 
provided informed consent were enrolled.  
 Potential participants were identified by querying CPRS to create a master 
list of OEF/OIF veterans who had at least moderate pain intensity (pain score ≥ 
4) according to the pain scale (“0” no pain to “10” worst pain imaginable) routinely 
measured in VA outpatient clinics within the preceding 6 months. Potential 
participants were then contacted by phone to assess eligibility and determine 
their interest in participating. If the veteran was eligible, verbal consent were 
obtained from those who desired to participate. An informed consent statement 
and HIPPA authorization were mailed to the patient with a pre-addressed, 
postage paid return envelope (with phone reminders if not returned). Additional 
patients were consented in person prior to the baseline interview.      
Participants were randomized to stepped care or usual care (N= 121 each 
group). The stepped care intervention consisted of optimizing analgesic and 
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adjuvant treatment coupled with a 12 week pain self-management program 
(PSMP) for step 1. Step 2 consisted of 12 weeks of brief cognitive behavioral 
therapy (CBT). Interviewers blinded to the study hypotheses and treatment 
assignments conducted outcome assessments at baseline, 3, 6, and 9 months.  
 
Sample Selection 
OIF/OEF veterans were eligible if they met all of the following criteria 
summarized in Table 3.1.  
Table 3.1: Eligibility criteria 
Inclusion Exclusion* 
• Musculoskeletal pain of low back, 
cervical spine, or extremities (hip, 
knee, or shoulder) 
• Severe medical conditions that 
would limit participation (e.g. Class 
III or IV heart failure) 
• Pain for 3 months or longer • Active psychosis 
• Moderate functional impairment 
defined as Roland Disability Score ≥ 
7 
• Incompetent for interview (per 
patient’s physician or research 
assistant) 
• Access to working telephone • Severe impairment of hearing or 
speech 
• Willing to travel at least once to 
study sites 
• Active suicidal ideation 
• Diagnosis of schizophrenia 
 • Prior back surgery or surgery 
pending 
 • Current alcohol (substance) 
dependence 
 • Pregnant or trying to become 
pregnant 
 
* Access to a telephone is required because both the intervention and outcome assessments will 
be conducted via phone   
* Exclusion criteria are designed to eliminate potential participants for whom the proposed 
interventions are inappropriate and/or for whom there may be disincentives for improvement. 
Most data to apply these 
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Data Collection 
A comprehensive set of relevant outcomes and key variables were 
measured and timing of assessment is listed in Table 3.2. The baseline interview 
lasted approximately one hour; the 3 month interviews about 30 minutes, and the 
6 and 9 month interviews about 45 minutes. Baseline patient characteristics 
included sociodemographics, work status, comorbid medical and psychiatric 
disorders, and prior treatments for pain. All study participants included received 
PTSD screening at baseline. Those who screened positive for PTSD were further 
assessed by the PCL-17 to evaluate PTSD severity at baseline and 9 months. 
Pain severity was evaluated at baseline, 1, 3, 6 and 9 months.  A PCL-C total 
score of 41 is considered a valid clinical cutoff for defining whether a patient’s 
symptoms are consistent with a DSM-IV diagnosis of PTSD (Sherman, Carlson 
et al. 2005). 
Table 3.2: ESCAPE outcome assessment protocol:  measures and 
administration timing  
 
Domain No Measure  Items 
  Schedule (month) 
BL 3 
 
6  9  
Demographics 1 
age, race, sex, 
education, marital, job 
status, income 
7 X    
Military 2 Duty, branch, deployment 3 X    
Medical 
comorbidity 3 9 diseases 9 X    
Pain related 
disability 
4 Roland Disability Scale 24 X X X X 
5 Brief Pain Inventory 7 X X X X 
Pain severity 
6 GCPS  8 X X X X 
7 Pain treatment and relief 2 X    
8 Bodily Pain scale of SF-36 † X X  X 
Work function 9 Work effectiveness item 1 X    
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10 Work productivity scale 7 X    
Generic health-
related quality of 
life (HRQL) 
11 SF-36v2 36 X X  X 
12 EQ-5D 5 X    
Pain Beliefs 
13 Pain Catastrophizing scale 13 X    
14 Arthritis self-efficacy scale 6 X X  X 
15 Pain Centrality Scale 12 X    
Depression 16 PHQ-9 9 X    
Anxiety 17 
GAD-7 (7), Social Anx 
(3) Panic (1 5) PTSD 
(1) 
13 X X  X 
PTSD 18 PTSD screener 4 X    19 PCL-Checklist 17 X    
Alcohol use 20 Audit 10 10 X    
Somatization 21 PHQ-somatic (12 items) 12 X X  X 
Stressors 22 PHQ stressor scale 9 X X  X 
Cognitive function 23 Sickness Illness Profile 7 X    
Social function and 
integration 24 
Social Provisions 
Scale 8 X    
Deployment 
exposure 25 
Deployment Stress 
Questionnaire 33 X    
Physical activity 26 IPAC 7 X    
Occupational  27 COPM 18 X   X 
 
PTSD diagnosis and severity are measured by PCL-17. Pain severity and 
pain-related disability are measured by GCPS. Other psychological symptoms 
measured include depression (PHQ-9), anxiety (GAD-7), stressors (PHQ 
stressor score), and pain beliefs (Pain Catastrophizing scale, Pain Centrality 
Scale, and Arthritis self-efficacy scale). These instruments will be used in our 
current analysis and will be discussed further in the next section.  
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Instrumentation 
PCL-17 
 The PCL-17 is derived from DSM III-R criteria for PTSD, and is used for 
diagnosis and as a severity measure. The PCL-17 has demonstrated adequate 
test–retest reliability (r=.96), internal consistency (coefficient alpha: 
r=.92),(Blanchard, Jones-Alexander et al. 1996) and sensitivity and specificity > 
70%.(Stamm 1996) The PCL-17 is a 17-item, clinician-rated instrument of PTSD 
symptoms (each item scored from 0 = not at all to 4 = extremely, total score 
ranging from 0 to 68). A PCL-17 total score of ≥41 is considered a valid cutoff for 
determining whether patient symptoms are consistent with a clinical diagnosis of 
PTSD. (Sherman, Carlson et al. 2005). We assume patients who screened 
negative for PTSD had a PCL-17 total score <41 even though their PCL-17 total 
scores were not measured in ESCAPE trial. 
 
GCPS 
 The Graded Chronic Pain Scale (GCPS) is a brief 7-item scale that rates 
global severity of chronic pain in two domains: intensity and disability (Von Korff, 
Dworkin et al. 1990). Rich normative data exists for the GCPS. Based on the 
combination of pain intensity, disability score and disability days, pain severity 
can be classified into 5 categories (table 3.3).  (Von Korff, Ormel et al. 1992; Von 
Korff, Deyo et al. 1993; Smith, Penny et al. 1997) 
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Table 3.3: Summary of pain grade categories 
Grade  Findings  Type Outcome 
0 no pain problems for the prior 
6 months  pain free  Good 
I 
characteristic pain intensity < 
50  
disability points < 3  
low disability low 
intensity  Good 
II 
characteristic pain intensity 
>= 50  
disability points < 3  
low disability high 
intensity  Fair 
III disability points 3 or 4  
 
high disability 
moderately limiting  Poor 
IV disability points 5 or 6  
 
high disability 
severely limiting  Poor 
 
 
PHQ-9 
The Patient Health Questionnaire (PHQ-9)(Kroenke, Spitzer et al. 2001) is 
a brief (9-item) measure of depression severity becoming widely used in clinical 
and research settings. 
A PHQ-9 score > or =10 was found to have a sensitivity of 88% and a 
specificity of 88% for major depression (Kroenke, Spitzer et al. 2001). The cut 
point of 10 or greater will therefore be used to classify patients with and without 
depression in our relationship modeling involving depression measurement. 
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GAD-7 
 Anxiety severity will be assessed with 7 items from the GAD-7 anxiety 
scale (0=not at all; 3=nearly every day).(Spitzer, Kroenke et al. 1999).  
 A GAD-7 score > or = 10 was found to have a sensitivity of 89% and a 
specificity of 82% for generalized anxiety disorder (GAD) (Spitzer, Kroenke et al. 
2006). The cut point of 10 or greater will therefore be used to classify patients 
with and without GAD in our relationship modeling involving GAD. 
 
Pain Catastrophizing Scale 
 Catastrophizing will be assessed with the Pain Catastrophizing Scale a 13-
item scale with three dimensions: rumination; magnification, and 
helplessness.(Osman, Barrios et al. 1997)  
 
Hypotheses 
Based on our literature review of previously published theories (primarily 
the Mutual Maintenance model)(Sharp and Harvey 2001) and studies, we posit 
the following hypotheses related to each pre-stated research objective. For clarity 
purpose, we have listed in Appendix G (table 3.5) examples of published studies 
that are found to support some of these hypotheses. 
OBJECTIVE 1: Examine the cross-sectional relationships between PTSD, 
depression, anxiety, chronic musculoskeletal pain severity, pain disability and 
quality of life using multiple regression, structural equation modeling, and 
decision tree techniques.  
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 The following hypotheses will be tested for this objective: 
1) Higher PTSD symptoms will be associated significantly with poorer 
pain-related and psychosocial outcomes. While many studies have 
found higher PTSD symptoms are associated with increased pain 
severity and pain disability as shown in Appendix G (table 3.5) (Geisser, 
Roth et al. 1996; Beckham, Crawford et al. 1997; Jenewein, Wittmann 
et al. 2009; Zatzick, Jurkovich et al. 2008), few studies have shown 
higher PTSD symptoms are also related to higher pain catastrophizing 
scores or poorer quality of life among patients with chronic pain.  
2) Higher pain severity will be associated with more severe PTSD and 
psychosocial outcomes. Only one study is found to support this 
hypothesis among formerly-abused women population (Humphreys, 
Cooper et al. 2010). Little is known about whether this association still 
exists among war veterans with no gender restriction. 
3) Besides pain severity, there are other key factors that are associated 
with PTSD. PTSD tends to be associated with multiple factors. For 
example, the Shared Vulnerability model considers anxiety sensitivity as 
a major risk factor shared by both PTSD and chronic pain (Asmundson, 
Coons et al. 2002), while the Triple Vulnerability Model considers other 
generalized biological and psychological risk factors (Otis, Keane et al. 
2003). Several studies found other risk factors of PTSD such as higher 
functional disability, higher average pain intensity, a previously 
diagnosed substance use disorder, or post-traumatic amnesia 
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(Magruder and Yeager 2008; Mak, Chu et al. 2010; Chossegros, Hours 
et al. 2011). In this dissertation, we are most interested in the 
relationship between PTSD and chronic pain, and hypothesize a clinical 
PTSD diagnosis is associated with patients whose pain severity 
exceeds a certain level (cut point). We also hypothesize clinical PTSD is 
more likely to develop in patients with comorbid depression or 
generalized anxiety. 
4) The relationship between PTSD severity and chronic musculoskeletal 
pain severity will be mediated through depression, anxiety, or pain 
catastrophizing. Moreover, PTSD and pain severity will adversely affect 
quality of life (SF-36, MCS/PCS components) independently; and 
patients with high chronic musculoskeletal pain (GCPS severity grade 
≥3) and PTSD will have worse quality of life than patients with only one 
or neither of these conditions (i.e., high chronic musculoskeletal pain or 
PTSD). This hypothesis is implied by both the Mutual Maintenance 
model and the Diathesis-Stress model. 
 OBJECTIVE 2: Examine the relationships between different PTSD 
symptom domains, pain outcomes (pain intensity and pain disability) and pain 
beliefs (pain-related catastrophizing) using confirmatory factor analysis and 
structural equation modeling techniques. 
 The following hypothesis will be tested: 
5) Different PTSD symptom domains will have differential relationships 
with chronic musculoskeletal pain outcomes, either directly, or through 
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mediating factors such as depression or general anxiety disorder. This 
hypothesis was supported by a cross-sectional study among female 
patients with orofacial pain (Cyders 2010). It is worthwhile to test this 
hypothesis in both cross-sectional and longitudinal analyses among a 
different population.  
 OBJECTIVE 3: Examine the longitudinal relationships between PTSD and 
chronic musculoskeletal pain using mixed models repeated measures and cross-
lagged panel analysis techniques.  
 The following hypothesis will be tested: 
6) Baseline PTSD domains will predict chronic musculoskeletal pain 
severity grade  at 9 months, and baseline chronic musculoskeletal pain 
severity grade  will predict PTSD domains at 9 months. This hypothesis 
is implied by the Mutual Maintenance model (Sharp and Harvey 2001), 
and was supported by several longitudinal studies (Whitehead, Perkins-
Porras et al. 2006; Glynn, Shetty et al. 2007; Jenewein, Wittmann et al. 
2009); (Ramchand, Marshall et al. 2008; Zatzick, Jurkovich et al. 2008). 
However most of these studies were conducted among civilians with 
accident related injuries in non-primary care setting. It is therefore 
valuable to test this hypothesis with ESCAPE trial data among veterans 
in primary care setting. 
7) The longitudinal change in pain severity will be predicted by PTSD at 
baseline. The PTSD at 9 months will be predicted by pain intensity and 
disability at baseline. This hypothesis is also implicated by the Mutual 
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Maintenance model but is supported by a couple of longitudinal study 
(Norman, Stein et al. 2008; Van Loey, Maas et al. 2003) in non-primary 
care setting. 
In sum, although most of the above hypotheses are supported or partially 
supported by one or more other clinical trials, none of those trials were 
conducted within a primary care setting, or designed for war veterans suffering 
from musculoskeletal pain. Besides, to our best knowledge, our present study is 
the only one to take the combination of pain intensity and pain disability (five pain 
grades) into model construction, the only one to use decision tree technique to 
explore the relationship between PTSD and chronic pain, and the only one to 
include the quality of life measures in the complex model of PTSD and chronic 
pain relationship that may be mediated or moderated through various 
psychological factors. Finally, this study is also the only one to apply various 
statistical methods to test a comprehensive list of hypotheses implicated by 
existing conceptual models and theories. A combination of all these tests and 
corresponding findings will give us a better overall picture of the direction and 
strength of the relationship between PTSD, chronic pain and other variables. 
These hypotheses will be tested by various statistical methods including 
Multiple Regression, Structural Equation Modeling, Classification and Regression 
Tree (CART) and multiple regression analysis, which will be discussed further in 
the next section. 
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Analysis 
The following analyses are proposed to test our hypotheses above.  
Baseline Data Analysis 
1) Hypothesis 1 (Higher PTSD symptoms will be associated significantly with 
poorer pain-related and psychosocial outcomes): To test this hypothesis, 
the following 3 analyses will be conducted: 
• Univariate analysis: Evaluate patients’ demographic and clinical 
outcome differences among patients with (PCL-C total score>=41) 
vs. without clinical PTSD symptoms (PTSD screening negative or 
PCL-C total score<41). T-tests (for continuous variables) and chi-
square tests (for categorical variables) will be utilized to assess 
differences. 
• Pearson correlation: To explore the relationships among multiple 
measures, Pearson correlation coefficients will be calculated. 
• Logistic regression: Demographic and clinical predictors of PTSD 
(PCL-17 total score>=41) will be determined through multiple 
logistic regression (MLR). This analysis will help us determine 
parameters included in our relationship modeling. 
2) Hypothesis 2 (Higher pain severity will be associated with more severe 
PTSD and psychosocial outcomes.): To test this hypothesis, the following 
3 analyses will be conducted: 
• Univariate analysis: Evaluate patients’ demographic and clinical 
outcome difference among patients with GCPS pain severity in (1, 
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2) and GCPS pain severity in (3, 4). 
• Pearson correlation: To explore the relationships among multiple 
measures, Pearson correlation coefficients will be calculated. 
• Logistic regression: Demographic and clinical predictors of GCPS 
pain severity will be determined through multiple logistic regression 
(MLR). 
3) Hypothesis 3 (Besides pain severity, there are other key factors that are 
associated with PTSD): The classification and regression tree (CART) 
analysis will be employed using SAS Enterprise Miner 6.1 to identify 
significant factors associated with PTSD.  CART analysis, a tree building 
technique, is able to select many possible ‘predictors’, deal with complex 
interactions between predictors, and non-normal and non-linear distributed 
clinical variables. In this analysis, the target is clinical PTSD (PCL-17 total 
score>=41). The binary recursive partitioning is accomplished by 
searching all potential predictors to best classify patients into clinically 
significant PTSD or non-clinically significant PTSD groups. The possible 
‘predictors’ include pain (severity and disability), pain beliefs, and 
psychological symptoms. 
4) Hypothesis 4 (The relationship between PTSD severity and chronic 
musculoskeletal pain severity will be mediated through depression, 
anxiety, or pain catastrophizing. Moreover PTSD and pain severity will 
adversely affect quality of life independently; and patients with high 
chronic musculoskeletal pain and PTSD will have worse quality of life than 
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patients with only one or neither of these conditions): The following 
analyses will be conducted:  
• ANCOVA analysis will be used to test the hypothesis that patients 
with GCPS pain severity ≥3 and PCL-17 total score ≥41 were 
associated with worse SF-36. 
• Structural equation modeling analysis will be conducted to test the 
hypothesis of mediating factors between PTSD (PCL-17>=41 or 
not) and chronic pain severity implicated by the Mutual 
Maintenance Model. Specifically, we will test two models. In Model 
#1, PTSD will have a direct effect on anxiety (GAD-7 total 
score>=10), and an indirect effect on pain severity through 
depression (PHQ-9 total score>=10); and pain severity will have an 
indirect effect on PTSD through pain catastrophizing (figure 3.1). 
Pain severity is classified into five categories based on the 
combination of pain intensity and pain disability (table 3.3).  In 
Model #2, PTSD will have an indirect effect on pain severity through 
pain catastrophizing and comorbid anxiety and depression (figure 
3.2). In both models, the physical health component score of the 
quality of life measure (SF-36 PCS)  will be affected by the severity 
of pain, and the mental health component score (SF-36 MCS)  will 
be affected by the severity of PTSD. 
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Figure 3.1: SEM path analysis diagram for model #1 
Pain Severity(Pain serity 
grade>=3) PTSD severity (PCL>=41)
Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Anxiety
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Figure 3.2: SEM path analysis diagram for model #2 
Pain Severity(Pain serity 
grade>=3) PTSD Severity (PCL>=41)
Anxiety&Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
 
• Structural equation modeling analysis will be conducted to test the hypothesis 
of mediating factors between PTSD (PCL-17>=41 or not), pain intensity and 
pain disability derived from the Mutual Maintenance Model. Specifically, we 
will test the following models (Model #3 and #4). In model #3, PTSD will have 
a direct effect on pain intensity, and an indirect effect on pain disability 
through pain catastrophizing and comorbid anxiety and depression (figure 
3.3). Meanwhile, pain disability will have a direct effect on PTSD and pain 
intensity. In model #4, pain intensity effects pain disability directly, and pain 
disability effects pain intensity indirectly through pain catastrophizing. 
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Comorbid anxiety and depression mediates the relationship between PTSD 
and pain catastrophizing, pain intensity and pain disability (figure 3.4). Similar 
to model #1 and #2, in both model #3 and #4, the physical health component 
score of the quality of life measure (SF-36 PCS)  will be affected by the 
severity of pain directly, and the mental health component score (SF-36 MCS)  
will be affected by the severity of PTSD directly. 
Figure 3.3: SEM path analysis diagram for model #3 
Pain Intensity (GCPS 
severity)
PTSD Severity 
(PCL>=41)
Anxiety&Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Pain Disability(GCPS 
disability)
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Figure 3.4: SEM path analysis diagram for model #4 
Pain Intensity (GCPS 
severity)
PTSD Severity (PCL>=41)
Anxiety&Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Pain Disability(GCPS 
disability)
 
• To test the sensitivity of above models, structural equation modeling analysis 
will also be conducted to test the four simplified models with the two quality of 
life measures (SF-36 PCS and MCS) removed from model #1, #2, #3, and #4, 
respectively. 
5) Hypothesis 5 (Different PTSD symptom domains will have differential 
relationships with chronic musculoskeletal pain outcomes, either directly, 
or through mediating factors such as depression or general anxiety 
disorder): To test this hypothesis, the following 2 analyses will be 
conducted for the patients with both PCL17 and GCPS evaluations: 
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Analysis 1: Confirmatory factor analyses will be conducted to determine 
PTSD domains using baseline information of patients who screened 
positive for PTSD. The following five models will be tested, based on a 
similar analysis conducted by Cyders et al (Cyders, Burris et al. 2010). 
The model summaries are presented in table 3.4. 
• Model A is a one-factor model where all PCL-17 items load onto a 
single PTSD factor. 
• Model B is an intercorrelated two-factor model, with one factor 
representing re-experiencing/avoidance symptoms and a second factor 
representing numbing/hyperarousal symptoms. 
• Model C is an intercorrelated three-factor model, with a re-
experiencing, an avoidance, and a hyperarousal model (the DSM-IV 
separation of PTSD symptoms). 
• Model D is comprised of four intercorrelated factors: re-experiencing, 
avoidance, numbing, and hyperarousal factors. 
• Model E is comprised of four different intercorrelated factors: 
reexperiencing, avoidance, dysphoria, and hyperarousal factors. 
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Table 3.4: Model summary of PCL-17 domains structure 
 
The confirmatory factory analysis (CFA) is used to assess how well the 
hypothesized factor models (Model A-E) of PCL-17 fit our data. Cyders et al 
found the two four-factor models, model D (figure 3.5) and E (figure 3.6), 
provided better model fit indices based on a  cross-sectional study on female 
patients with oral facial pain (Cyders, Burris et al. 2010). These findings will be 
validated in our study using ESCAPE trial data.  
  
Model Factors PCL-C items 
A PTSD All 17 items 
B Re-experience/avoidance 1-7 
 Numbing/hyperarousal 8-17 
C Re-experiencing 1-5 
 Avoidance 6-12 
 Hyperarousal 13-17 
D Re-experiencing 1-5 
 Avoidance 6-7 
 Numbing 8-12 
 Hyperarousal 13-17 
E Re-experiencing 1-5 
 Avoidance 6-7 
 Dysphoria 8-15 
 Hyperarousal 16-17 
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Figure 3.5: Confimatory factor analysis of model D 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17
Re-
experiencing
Avoidance Numbing Hyperarousal
 
Figure 3.6: Confirmatory factor analysis of model E 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17
Re-
experiencing Avoidance Dysphoria Hyperarousal
 
 Following the determination of the best factor structure of PTSD 
symptoms (Analysis 1) and a series of descriptive and correlation analyses, we 
will conduct additional SEM in the following analysis (Analysis 2) to explore and 
test our hypothesis about the differential relationships of different PTSD symptom 
domains (Hypothesis 5). The PTSD symptom factors will be defined as latent 
variables. Pain severity and disability, and other mediated factors (mentioned 
above) will be defined as measured variables in SEM tests.  
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Analysis 2: Structural equation modeling will be used to test the following 
sub-hypotheses:  
• Hyperarousal and re-experiencing symptom clusters will predict pain 
severity; 
• Avoidance and numbing/dysphoria symptom clusters will predict pain-
related disability 
• The above relationships will be mediated by the following factors:  
o Depression 
o Any mental disorder (depression, GAD) 
o Catastrophizing 
 Specifically, we’re going to test the following two structural equation 
models. In the first model (figure 3.7), we hypothesize the numbing factor will 
have an indirect effect on pain disability through depression. In the second model 
(figure 3.8), the dysphoria factor will have a similar indirect effect on pain 
disability through depression. In both models, hyperarousal factor will have a 
direct effect on pain intensity, and avoidance will have a direct effect on pain 
disability. In addition, the relationship between reexperienceing and pain 
disability will be mediated by pain catastrophyzing. And quality of life (SF-36 PCS 
and MCS) will be affected directly by numbing/dysphoria and pain disability. 
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Figure 3.7: Structural equation modeling based on a four-factor model 
(model D) of PTSD symptom clusters 
Re-
experiencing
Avoidance
Numbing
Hype-
rarousal
Anxiety
Depression
Pain 
Catastrophizing
SF-36 PCS
SF36 MCS
Pain Disability
Pain Intensity
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Figure 3.8: Structural equation modeling based on a four-factor model 
(model E) of PTSD symptom clusters  
Re-
experiencing
Avoidance
Dysphoria
Hype-
rarousal
Anxiety
Depression
Pain 
Catastrophizing
SF-36 PCS
SF36 MCS
Pain Disability
Pain Intensity
 
 
Longitudinal Data Analysis 
6) Hypothesis 6 (Baseline PTSD will predict chronic musculoskeletal pain 
severity grades at 9 months, and baseline chronic musculoskeletal pain 
severity grades would predict PTSD at 9 months): To test this hypothesis, 
we’ll conduct a cross-lagged panel analysis using SEM (figure 3.9). 
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Figure 3.9: Cross-lagged panel model of the relationship of pain severity 
and PTSD symptom clusters based on a four-factor model (model D) 
 
Re-
experiencing Avoidance
Numbing Hyperarousal Pain Severity
Re-
experiencing Avoidance
Numbing Hyperarousal Pain Severity
Baseline
9 months 
 
7) Hypothesis 7 (The longitudinal change in pain severity will be predicted by 
PTSD at baseline. The PTSD at 9 months will be predicted by pain 
intensity and disability at baseline.): A repeated measures model analysis 
and logistic regression analysis will be used to examine this hypothesis. 
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Chapter IV: Results 
Introduction 
We used SAS Enterprise 6.1 for CART analysis, Mplus 5.1 for 
Confirmatory Factor Analysis and Structural Equation Modeling (SEM) analysis, 
and SAS 9.2 for other statistical analyses such as regression and correlation 
analyses. In our analyses, PTSD diagnosis and severity are measured by the 
PCL-17. Pain intensity and pain-related disability are measured by the GCPS. 
Pain severity is defined by five grades (ranges 0 to 4) based on the combination 
of pain intensity and pain-related disability measured by the GCPS (see chapter 
3). 
We first conducted a series of descriptive, correlational and logistic 
regression analyses with baseline data to explore how chronic musculoskeletal 
pain outcomes are associated with PTSD outcomes after adjusting for 
demographic, social, economic, and psychological factors. These analyses were 
used to test our hypothesis 1 (Higher PTSD symptoms will be significantly 
associated with poorer pain-related and psychosocial outcomes) and hypothesis 
2 (Higher pain severity will be associated with more severe PTSD and poorer 
psychosocial outcomes). We then conducted a CART analysis to identify the 
strongest predictors of PTSD and pain outcomes (hypothesis 3: Besides pain 
severity, there are other key factors that are associated with PTSD), followed by 
a confirmatory factor analysis and a series of SEM analyses with baseline data to 
examine the direct/indirect relationships between different PTSD symptom 
clusters, chronic musculoskeletal pain outcomes and other variables of interests. 
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These latter analyses were used to test our hypothesis 4 (The relationship 
between PTSD and chronic musculoskeletal pain severity will be mediated 
through depression, anxiety, or pain catastrophizing. Moreover PTSD and pain 
severity will adversely affect quality of life independently. And patients with high 
chronic musculoskeletal pain and PTSD will have worse quality of life than 
patients with only one or neither of these conditions) and hypothesis 5 (Different 
PTSD symptom domains will have differential relationships with chronic 
musculoskeletal pain outcomes, either directly, or through mediating factors such 
as depression or general anxiety symptoms). Finally we conducted longitudinal 
analyses using both mixed model repeated analysis and cross-lagged panel 
analysis to examine if there are predictable relationships 1) between baseline 
PTSD symptoms and chronic musculoskeletal pain symptoms at 9 months, and 
2) between baseline chronic musculoskeletal pain symptoms and PTSD 
symptoms at 9 months (hypothesis 6 and 7). 
For each SEM analysis, we report both absolute fit indices including Chi-
Squared test, Relative Chi Square, Root Mean Square Error of Approximation 
(RMSEA); and relative fit indices including Comparative Fit Index (CFI) and Non-
Normed Fit Index (NNFI). Interpretation and acceptable thresholds (“rules of 
thumb”) for these fit indices are listed in Appendix E.  
In subsequent sections, we first define a subsample of patients who had 
their PTSD symptoms assessed and compare it with the full sample in terms of 
patient demographics and baseline characteristics. This subsample was used in 
some of our analyses because more measurement data (e.g. PTSD symptom 
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assessment) was available on this sample. Next we report results from individual 
analyses in the order of associated hypotheses as outlined in Chapter 3. Lastly, 
we end with a brief summary. 
 
Baseline Characteristics of All ESCAPE participants vs. ESCAPE participants 
with PTSD 
Table 4.1 lists the baseline characteristics of all patients who participated 
in the ESCAPE trial. Of 241 participants, 52 (21.6%) screened negative for PTSD 
without further PTSD symptom assessment (i.e. baseline PCL-17 evaluation) and 
189 (78.4%) screened positive for PTSD with further baseline PCL-17 evaluation. 
Among 189 PTSD-screen positive participants, one patient did not respond to 
several items on PCL-17. Because of this missing data, this patient will be 
excluded from analyses resulting in a full sample of 240 patients, and a 
subsample of 188 patients assessed for PTSD symptoms. 
Depending on the availability of measurements required by the analysis, 
either the full sample (N=240) or the subsample (N=188) was analyzed. 
  1) Full sample: This sample includes all 240 participants (excluding one 
patient with PTSD-screen positive but missing PCL-17 total score). If participants 
screened negative (Prins 2003) for PTSD (N=52, 21.7%), we assumed their PCL-
17 total scores were less than 41 (a validated cut point for clinically significant 
PTSD symptoms) although these patients were not assessed with the PCL-17 
according to the study design. In other words, we assumed that participants had 
either no or mild PTSD symptom which did not meet criteria for clinically 
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meaningful PTSD symptoms. Table 2 contains the baseline characteristics of 
participants in the full sample (N = 240).  Participants’ average age was 36.7 
years old. Most participants were male (88.3%) and Caucasian (77.6%). More 
than half of participants (54.6%) were married and all participants had graduated 
from high school or received some higher education.  
 2) Subsample: This sample includes all participants who screened positive 
for PTSD (N=188) and were subsequently assessed with the PCL-17 instrument 
for PTSD symptoms. Compared with participants who screened negative for 
PTSD, participants who screened positive for PTSD were younger (39.9 vs. 35.7 
years old), reported less comfort with their level of income and lower employment 
rate, reported more severe pain intensity, more disability days, and  higher pain 
catastrophizing, anxiety, and depression scores (table 4.1). 
Table 4.1: Baseline characteristics: all ESCAPE participants (N = 240) 
Characteristic Overall 
PTSD 
Screening 
negative 
(N=52) 
PTSD screen 
positive 
(N=188) P value 
Age in Years, mean 
(std) 
36.7 (10.2) 39.9 (11.7) 35.7 (9.6) 0.0084 
Men, n (%) 212 (88.3) 49 (94.2) 163 (86.7) 0.1345 
White, n (%) 184 (77.6) 40 (80.0) 144 (77.0) 0.6517 
Black, n (%) 31 (13.1) 8 (16.0) 23 (12.3) 0.4906 
High school, n (%) 239 (100.0) 51 (100.0) 188 (100.0)  
Married, n (%) 131 (54.6) 30 (57.7) 101 (53.7) 0.6109 
Income, “comfortable”, 
n (%) 
88 (36.7) 27 (51.9) 61 (32.4) 0.0099 
Employed, n (%) 176 (73.3) 44 (84.6) 132 (70.2) 0.0376 
GCPS pain intensity, 
mean (std) 
66.3 (13.7) 62.1 (15.7) 67.5 (12.9) 0.0110 
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Characteristic Overall 
PTSD 
Screening 
negative 
(N=52) 
PTSD screen 
positive 
(N=188) P value 
GCPS pain disability, 
mean (std) 
54.4 (24.4) 49.68 (19.4) 55.7 (25.5) 0.1166 
GCPS pain disability 
days, mean (std) 
14.1 (22.3) 5.4 (8.3) 16.4 (24.3) 0.0017 
GCPS pain severity 
categories, n (%)  
 
   0.0012 
1 20 (8.3) 8 (15.4) 12 (6.4)  
2 106 (44.2) 27 (51.9) 79 (42.0)  
3 66 (27.5) 15 (28.8) 51 (27.1)  
4 48 (20.0) 2 (3.8) 46 (24.5)  
GCPS pain severity in 
(3, 4), n (%) 
114 (47.5) 17 (32.7) 97 (51.6) 0.0157 
Pain catastrophizing, 
mean (std) 
21.7 (12.3) 16.92 (11.1) 23.0 (12.3) 0.0014 
GAD-7 anxiety, mean 
(std) 
8.8 (5.3) 5.2 (4.2) 9.9 (5.1) <.0001 
GAD-7 anxiety ≥ 10, n 
(%) 
107 (44.6) 10 (19.2) 97 (51.6) <.0001 
PHQ-9 depression, 
mean (std) 
11.2 (5.9) 7.56 (5.5) 12.2 (5.6) <.0001 
PHQ-9 depression 
 ≥ 10, n (%) 
137 (57.1) 15 (28.8) 122 (64.9) <.0001 
GAD-7 and PHQ-9  
 ≥ 10, n (%) 
96 (40.0) 8 (15.4) 88 (46.8) <.0001 
 
 
Correlations of baseline PTSD, pain, health-related quality of life, and 
psychological factors  
To assess the relationships between PTSD, pain, health-related quality of 
life, and other psychological factors, we first calculated the Pearson correlations 
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of the variables of interest, including pain, PCL17, GAD-7 anxiety, PHQ-9 
depression and SF-36 quality of life. Because participants screened negative for 
PTSD were not evaluated with PCL17 according to the ESCAPE trial protocol, 
the subsample (N=188) of participants with PCL-17 score measured were 
included in this analysis. The results are listed in table 4.2 (Appendix H). In 
summary, a strong correlation (r ≥ 0.6 or r≤-0.6) was found between 1) PCL-17 
and depression, anxiety, SF-36 mental component summary scores; 2) pain 
disability and SF-36 physical component scores; 3) depression (PHQ-9), anxiety 
(GAD-7), and SF-36 mental component scores.. A moderate correlation (0.4 ≤ r 
<0.6 or -0.6<r≤-0.4) was found between 1) PTSD symptoms (PCL17) and pain 
catastrophizing; 2) between pain intensity and pain disability, SF-36 physical 
component scores; 3) between pain disability and depression, SF-36 physical 
component scores; 4) between depression and pain catastrophizing; 5) between 
anxiety and pain catastrophizing; 6) between pain catastrophizing score and SF-
36 mental component score. 
 
Hypothesis #1: Higher PTSD symptoms will be significantly associated with 
poorer pain-related and psychosocial outcomes 
To test hypothesis #1, we first categorized patients according to clinically 
significant PTSD symptoms.  Clinically significant PTSD symptoms were defined 
as a PCL17 total score ≥ 41 (yes/no).  We then compared baseline 
characteristics between those with and without clinically significant PTSD 
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symptoms and fit a logistic regression model to further assess the association of 
PTSD severity with pain outcomes.  
 
Comparisons of baseline characteristics between patients with and without 
clinically significant PTSD symptoms 
Overall, 68 (28.3%) participants were categorized as having clinically 
significant PTSD symptoms (PTSD group) (PCL17 total score ≥ 41). Compared 
to patients without clinically significant PTSD symptoms (those screened 
negative or with PCL17 total score < 41), the participants in the PTSD group 
were similar in age, gender, educational attainment, and marital status (all p-
value>0.5). As shown in table 4.3, the PTSD group was more likely to report 
having an inadequate income, to be unemployed, have more severe and 
disabling pain,  greater pain catastrophizing, and more severe anxiety,  
depression, and SF-36 mental scores.  
These results confirmed our hypothesis that PTSD is associated with 
poorer pain-related, psychosocial, and quality of life outcomes. 
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Table 4.3: All ESCAPE participants (N = 240) baseline characteristics: PTSD 
group vs. non-PTSD group 
 
Characteristic Overall 
Non-PTSD  
group  
(N=172) 
PTSD group  
 
(N=68) P value 
Age in Years, mean 
(std) 
36.7 (10.2) 37.3 (10.6) 35.1 (9.2) 0.1432 
Men, n (%) 212 (88.3%) 152 (88.4%) 60 (88.2%) 0.9763 
White, n (%) 184 (77.6%) 134 (79.3%) 50 (73.5%) 0.3357 
Black, n (%) 31 (13.1%) 24 (14.2%) 7 (10.3%) 0.4197 
High school, n (%) 239 
(100.0%) 
171 
(100.0%) 
68 (100.0%) . 
Married, n (%) 131 (54.6%) 98 (57.0%) 33 (48.5%) 0.2363 
Income, 
“comfortable”, n (%) 
88 (36.7%) 74 (43.0%) 14 (20.6%) 0.0012 
Employed, n (%) 176 (73.3%) 136 (79.1%) 40 (58.8%) 0.0014 
GCPS pain intensity, 
mean (std) 
66.3 (13.7) 63.9 (13.7) 72.3 (11.6) <.0001 
GCPS pain disability, 
mean (std) 
54.4 (24.4) 49.8 (23.8) 66.1 (21.9) <.0001 
GCPS pain disability 
days, mean (std) 
14.1 (22.3) 10.7 (18.4) 22.7 (28.3) 0.0001 
GCPS pain severity 
categories, n (%) 
 
   0.0004 
1 20 (8.3%) 18 (10.5%) 2 (2.9%)  
2 106 (44.2%) 86 (50.0%) 20 (29.4%)  
3 66 (27.5%) 43 (25.0%) 23 (33.8%)  
4 48 (20.0%) 25 (14.5%) 23 (33.8%)  
GCPS pain severity ≥ 
3, n (%) 
114 (47.5%) 68 (39.5%) 46 (67.6%) <.0001 
Pain catastrophizing, 
mean (std) 
21.7 (12.3) 19.0 (11.2) 28.6 (12.2) <.0001 
GAD-7 Anxiety, mean 
(std) 
8.8 (5.3) 5.2 (4.2) 9.9 (5.1) <.0001 
GAD-7 ≥ 10, n (%) 178 (74.2%) 111 (64.5%) 67 (98.5%) <.0001 
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Characteristic Overall 
Non-PTSD  
group  
(N=172) 
PTSD group  
 
(N=68) P value 
PHQ-9 depression, 
mean (std) 
11.2 (5.9) 9.2 (5.1) 16.3 (4.5) <.0001 
PHQ-9 depression ≥ 
10, n (%) 
137 (57.1%) 76 (44.2%) 61 (89.7%) <.0001 
GAD-7 and PHQ-9 ≥ 
10, n (%) 
96 (40.0%) 8 (15.4%) 88 (46.8%) <.0001 
SF36 PCS, mean 
(std) 
37.4 (7.5) 37.8 (7.3) 36.5 (7.8) 0.2409 
SF36 MCS, mean 
(std) 
41.6 (12.6) 45.9 (11.2) 30.8 (8.9) <.0001 
Note: GCPS pain intensity: ranges 0 to 100, higher scores represent higher pain intensity. 
GCPS pain disability: ranges 0 to 100, higher scores represent higher pain disability. 
GCPS pain disability days: range 0 to 90 days. 
GCPS pain severity: classified to five grades based on both GCPS pain intensity and GCPS pain 
disability; range 0 to 4, higher grades represent higher GCPS pain intensity (range 0 to 100) 
and/or higher GCPS pain disability (range 0 to 100). 
GAD-7 anxiety: range 0-21, higher scores represent higher anxiety. 
PHQ-9 depression:  range 0-27, higher scores represent higher depression. 
 
 
Multivariate ordinal logistic regression models to assess the relationship between 
PTSD (independent variable) and pain severity grades (dependent variable) 
We conducted a multiple ordinal logistic regression analysis to examine if 
clinically significant PTSD (PCL-17 score ≥ 41) is associated with pain severity 
(according to GCPS severity 4 categories/grades) using two models. The two 
models differ only in the choice of covariates. The covariates were various 
comorbidities of pain (depression, anxiety and pain catastrophizing) in the first 
model, or comorbidities plus socialdemographic factors including income and 
employment status in the second model. The results of logistic regression 
analysis are listed in table 5. In the first model, pain catastrophizing and 
depression were positively associated with pain severity (i.e. more pain 
catastrophizing thoughts and depression symptoms are associated with more 
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severe pain). After adding demographic and economic factors in the second 
model, employment status, pain catastrophizing and depression were all 
statistically significant (p<0.05). Except for employment status, there were no 
statistically significant associations between pain severity and other baseline 
sociodemographic characteristics (table 4.4). 
To evaluate the effect of possible colinearity between PTSD and anxiety, 
we removed anxiety from the covariate list in our models. The results still show 
PTSD has no significant effect on pain severity (see table 4.4 footnote). 
The ordinal logistic regression results therefore did not show PTSD was 
independently associated with pain severity controlling for depression, anxiety, 
catastrophizing and social demographic factors. 
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Table 4.4: Ordinal logistic regression to evaluate associations between 
GCPS pain severity, PTSD, and other factors in all ESCAPE (n = 240) 
participants 
 
 Response variable: GCPS pain severity categories (1, 2 ,3 ,4) 
 Model without socio-
demographic characteristics 
adjustment 
Model with socio-demographic 
characteristics adjustment 
 OR (95% CI) p-value OR (95% CI) p-value 
PTSD (PCL17≥ 
41) 
1.55 ( 0.86,  2.79)* 0.137 1.37 ( 0.74, 2.52)** 0.31 
pain 
catastrophizing 
1.03 (1.01, 1.06) 0.002 1.03 (1.01,  1.06) 0.004 
GAD-7 anxiety 
≥10 1.40 ( 0.69,  2.86) 
0.966 1.27 ( 0.60, 2.66) 0.782 
PHQ-9 
depression≥10 
1.96 (1.05,  3.67) 0.025 1.96 (1.03, 3.75) 0.029 
Age   0.98 (0.96,  1.01) 0.173 
Male   0.42 (0.2,  0.94) 0.08 
white   0.52 (0.29,  0.96) 0.082 
Married   1.01 ( 0.6,  1.68) 0.61 
Income, 
“comfortable” 
  1.38 (0.8, 2.38) 0.418 
Employed   0.3 ( 0.18,  0.56) <.0001 
*After removing GAD-7 flag from the model without socio-demographic characteristics 
adjustment, the OR for PTSD is 1.59 (0.88, 2.86) 
** After removing GAD-7 flag from the model with socio-demographic characteristics adjustment, 
the ORfor PTSD  is 1.39 (0.76, 2.56) 
 
Hypothesis #2: Higher pain severity will be associated with more severe PTSD 
symptoms and psychosocial outcomes 
To test hypothesis #2, we first compared patients with different GCPS pain 
severity grades at baseline (table 4.5). Next, multiple logistic regression models 
were developed to further assess the association of pain severity with PTSD. 
Baseline characteristics among patients with lower versus higher pain 
At baseline, 126 (52.5%) patients had a GCPS pain severity grade 1 or 2 
(mild pain group), and 114 (47.5%) patients had a GCPS pain severity grade 3 or 
4 (moderate to severe pain group). Pain severity grade, ranging from 1 to 4, was 
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defined based on the combination of pain intensity, disability score and disability 
days (see chapter 3). Table 4.5 summarizes the baseline characteristics among 
patients with lower grades of pain severity (1, 2)  versus those with higher grades 
(3, 4). The two groups did not differ according to demographic characteristics (i.e. 
age, gender, race, married status). The high pain severity group was less likely to 
be employed. Moreover, the high pain severity group reported greater pain 
catastophizing thoughts, and showed a higher prevalence of clinically significant 
PTSD, anxiety and depression. These results therefore support our hypothesis 
that higher pain severity is associated with PTSD and worse psychosocial 
outcomes. 
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Table 4.5: Baseline characteristics of patients (n = 240) with low vs. high 
pain severity 
 
Characteristic  Overall 
Low pain 
group* 
(N=126) 
High Pain 
group* 
(N=114) P value 
Age in Years, mean 
(std) 
36.7 (10.2) 37.9 (10.4) 35.3 (9.8) 0.0565 
Men, n (%) 212 (88.3) 116 (92.1) 96 (84.2) 0.0584 
White, n (%) 184 (77.6) 101 (81.5) 83 (73.5) 0.1399 
Black, n (%) 31 (13.1) 16 (12.9) 15 (13.3) 0.9326 
High school, n (%) 239 (100.0) 125 (100.0) 114 (100.0) . 
Married, n (%) 131 (54.6) 74 (58.7) 57 (50.0) 0.1749 
Income, 
“comfortable”, n (%) 
88 (36.7) 51 (40.5) 37 (32.5) 0.1979 
Employed, n (%) 176 (73.3) 105 (83.3) 71 (62.3) 0.0002 
Pain catastrophizing, 
mean (std) 
21.7 (12.3) 18.2 (11.0) 25.5 (12.6) <.0001 
PCL 17≥41, n (%) 68 (28.3) 22 (17.5) 46 (40.4) <.0001 
GAD-7 anxiety, mean 
(std) 
16.5 (8.7) 13.9 (8.2) 19.4 (8.3) <.0001 
GAD-7 ≥ 10, n (%) 178 (74.2) 80 (63.5) 98 (86.0) <.0001 
PHQ-9 depression, 
mean (std) 
11.2 (5.9) 9.2 (5.3) 13.4 (5.8) <.0001 
PHQ-9 depression ≥ 
10, n (%) 
137 (57.1) 55 (43.7) 82 (71.9) <.0001 
GAD-7 and PHQ-9 ≥ 
10, n (%) 
132 (55.0) 51 (40.5) 81 (71.1) <.0001 
GAD-7 or PHQ-9 ≥ 
10, n (%) 
183 (76.3) 84 (66.7) 99 (86.8) 0.0002 
         *Low pain group: GCPS severity in (1, 2); **High pain group: GCPS severity in (3, 4). 
 
Logistic regression assessing the relationship between pain severity 
(independent variable) and PTSD (dependent variable) 
We conducted a multiple logistic regression analysis to examine if PTSD 
can be explained by pain severity using two models. In both models, the 
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response variable is PTSD status defined as PCL-17 ≥ 41 (Y/N). In the first 
model, the covariates included only the physical and psychological comorbidities 
of PTSD (i.e. pain, anxiety, depression, and pain catastrophizing). In the second 
model, socio-demographic factors were also added as covariates. Results for 
both models are listed in table 4.6. In the first model, almost all parameters 
included are statistically significant (p<0.05) except pain severity (overall 
p=0.469). In the second model, pain catastrophizing, anxiety, depression were 
significant (p<0.05) even after adjustment for socio-demographic factors. There 
were no statistically significant associations between clinically significant PTSD 
(PCL-17 score ≥ 41) and baseline socio-demographic characteristics (table 4.6). 
The multiple logistic regression results therefore did not show pain 
severity had an independent relationship to PTSD severity in models with and 
without socio-demographic adjustment. 
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Table 4.6: Logistic regression to examine associations between PTSD, pain 
severity, and other factors in all 240 ESCAPE participants 
 
 Response variable: PTSD (PCL-17 ≥ 41)  
 Model without socio-
demographic characteristics 
adjustment 
Model without socio-
demographic characteristics 
adjustment 
 OR (95% CI) p-value OR (95% CI) p-value 
GCPS pain severity 
categories 
    
 1 vs. 4 0.43 (0.08 ,  2.39) 0.21 0.58 (0.1,  3.5) 0.545 
 2 vs.  4 0.63 (0.28,  1.46) 0.7 0.88 (0.35,  2.21) 0.716 
 3 vs . 4 1.04 (0.45,  2.43) 0.306 1.35 (0.54,  3.39) 0.273 
pain catastrophizing  1.04 (1.01,  1.07) 0.011 1.03 (1.004, 1.07) 0.025 
GAD-7 anxiety ≥10 8.9 (1.09,  72.44) 0.038 9.37 (1.12,  78.38) 0.037 
PHQ-9 depression≥10 4.2 ( 1.68, 10.54) 0.002 4.15 (1.62,  10.65) 0.003 
Age   1 (0.96, 1.04) 0.981 
Male   1.05 (0.37,  3) 0.942 
white   0.76 (0.34,  1.72) 0.493 
Married   0.64 (0.32,  1.3) 0.224 
Income, “comfortable”   0.52 (0.24,  1.13) 0.113 
Employed   0.62 (0.28,  1.34) 0.212 
 
 
Hypothesis #3: Besides pain severity, there are other key factors that are 
associated with PTSD 
We used CART analysis to test hypothesis #3. CART analysis can be 
used to uncover the existing interactions or nonlinear relationships among a 
given response variable and multiple predictor variables, and provide thresholds 
for each predictor variable, at which its predictive power becomes statistically 
significant. CART analysis presents a "hierarchy" or decision tree of predictors by 
finding the best combination of predictors for a given outcome. 
In our study, CART analysis was used to identify the most important 
covariates associated with PTSD besides pain severity. The target variable is 
PTSD status defined as a PCL-17 score ≥ 41 (Yes/No).  To identify the 
 
 
83 
 
relationship between PTSD and pain severity, pain severity grade (ranges 1 to 4) 
was “forced” as the first decision variable. The next decision variable was 
determined by searching all other input variables (i.e. socio-demographic, 
moderately severe depression, moderately severe anxiety, and pain 
catastrophizing score). The final decision tree is shown in figure 4.1. In the study 
baseline data, 68 of 240 patients (28%) had clinically significant PTSD based on 
total PCL 17 score ≥ 41. At the first branching level, 240 patients were partitioned 
based on whether their GCPS severity grade was less than 3. Among patients 
with GCPS pain severity grade of 3 or 4, 40% had clinically significant PTSD, 
compared to 17% among the group with GCPS pain severity less than 3. At the 
next branch point, patients were continually partitioned based on whether both 
PHQ-9 depression and GAD-7 scores were ≥10 (representing moderately severe 
depression and anxiety symptoms, respectively). The highest PTSD prevalence 
(62.9%) was identified among patients whose GCPS severity grade was 3 or 4 
and who met the second criteria of having moderately severe depression and 
anxiety symptoms. In contrast, the PTSD prevalence rate was 47.1% among 
patients who did not meet the first GCPS severity grade criteria but did meet the 
second criteria of clinically significant depression (PHQ≥10) and anxiety 
(GAD≥10).  
The CART analysis results tended to support our hypothesis that patients 
with higher pain severity and coexisting depression and anxiety are more likely to 
have clinically significant PTSD symptoms. 
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Figure 4.1: Full Sample (N=240): CART analysis to predict clinically 
significant PTSD (PCL17 ≥ 41) 
 
Target: PCL17≥41
Total count: 240
Yes: 28%
No: 72%
Target: PCL17≥41
Total count: 114
Yes: 40%
No: 60%
Target: PCL17≥41
Total count: 126
Yes: 17%
No: 83%
Target: PCL17≥41
Total count: 62
Yes: 62.9%
No: 37.1%
Target: PCL17≥41
Total count: 52
Yes: 13.5%
No: 86.5%
Target: PCL17≥41
Total count: 34
Yes: 47.1%
No: 52.9%
Target: PCL17≥41
Total count: 92
Yes: 6.5%
No: 93.5%
GCPS severity
1, 2 3,4
PHQ-9≥10 and GAD-7≥10 PHQ-9≥10 and GAD-7≥10
1 0 1   0
 
 
 
Hypothesis #4: The relationship between PTSD and chronic pain severity will be 
mediated through depression, anxiety, or pain catastrophizing (4a). Moreover 
PTSD and pain severity will adversely affect quality of life independently (4b). 
And patients with high chronic pain (GCPS severity grade ≥3) and PTSD will 
have worse quality of life than patients with only one or neither of these 
conditions (i.e., high chronic pain or PTSD) (4c) 
In order to test the first two parts of hypothesis #4 (4a and 4b), we 
conducted a series of Structured Equation Modeling (SEM) path analysis to test 
four models (model A to D) pre-specified in chapter 3. All variables included in 
these models were considered measured. No latent variables were included in 
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these models. To test the third part of hypothesis #4 (4c), we conducted an 
ANCOVA analysis to compare the quality of life of chronic pain patients with 
clinically significant PTSD versus those without. 
 
SEM analysis: model A (N=240) 
Model A and its fitting results are depicted in figure 4.2 (full sample). For 
comparison purpose, the hypotheses and fitting results of this model are also 
listed in a table in Appendix I along with other models. Model A fits our data fairly 
(ref. Appendix A: relative Chi-square slightly bigger than the 3:1 cut point, 
RMSEA =0.092 slightly bigger than the 0.08 cut point, CFI>0.95, TLI>0.9) and 
provides empirical support for hypothesis #4a and #4b. In particular, this model 
shows that PTSD is indirectly associated with pain severity through depression, 
and pain severity is indirectly associated with PTSD through catastrophizing 
(hypothesis #4a). This model also shows pain severity has a direct negative 
relationship with quality of life as measured by the SF-36 physical component 
summary score (SF-36 PCS) (standardized coefficient=-0.474), and PTSD has 
an indirect negative relationship with the SF-36 mental component summary 
score (SF-36 MCS)  (hypothesis #4b).  This indirect relationship is mediated 
through depression. The model shows PTSD severity is strongly associated with 
both anxiety (standardized coefficient=0.994) and depression (standardized 
coefficient=0.8). And depression has a strong negative association with the SF-
36 MCS (standardized coefficient=-0.645). The direct relationship between PTSD 
and quality of life (SF-36 PCS and SF-36 MCS) is, however, not significant. 
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Figure 4.2: SEM model A related to hypothesis 4. Coefficients reflect 
standardized path coefficients 
 
 
Pain Severity(Pain serity 
grade>=3) PTSD (PCL-17>=41)
Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Anxiety
Model fit statistic: Chi-squre30.449, df=10, p<.05; RMSEA 0.092(p<.05); CFI 0.971; TLI 0.939
*P-vlue<0.05; **P-value <0.01
0.355**
0.294** 0.481**
0.994**
0.8**
-0.192
-0.474**
-0.645**
  
 
 
SEM analysis: model B (N=240) 
 Model B and its fitting results are depicted in figure 4.3 (full sample), and 
are also included in the table of Appendix I for comparison purpose This model 
combines anxiety and depression into a single predictor and examines how 
PTSD is associated with pain severity. The fit is very good in terms of relative 
chi-square (<2). Other fit indices are also in an acceptable (RMSEA =0.041) or 
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better (CFI>0.95, TLI>0.95) range. Model B shows PTSD severity has an indirect 
association on pain catastrophizing through the mediation of the combination of 
anxiety and depression, and both anxiety/depression and pain catastrophizing 
are directly related to pain severity (hypothesis #4a). Like model A, model B also 
shows pain severity has a strong negative association with SF-36 PCS 
(standardized coefficient=-0.514) (hypothesis #4b). But the hypothesized 
relationship between PTSD and pain catastrophizing was not significant 
(standardized coefficient= coefficient < 0.2, p>0.05). The hypothesized direct 
negative  association of PTSD with SF-36 MCS was not significant(-0.143), but 
indirect negative  association was significant (hypothesis4b). 
 
 
88 
 
Figure 4.3: SEM model B related to hypothesis 4. Coefficients reflect 
standardized path coefficients
Pain Severity(Pain serity 
grade>=3) PTSD (PCL-17>=41)
Anxiety&Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Model fit statistic: Chi-squre8.39, df=6, p>.05; RMSEA 0.041 (p>.05); CFI 0.992; TLI 0.98
*P-vlue<0.05; **P-value <0.01
0.243*
0.326**
0.108
0.443**
0.556**
-0.143
-0.72**-0.514**
  
 
 
SEM analysis: model C (N=240) 
 Model C and its fitting results are depicted in figure 4.4 (full sample), and 
are also included in the table of Appendix I for comparison purpose This model 
also combines anxiety and depression into a single predictor, but separates pain 
intensity from pain disability. The model fit is good in terms of RMSEA (0.038). 
Other fit indices are also in a good fit range (relative chi square < 2, TLI>0.95, 
CFI>0.95). All paths are significant at p<0.05. This model shows: 1) Pain 
disability has direct associations with pain intensity (standardized 
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coefficient=0.351) , PTSD (standardized coefficient=0.277) and SF-36 PCS  
(standardized coefficient=-0.51); 2) PTSD has direct associations with pain 
intensity (standardized coefficient=0.23) and SF-36 MCS  (standardized 
coefficient=-0.301); 3) PTSD also has an indirect association with SF-36 MCS 
through the mediation of comorbid anxiety and depression (standardized 
coefficient= -0.571),  and an indirect association with pain intensity through the 
mediation of comorbid anxiety and depression, and catastrophizing (standardized 
coefficient= -0.371). Like model A, the fitting results of model C supported both 
hypothesis #4a and #4b. Furthermore, these results highlighted the differential 
associations of pain intensity and pain disability with PTSD, and with quality of 
life as assessed by SF-36 PCS. 
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Figure 4.4: SEM model C related to hypothesis 4. Coefficients reflect 
standardized path coefficients 
 
Pain Intensity (GCPS 
severity)
PTSD (PCL-17>=41)
Anxiety&Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Pain Disability(GCPS 
disability)
Model fit statistic: Chi-squre12.21, df=9, p<.05; RMSEA 0.038 (p>.05); CFI 0.992; TLI 0.98
*P-vlue<0.05; **P-value <0.01
0.351**
0.371**
0.472**
0.23**
0.277**
0.78**
-0.51**
-0.301**
-0.571**
. 
 
 
SEM analysis: model D(n=240) 
 Model D and its fitting results are depicted in figure 4.5 (full sample), and 
are also included in the table of Appendix I for comparison purpose This model is 
very similar to model C except that we hypothesized in model D that 1) pain 
disability has an indirect association with pain intensity through pain 
catastrophizing; and 2) pain intensity has a direct association with pain disability. 
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The fit of model D is good in terms of RMSEA (0.062), and other fit indices are in 
a good (relative chi square <3, TLI>0.9, CFI>0.95) range. All paths are significant 
at p<0.05. These test results supported our hypothesis that 1) Pain disability has 
an indirect association with pain intensity through pain catastrophizing; 2) pain 
intensity has a direct association with pain disability; 3) pain disability has direct 
associations with PTSD and SF-36 PCS; 4) PTSD has a direct association (and 
an indirect association through comorbid anxiety and depression) with the SF-36 
MCS , and an indirect association with pain intensity through comorbid anxiety 
and depression, and pain catastrophizing. Like model C, the fitting results of 
model D provided additional support for our hypothesis #4a and #4b. Unlike 
model C, model D demonstrated bidirectional (versus unidirectional in Model C) 
associations between pain intensity and pain disability through the mediation of 
pain catastrophizing. In addition, model D showed PTSD has an indirect 
relationship with pain intensity through comorbid depression and anxiety and 
pain catastrophizing, while model C demonstrated a direct association of PTSD 
with pain intensity. 
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Figure 4.5: SEM model D related to hypothesis 4. Coefficients reflect 
standardized path coefficients 
 
Pain Intensity (GCPS 
severity)
PTSD (PCL-17>=41)
Anxiety&Depression
Pain Catastrophizing
SF-36 PCS
SF-36 MCS
Pain Disability(GCPS 
disability)
Model fit statistic: Chi-squre21.118, df=11, p<.05; RMSEA 0.062(p>.05); CFI 0.973; TLI  0.949
*P-vlue<0.05; **P-value <0.01
0.181* 0.43**
0.216**0.444**
0.417**
0.732**
-0.541**
-0.276*
-0.575**
 
 
Summary of above four SEM models (model A to D) 
 To test hypotheses 4a and 4b, four different SEM models (model A to D) 
were used to examine the possibility of complex bidirectional relationships, and 
multiple ways of direct and indirect relationships between PTSD, chronic pain 
and other variables. These relationships cannot be examined with a single SEM 
model due to sample size limitation of present study. The results of the four SEM 
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models are instead combined together and summarized below with further detail 
outlined in Appendix I: 
1. PTSD has a direct effect on anxiety (model A). 
2. PTSD has an indirect effect on pain severity through depression (model 
A), or through the combination of depression and anxiety (model B).  
3. PTSD has a direct effect on pain intensity (model C), and an indirect effect 
on pain intensity through comorbid anxiety and depression and pain 
catstrophizing (model D). 
4. PTSD has an indirect effect on pain disability through comorbid anxiety 
and depression and pain catastrophizing (model C). 
5. Pain severity has an indirect effect on PTSD through pain catastrophizing 
(model A).  
6. Pain disability has a direct effect on PTSD (model C and D). 
7. The mental health component score is affected by depression (model A) 
or the combination of depression and anxiety (model B, C, and D), and by 
PTSD (model C and D).  
8. The physical health component score is affected by pain severity (model A 
and B), or by pain disability (model C and D). 
 
ANCOVA analysis 
 The patients’ quality of life (QOL) was measured by the SF-36 which 
consists of eight QOL domains that comprise two summary measures – the 
physical component summary (PCS) and the mental component summary 
(MCS). At least moderate negative correlations (r≤-0.4) were identified through 
Pearson correlation analysis between GCPS pain intensity and PCS, GCPS pain 
disability; between SF-36 PCS and MCS, PCL-17 and SF-36 MCS. The 
ANCOVA analyses showed that patients with GCPS pain severity grade ≥3 and 
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clinically significant PTSD (PCL-17 ≥41) were associated with worse SF-36 PCS 
(p-value= 0.024) and MCS scores (p-value<0.001) (table 4.7). These results 
therefore supported our hypothesis #4c that patients with high chronic pain 
(GCPS severity grade ≥3) and PTSD will have worse quality of life than patients 
with only one or neither of these conditions (i.e., high chronic pain or PTSD). 
Table 4.7: ANCOVA analysis to test hypothesis #4c: patients with high 
chronic pain and PTSD will have worse quality of life than patients with 
only one or neither of these conditions 
 
SF-PCS SF-MCS 
Least-Squares Means p-value Least-Squares Means p-value 
GCPS pain 
severity≥3 
and PCL-17 
total score 
≥41 
GCPS pain 
severity<3 or 
PCL-17 total 
score<41 
 GCPS pain 
severity≥3 
and PCL-
17 total 
score ≥41 
GCPS pain 
severity<3 or 
PCL-17 total 
score<41 
 
34.2 37.2 0.024 38.9 45.2 <0.001 
Note: Model adjusted by other factors, including age, gender, marriage, income, employment 
status, pain catastrophizing, anxiety and depression. 
 
Hypothesis #5: Different PTSD symptom domains will have differential 
relationships with chronic pain outcomes, either directly, or through mediating 
factors such as depression or anxiety symptoms 
 In order to test our hypothesis #5, we conducted a confirmatory factor 
analysis to find the best factor structures of PTSD, followed by a series of SEM 
analysis to test two SEM models with latent variables. In these models, individual 
PTSD symptom domain severity was treated as latent variable measured by 
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corresponding PCL-17 item scores as determined by the results of confirmatory 
factor analyses. All models (model E to I) are based on the subsample (N=188) 
of participants who screened positive for PTSD and had measured PCL17. 
 
Confirmatory factor analysis  
 Table 4.8 lists the results of confirmatory factor analysis for five factor 
structure models of PTSD symptoms measured by PCL-17 (model E to I). 
Among these models, the two models with four factors (Model H and I) have the 
best fit indices. Both provide good fit for our data as indicated by relevant fit 
indices (RMSEA <0.08, CFI > 0.9, TFI > 0.9), and Model I fits our data slightly 
better than Model H. This finding is consistent with that reported in Cyders’ study 
(Cyders, Burris et al. 2010) in patients with PTSD and chronic orofacial pain. 
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Table 4.8: Confirmatory factor analysis (subsample N=188): summary of 
factor structures of five models (E-I) 
 
Model Factors PCL17  χ2 DF RMSEA CFI TFI Adjusted 
BIC* 
E PTSD All 17 
items 
422.41 119 0.116 0.82 0.80 9376.60 
F Re-
experience/ 
avoidance 
1-7 296.54 118 0.090 0.90 0.88 9252.81 
 Numbing/ 
hyperarousal 
8-17       
G Re-
experiencing 
1-5 299.99 116 0.092 0.89 0.88 9260.40 
 Avoidance 6-12       
 Hyperarousal 13-17       
H* Re-
experiencing 
1-5 201.55 113 0.065 0.95 0.94 9168.16 
 Avoidance 6-7       
 Numbing 8-12       
 Hyperarousal 13-17       
I* Re-
experiencing 
1-5 172.43 113 0.053 0.97 0.96 9139.04 
 Avoidance 6-7       
 Dysphoria 8-15       
 Hyperarousal 16-17       
Note: * Sample size adjusted Bayesian information criterion (BIC) is a parsimony fit index, with a 
smaller value representing a better fit (complex model will be penalized).  
 
 The factor loadings and correlation coefficients of model H and model I 
were depicted in detail in figure 4.6 and 4.7, respectively. 
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Figure 4.6: Confirmatory factor analysis for model H 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17
Re-
experiencing Avoidance Numbing Hyperarousal
0.81 0.78 0.78 0.80 0.81
0.80 0.86
0.40 0.80 0.90 0.82 0.54
0.57 0.66 0.71 0.74 0.71
0.82
0.70
0.68
0.78
0.80
0.80
Note: Re-experiencing (PCL-17 items 1–5), Avoidance (PCL-17 items 6–7), Numbing (PCL-17 
items 8–12), and Hyperarousal (PCL-17 items 13–17).  
 
Figure 4.7: Confirmatory factor analysis for model I 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17
Re-
experiencing Avoidance Dysphoria Hyperarousal
0.81 0.78 0.78 0.80 0.81
0.80 0.86
0.40 0.79 0.87 0.81 0.55 0.55 0.65 0.67
0.84 0.84
0.82
0.72
0.72
0.71
0.70
0.66
 
Note: Re-experiencing (PCL-17 items 1–5), Avoidance (PCL-17 items 6–7), Dysphoria (PCL-17 
items 8–15), and Hyperarousal (PCL-17 items 16–17).  
 
 
 
SEM analysis based on model H and I 
 SEM analysis was conducted next to test the hypothesized relationships 
between the PTSD symptom clusters and pain outcomes (pain intensity and pain 
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disability), and the mediating roles of depression, anxiety, and pain 
catastrophizing. Two SEM models (based on factor model H and I, respectively) 
with latent variables specified were tested. 
 Figure 4.8 depicts the test results of the SEM model based on factor 
model H. In this model, we observed the following fit indices: relative chi square 
<2, CFI=.917, TLI=.903, RMSEA=.072.  The hyperarousal symptom cluster was 
not directly associated with pain intensity, but indirectly related, through anxiety 
and pain catastrophizing. The numbing symptom cluster was indirectly 
associated with pain disability through its association with depression. Avoidance 
was not directly associated with pain-related disability. Re-experiencing was not 
directly associated with anxiety, while anxiety was indirectly associated with pain 
intensity though pain catastrophizing. Pain catastrophizing was directly 
associated with pain intensity, disability and depression.  
The results showed that none of the four PTSD symptom clusters has a 
significant direct relationship with either pain intensity or pain disability. This 
finding is consistent with the previous analysis based on the SEM model D.  
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Figure 4.8: SEM path analysis of the relationships among PTSD symptom 
clusters defined by factor model H 
Re-
experiencing
Avoidance
Numbing
Hype-rarousal
Anxiety
Depression
Pain 
Catastrophizing
Pain Disability
Pain Intensity
Model fit statistic: Chi-squer 391.298, df=236 (p<0.05); RMSEA 0.072 
(p<0.01); CFI 0.917; TLI 0.903
0.118
0.688**
0.742**
0.134
-0007
0.168**
0.523**
0.244**
0.254**
0.328**
 
 Note: Re-experiencing (PCL-17 items 1–5), Avoidance (PCL-17 items 6–7), Numbing (PCL-17 
items 8–12), and Hyperarousal (PCL-17 items 13–17))  
 
 
  
 
 
100 
 
SEM analysis: model I 
 Figure 4.9 depicts the test results of the SEM model based on factor 
model I. This model’s fitting indices were slightly improved (CFI=.925, TLI=.913, 
RMSEA=0.069) compared to  model H. Similar to  model H, this model also 
showed the hyperarousal symptom cluster was indirectly associated with pain 
intensity and pain disability through anxiety and pain catastrophizing; and 
avoidance was not directly associated with pain-related disability. Contrary to 
model H where the relationship between re-experiencing and anxiety is not 
significant, the model I showed a significant association between re-experience 
and anxiety. The model I further showed that reexperiencing was indirectly 
associated with pain outcomes through anxiety’s significant association with pain 
catastrophinzing, and catastrophizing’s significant association with both pain 
intensity and pain disability. In addition, dysphoria, like numbing in the previous 
SEM model, demonstrated an indirect association with pain-related disability 
through depression. 
 Thus, compared to model H, model I revealed more statistically significant 
direct and indirect relationships between PTSD symptom clusters and various 
pain and psychological outcomes of interest. However, like model H, model I 
shows none of the four PTSD symptom clusters has a significant direct 
relationship with either pain intensity or pain disability. 
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Figure 4.9: SEM path analysis of the relationships among Model I PTSD 
symptom clusters 
Re-
experiencing
Avoidance
Dysphoria
Hype-rarousal
Anxiety
Depression
Pain 
Catastrophizing
Pain Disability
Pain Intensity
0.175**
Model fit statistic : Chi-square 371.92, df=236(p<0.05); RMSEA 0.069 (p<0.05); CFI 
0.925; TLI 0.913
0.447**
0.344**
0.757**
0.133
-0.007
0.523**
0.247**
0.26**
0.316**
 
Note: Re-experiencing (PCL-17 items 1–5), Avoidance (PCL-17 items 6–7), Dysphoria (PCL-17 
items 8–15), and Hyperarousal (PCL-17 items 16–17)) 
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Hypothesis #6: Baseline PTSD will predict pain severity at 9 months, and 
baseline pain severity will predict PTSD at 9 months 
 In the ESCAPE trial, PTSD symptoms were measured at baseline and 9 
months. Patients who screened positive for PTSD were evaluated further using 
the PCL-17 instrument. Patients PTSD were defined as those who were 
screened positive for PTSD and had a PCL-17 total score ≥ 41. To test 
hypothesis #6, logistic regression was conducted first, followed by cross-lagged 
panel analysis.  
 
Logistic regression analysis 
 Logistic regression analyses were used to determine whether baseline 
pain intensity (model 1) or pain disability (model 2), together with baseline PTSD, 
depression, anxiety symptoms and patients’ demographics, predicted PTSD at 9 
months. After adjusting for other factors, both baseline pain intensity score (p-
value=0.02) and baseline pain disability score (p-value=0.003) were independent 
predictors of PTSD at 9 months (table 4.9).  
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Table 4.9: Logistic regression to predict PTSD (PCL-17 total score ≥41) at 9 
months visit 
 
Effect 
Model 1  
(pain intensity as predictor) 
Model 2  
(pain disability as predictor) 
Odds Ratio (95% CI ) p-value Odds Ratio (95% CI ) p-value 
Baseline PTSD 
(PCL-17 ≥ 41) 
13.9 (5.5, 35.1) <.0001 14.2 (5.5, 36.6) <.0001 
Baseline GCPS 
intensity score 
1.03 (1.01, 1.06) 0.02 N.A N.A 
Baseline GCPS 
disability score 
N.A N.A 1.03 (1.01, 1.05) 0.003 
Baseline  Pain 
catastrophizing 
1 (0.96, 1.04)  0.828 0.996 (0.96, 1.04) 0.826 
Baseline PHQ-9 
depression≥10 
1.9 (0.6, 5.7) 0.261 1.71 (0.55, 5.29) 0.351 
Baseline GAD-
7≥10  
9.7 (0.995, 93.7) 0.051 7.13 (0.73, 69.6) 0.091 
Age 1.03 (0.99, 1.09) 0.133 1.03 (0.98, 1.08) 0.194 
Male 1.6 (0.43, 5.9) 0.479 1.7 (0.45, 6.46) 0.434 
White 0.6 (0.23, 1.65) 0.342 0.63 (0.23, 1.71) 0.368 
Employee 0.7 (0.3, 1.7) 0.437 0.7 (0.28, 1.72) 0.433 
Married 1.03 (0.42, 2.5) 0.953 1.12 (0.45, 2.79) 0.809 
Income 
comfortable 
1.58 (0.58, 4.25) 0.369 1.36 (0.5, 3.73) 0.548 
Note: Odds ratio>1 means the variable is a predictor of PTSD at 9 months visit. 
 
 
Cross-lagged panel analysis 
 We examined the cross-lagged relationships between PTSD symptom 
domains and pain severity grade (ranges 1 to 4), using a sample of 144 persons 
with PCL-17 scores assessed at baseline and 9 month visit. Structural equation 
modeling was used to assess the longitudinal relationship between PTSD 
symptoms and pain severity. Based on the results of previous confirmatory factor 
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analysis (table 8), we constructed a cross-lagged model using the two four-factor 
models (model H and I) for PTSD symptoms that provided the best fit of our data.  
Figure 4.10 depicts the cross-lagged model using PTSD factor model H, 
including the factors of re-experiencing (PCL-17 items 1–5), avoidance (PCL-17 
items 6–7), numbing (PCL-17 items 8–12), and hyperarousal (PCL-17 items 13–
17). Figure 4.11 depicts the cross-lagged model using PTSD factor model I, 
including the factors of re-experiencing (PCL-17 items 1–5), avoidance (PCL-17 
items 6–7), dysphoria (PCL-17 items 8–15), and hyperarousal (PCL-17 items 16–
17).  In figure 4.10 and 4.11, coefficients and arrow thicknesses reflect 
significance of standardized path coefficients. Dashed arrows represent 
coefficients that were not significant at p ≥0 .05. For the cross-lagged panel 
analysis based on factor model H, the model fitting is not good, RMSEA=0.087, 
CFI=0.818 and TLI=0.793. The model fitting is slightly better for the cross-lagged 
panel analysis based on factor model I, RMSEA=0.074, CFI=0.868 and TLI=0.85. 
Not surprisingly both models showed the pain severity and PTSD symptom at 9 
months are predicted by baseline values of pain and PTSD respectively. None of 
the PTSD symptom domains were found to be a significant predictor of other 
PTSD symptom domains or pain severity at 9 months. Baseline pain severity was 
not a significant predictor of any of the PTSD symptom domains at 9 months 
either. The results of our cross-lagged panel analysis therefore did not seem to 
support our hypothesis #6.  
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Figure 4.10: Cross-lagged panel analysis based on factor model H 
 
Re-
experiencing
Avoidance
Numbing
Hyperarousal
Pain Severity
Re-
experiencing
Avoidance
Numbing
Hyperarousal
Pain Severity
Baseline 9 months 
Model fit statistic; Chi-squre 1160.773, df=555 (p<0.05); 
RMSEA 0.087 (p<0.05) ; CFI 0.818; TLI 0.793. 
*P<0.05; **P<0.01
0.337*
0.455*
0.668**
0.689**
0.454**
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Figure 4.11: Cross-lagged panel analysis based on factor model I 
 
Re-
experiencing
Avoidance
Dysphoria
Hyperarousal
Pain Severity
Re-
experiencing
Avoidance
Dysphoria
Hyperarousal
Pain Severity
Baseline 9 months 
Model fit statistic; Chi-squre 993.35, df=555 (p<0.05); RMSEA 
0.074 (p<0.05) ; CFI 0.868; TLI 0.85. 
*p<0.05; **P<0.01
0.335*
0.47**
0.667**
0.656**
0.456**
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Hypothesis #7: The longitudinal change in pain severity will be predicted 
by PTSD at baseline. The PTSD at 9 month will be predicted by pain 
intensity and disability at baseline 
 
 To test hypothesis #7, a repeated measures model analysis was 
conducted. 
 
Repeated measure model analysis 
 As shown in table 4.10, two repeated-measures models were conducted 
to examine if the change from baseline to 9 months in pain intensity and pain 
disability was predicted by baseline pain, PTSD, comorbid depression, and 
comorbid anxiety. In model one, the dependent variable is change from baseline 
of GCPS intensity score at each post-baseline visit and baseline GCPS intensity 
is included as a covariate. In model 2, the dependent variable is change from 
baseline of GCPS disability score at each post-baseline visit and baseline GCPS 
disability is included as a covariate. In both models, the independent variables 
also include month (visit), baseline GAD flag, baseline depression flag, baseline 
pain catstrophizing score, and social demographics. After adjustment of patients’ 
demographic effects, the results of the repeated measure model analysis showed 
patients with severe pain intensity and lower pain catastrophizing score at 
baseline achieved more improvement in pain severity after 9 months of 
treatment. Moreover, baseline PTSD symptom severity was found to predict less 
improvement of pain disability over time, while its impact on the improvement of 
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pain intensity was not significant.  In other words, patients with clinically 
significant PTSD symptoms did show significantly less improvement on pain 
disability score (but not pain intensity score) after 9 months. 
Table 4.10: MMRM model: baseline demographics and clinical 
characteristics predict change of pain intensity and disability from baseline 
by visits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: *Negative value means positive effect for pain improvement.  
 
Change from baseline to 9 
months in GCPS intensity 
Change from baseline to 9 
months in GCPS disability 
Effect Estimate* StdErr p-value Estimate* StdErr p-value 
Visits (months)       
  3 vs. 9 2.71 1.03 0.009 3.1 1.38 0.026 
  6 vs. 9 -0.11 0.96 0.907 1.81 1.30 0.166 
PTSD (Baseline 
PCL 17≥41) 
2.26 2.11 0.286 6.38 2.94 0.031 
Baseline GCPS 
intensity 
-0.28 0.06 <.0001 N.A N. A N.A  
Baseline GCPS 
disability 
N.A N. A N.A  -0.44 0.05 <.0001 
Baseline GAD-
7≥10 
0.78 2.42 0.745 0.07 3.33 0.983 
Baseline  Pain 
catastrophizing 
0.19 0.08 0.017 0.38 0.11 0.0008 
Baseline  PHQ-9 
depression≥10 
-0.32 2.13 0.88 1.21 3 0.69 
Age 0.1 0.08 0.252 0.26 0.12 0.031 
Male 0.37 2.52 0.02 -2.56 3.54 0.471 
White -2.52 2.02 0.212 -4.07 2.81 0.149 
Employee 1.34 1.93 0.488 1.9 2.7 0.482 
Married -0.08 1.7 0.945 -0.85 2.38 0.722 
Income 
comfortable 
1 1.78 0.575 2.02 2.49 0.42 
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Chapter V: Discussion and Conclusion 
Overview of significant findings 
 We conducted a series of statistical analyses based on ESCAPE trial data 
to test our hypotheses to the following three research questions: 
1) How strong is the relationship between PTSD and chronic musculoskeletal 
pain?  
2) Which factors affect the relationship between PTSD and chronic 
musculoskeletal pain? 
3) Do specific PTSD symptom domains affect chronic musculoskeletal pain 
outcomes differently? 
 In our analyses and conclusions, PTSD is defined as a positive PTSD 
screen and a PCL-17 score ≥ 41. Pain intensity and pain-related disability are 
measured by the GCPS. Pain severity is defined by 5 grades (ranges 0 to 4) 
based on the combination of pain intensity and pain-related disability measured 
by GCPS (see chapter 3).  
 Table 5.1 (Appendix J) lists the results of our analyses and the 
corresponding hypotheses and research questions. In summary, we found the 
following significant findings: 
1. PTSD was associated with greater pain severity, more psychological 
comorbidity (depression and anxiety), worse pain cognitions (e.g. pain 
catastrophizing), and poorer quality of life.  
2. Greater pain severity was associated with a greater likelihood of PTSD, 
and more depression, anxiety, and pain catastrophizing. 
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3. The coexistence of PTSD and more severe pain severity grade was 
associated with worse SF-36 Physical Component Summary (PCS) and 
Mental Component Summary (MCS) scores. In particular, pain disability 
was directly related to SF-36 PCS scores and PTSD was directly and 
indirectly related to SF-36 MCS scores.  
4. Patients with greater pain severity grade or comorbid depression and 
anxiety were more likely to have PTSD. 
5. Regarding the impact of PTSD on pain, PTSD was related to pain intensity 
directly and indirectly, to pain disability indirectly, and to pain severity 
grade (ranges 1 to 4 based on the combination of pain intensity and pain 
disability) indirectly. The indirect relationships were through the 
association of PTSD with anxiety, depression or pain catastrophizing.  
6. Regarding the impact of pain on PTSD, pain severity grade was related to 
PTSD indirectly through pain catastrophizing. Pain disability was related to 
PTSD directly. Pain intensity was related to PTSD indirectly through pain 
disability. There is a bidirectional relationship between pain intensity and 
pain disability. 
7. In confirmatory factor analyses to examine PTSD symptom domains, the 
two four-factor models of PTSD provided the best fit of our data. The first 
model contained reexperiencing, avoidance, numbing and hyperarousal 
factors. The second model contained reexperiencing, avoidance, 
dysphoria and hyperarousal factors. While none of the four PTSD 
symptom domains were directly related to either pain intensity or pain 
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disability, our analyses showed numbing and dysphoria were indirectly 
related to pain disability through the influence of depression.  
Hyperarousal and reexperiencing were indirectly related to pain disability 
and pain intensity through anxiety and pain catastrophizing.  
8. Patients with PTSD demonstrated less improvement in pain disability over 
9 months. No evidence was found to support the hypothesis that any of 
the four PTSD factors (reexperiencing, avoidance, numbing/dysphoria and 
hyperarousal) were significant predictors of any other PTSD factor or pain 
severity over 9 months.  However, baseline pain intensity and baseline 
pain disability were significant predictors of PTSD at 9 months.  
 
Comparisons with findings from other studies 
 Our first finding (i.e., PTSD was associated with greater pain severity and 
pain catastrophizing, more depression and anxiety, and poorer quality of life) is 
consistent with several other published studies. These studies vary in study 
designs, outcomes, care settings, and sample populations. For example, PTSD 
was found to be significantly associated with higher rates of psychiatric 
comorbidity (including depression and anxiety) in a recent cross-sectional study 
among civilian primary care patients (Lowe, Kroenke et al. 2011). In a 
prospective study of U.S. veterans with rheumatoid arthritis (RA),  patients with 
PTSD  had worse pain than patients with no psychiatric diagnosis (Mikuls, 
Padala et al. 2012). PTSD was also found to be associated with poor quality of 
life in a large community sample of patients, after adjusting for sociodemographic 
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factors, mental disorders, and severity of physical disorders (Sareen, Cox et al. 
2007), as well as greater catastrophizing in a study of 194 veterans with chronic 
pain (Alschuler and Otis 2011).  
 Our second finding (The cohort of veterans with higher pain severity 
reported significantly higher pain catastrophizing scores, and significantly higher 
frequencies and odds of clinically significant PTSD, anxiety and depression) is 
also consistent with other published studies. For example, the National 
Comorbidity Survey, in a representative sample of the general US civilian 
population, found significant positive associations between chronic pain and 
mood and anxiety disorders including depression, generalized anxiety disorder, 
and PTSD (McWilliams, Cox et al. 2003). In a sample of VA primary care patients 
with moderate to severe pain, a sample similar to our ESCAPE study, a high risk 
for psychological distress (including PTSD and depression) was found 
(Sherbourne, Asch et al. 2009). The association between pain severity and pain 
catastrophizing has also been reported in a recent systematic review. In this 
review, high catastrophizing levels were found to be associated with increased 
pain severity, an increased incidence of development of chronic pain, and poorer 
quality of life after surgery (Khan, Ahmed et al. 2011). Another study found both 
patients and their spouses’ catastrophizing was related to pain severity (Cano, 
Leonard et al. 2005). These findings coupled with finding from our study may 
imply that catastrophizing is a common moderator or mediator of both PTSD and 
chronic musculoskeletal pain severity. 
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 Our third finding (The coexistence of more severe pain and clinically 
significant PTSD was associated with worse SF-36 PCS and MCS scores. In 
particular, pain disability was directly related to SF-36 PCS scores and PTSD 
was directly and indirectly related with SF-36 MCS scores. In addition, the 
coexistence of PTSD and chronic pain is associated with poorer SF-36 PCS and 
MCS scores) is consistent in part with a published study, which found patients 
with fibromyalgia syndrome and PTSD reported greater pain, lower quality of life, 
higher functional impairment and suffered more psychological distress than 
patients with PTSD without fibromyalgia syndrome (Amir, Kaplan et al. 1997). 
Although our study bears similarity with other studies regarding the general 
relationship between PTSD, chronic pain, disability and quality of life, our study 
examined these relationships in the latest cohort of veterans and in the context of 
clinical trial. Our study also emphasized the relationship of pain disability (rather 
than pain intensity) with the physical component of quality of life, and the 
relationship of PTSD with the mental component of quality of life. The differential 
relationship of PTSD and pain with the mental and physical domains of quality of 
life seems to complement the finding reported by another study. Palyo and Beck 
(Palyo and Beck 2005) examined the differential association of co-occurring pain 
complaints and PTSD symptoms with disability in the domains of psychosocial 
and physical functioning in participants with motor vehicle accident. Using 
Structural Equation Modeling, they found more severe PTSD symptoms and 
greater pain complaints were related to psychosocial impairment. However, only 
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pain, but not PTSD was significantly related to impairment in physical functioning 
(Palyo and Beck 2005).  
 Our fourth finding (Patients with higher musculoskeletal pain severity 
grade or comorbid depression and anxiety were more likely to have PTSD) is 
consistent with several other studies that reported increased prevalence of PTSD 
among patients with chronic pain (Bryant 1999; Raphael 2004), or with 
preexisting anxiety or depression (Breslau, Davis et al. 1991; Breslau, Peterson 
et al. 2008). Our study is, however, the first one to use CART analysis to identify 
the most important covariates associated with PTSD among patients with chronic 
musculoskeletal pain. Our CART analysis showed that patients with GCPS pain 
severity grades 3 or 4, and comorbid depression and anxiety had the highest 
proportion (54%) of clinically significant PTSD symptoms.  
 Our fifth finding (Regarding the impact of PTSD on pain, PTSD was 
related to pain intensity directly and indirectly, to pain disability indirectly, and to 
pain severity grade indirectly. The indirect relationships were through the 
association of PTSD with anxiety, depression or pain catastrophizing) is 
consistent with several other studies. For example, Lowe et al found that 
adjusting for depression substantially attenuated the association of PTSD and 
trauma with somatic symptoms including chronic pain (Lowe, Kroenke et al. 
2011).  In a sample of 130 male veterans seeking assessment or treatment for 
deployment-related PTSD,  PTSD and pain were moderately related (r = .29), 
and  this relationship was mediated by depression (Poundja, Fikretoglu et al. 
2006). In another cross-sectional, retrospective  study of 411 female patients with 
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orofacial pain, SEM analyses indicated PTSD symptoms likely exert their 
influence on pain severity through depression and sleep quality (Burris, Cyders et 
al. 2009). Relative to the large number of studies reporting depression as a 
mediator of the PTSD-chronic pain relationship, there are much fewer studies 
reporting pain catastrophizing as a mediator of this relationship. Interestingly, one 
study among women undergoing a hysterectomy found pain catastrophizing was 
a full mediator between pre-surgical anxiety (as compared to PTSD) and post-
surgical pain intensity  (Pinto, McIntyre et al. 2012).  The direct association 
between PTSD and pain catastrophizing seen in our study provides additional 
support for a possible mutual maintaining relationship between PTSD and 
chronic pain through catastrophizing.  
 The first part of our sixth finding (Pain severity grade was related to PTSD 
indirectly through pain catastrophizing.) is consistent with another study, which 
found pain catastrophizing, rather than pain severity, was a significant 
determinant of the persistence of post-traumatic stress symptoms (Sullivan, 
Thibault et al. 2009). The second part of our fifth finding (Pain disability was 
directly related to PTSD. Pain intensity was related to PTSD indirectly through 
pain disability.) is partially in line with another published study, which found that 
PTSD symptoms are indirectly influenced by pain intensity through depression 
severity (Roth, Geisser et al. 2008). Both studies used SEM to assess the 
relationship between PTSD and pain intensity. However, unlike our present 
study, which used the Graded Chronic Pain Scale (GCPS) to measure both pain 
intensity and pain disability, the Patient Health Questionnaire (PHQ-9) to 
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measure depression severity, and PCL-17 to measure PTSD symptoms, Roth et 
al. study used the McGill Pain Questionnaire (MPQ) to measure self-reported 
pain intensity, the Pain Disability Index (PDI) to measure pain disability, the 
Center for Epidemiological Studies – Depression Scale (CES-D) to measure 
depression, and the Post-traumatic Chronic Pain Test (PCPT) to measure 
symptoms of PTSD related to pain. The discrepancy between the findings of 
these two studies may result from the different choices of measurement for 
PTSD and pain, which may differ (e.g. PCPT and PCL-17) psychometrically or 
conceptually. The discrepancy may also be due to the fact that different 
hypothesized SEM models were tested, both of which fit sample data well. The 
last part of our sixth finding (There is a bidirectional relationship between pain 
disability and pain intensity.) complements another prospective longitudinal study 
(Katz, Asmundson et al. 2009), of patients who underwent postero-lateral 
thoracotomy for intrathoracic malignancies. This study found concurrent pain 
intensity and emotional numbing, but not avoidance symptoms, made unique, 
significant contributions at each follow-up to pain disability. Together these 
findings (i.e. Pain disability was directly related to PTSD, There is a bidirectional 
relationship between pain disability and pain intensity. And pain intensity 
influences subsequent pain disability) suggest disability may be another 
mechanism to explain a mutual maintaining relationship between PTSD and 
chronic pain. 
 The first part of our seventh finding (In confirmatory factor analyses to 
examine PTSD symptom domains, the two four-factor models provided the best 
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fit for our data. The first model contained reexperiencing, avoidance, numbing 
and hyperarousal factors. The second model contained reexperiencing, 
avoidance, dysphoria and hyperarousal factors.) replicated the results of a cross-
sectional SEM study conducted by Cyders et al (Cyders, Burris et al. 2010), who 
also found the two four-factor models provided the best fit for their data. The 
second part of our finding (None of the four PTSD symptom domains were 
directly related to pain intensity or pain disability) however differs from Cyders et 
al who found that avoidance was directly associated with pain disability, and 
hyperarousal was directly associated with pain severity (intensity). Both Cyders’ 
study and our study found numbing and dysphoria were indirectly related to pain 
disability through the influence of depression. Cyders et al. found sleep quality 
mediates the relationships between reexperiencing and hyperarousal, and pain 
severity. We found anxiety and pain catastrophizing mediates the relationships 
between reexperiencing and hyperarousal, and pain severity and pain disability. 
The effects of the four symptom clusters of PTSD on pain intensity and pain 
disability are further listed in table 5.2 (Appendix K) for Cyders et al study and our 
present study, for comparison purpose. The differences are primarily due to the 
inclusion of different mediating variables in the SEM models. In Cyders et al 
models, sleep quality and general activity level are included, as compared to pain 
catastrophizing, which is included in our present model. The different choices of 
pain outcomes measurement (i.e. MPI vs GCPS) may also lead to a slightly 
different interpretation of pain intensity and pain-related disability, resulting in 
additional differences of complex relationships. 
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 The first part of our eighth finding (Patients with PTSD demonstrated less 
improvement in pain disability over 9 months) complements the finding from a 
published cross-sectional study. Dunn et al. reported patients with PTSD (n = 21) 
experienced significantly less improvement than those without PTSD (n = 119) 
on self-reported outcome measures of neck and low back disability (Dunn, 
Passmore et al. 2009). The second part of our finding (No evidence was found to 
support the hypothesis that any of the four PTSD factors were significant 
predictors of any other PTSD factor or pain severity over 9-months. However 
baseline pain intensity and baseline pain disability were significant predictors of 
PTSD at 9 months.) differed from a longitudinal study which found through SEM 
analyses that the baseline and 12-month pain relationship was mediated by 3-
month arousal; baseline and 12-month arousal and re-experiencing relationships 
were mediated by 3-month pain severity (Liedl, O'Donnell et al. 2010). However, 
our findings are consistent with a 1-year prospective study of 336 
socioeconomically disadvantaged adults treated for orofacial injury.  Glynn et al. 
found pain severity predicted PTSD symptoms at 12 months (Glynn, Shetty et al. 
2007). Our study further demonstrated that pain intensity and pain disability are 
independent predictors of PTSD at 9 months. 
 
Strengths and Limitations 
 Our findings are supported by several strengths in the original design of 
ESCAPE trial, including (1) a high interest study population (i.e. OIF/OEF 
veterans); (2) an explicit decision to include a broad, rather than narrow spectrum 
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of veterans with musculoskeletal pain, such that the study findings will be 
maximally generalizable and pragmatic; (3) a comprehensive set of variables 
collected over time allowing for the evaluation of various theories to explain the 
PTSD-chronic pain relationship. In addition, our hypotheses were based on a 
comprehensive review of published studies and conceptual models, making it 
possible to cross-validate our results against previously published evidence and 
theories. Finally, our study examined and tested a comprehensive set of 
hypotheses using various statistical methods. The combination of various 
findings and use of various statistical methods may give us a more accurate and 
more comprehensive picture of the PTSD-chronic pain relationship. For example, 
the use of CART analysis helped to identify the strongest risk factors of clinically 
significant PTSD symptoms among patients with chronic pain. The use of SEM 
analyses with latent variables helped to assess the simultaneous relationships 
between various PTSD symptom domains and other variables of interest and to 
minimize measurement error in our analyses. In addition, the use of traditional 
logistic regression and repeated measure model analyses helped to identify the 
longitudinal relationship between baseline PTSD/Pain severity and PTSD/Pain 
severity at 9 months.  
 It is worth noting that we used the full ESCAPE sample (N=240) for CART 
analysis and most of our structural equation modeling analyses, to ensure 
sufficient statistical power. While minimum sample size needed is affected by 
data  normality and the desired level of statistical power, the rule of thumb value 
is 10 participants for every free parameter estimated (Schreiber 2006). Although 
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there is little consensus on the recommended sample size for SEM,  several 
researchers have  (Sivo 2006),  (Garver 1999)  (Hoelter 1983) proposed a 
‘critical sample size’ of 200 to provide sufficient statistical power for data 
analysis. 
The present study also has its limitations including: 1) a study sample 
predominantly of white men which may not represent the general population with 
PTSD or chronic pain; 2) the subsample (N=188) may not be sufficient to support 
the analysis of some of our SEM models; 3) PTSD was measured at baseline 
and 9-months rather than every three month, which would have been more 
informative to assess causal relationships; 4) Not all variables of interest were 
measured in the ESCAPE study (e.g. anxiety sensitivity, substance abuse), 
making it impossible to test some relevant theories (e.g.  anxiety sensitivity 
measure to test the Shared Vulnerability model); 5) Only patients with moderate 
to severe pain were included in the ESCAPE study, which is adequate for 
measuring the treatment effect, but provide an inadequate range of pain levels 
for the evaluation of PTSD-pain severity relationship; 6) The cross-sectional 
nature of baseline data analyses prohibit causal inferences regarding to the 
relationship between PTSD, pain and other psychological comorbidities; 7) Lack 
of PCL-17 measurements for all patients (impact of missing data) required 
additional assumptions in the analysis; 8) No control for multiplicity; 9) Lack of 
Replication (not big enough N to have a split sample or replication study. 
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Contributions 
Our findings contribute significantly to what is currently understood about 
the relationship between PTSD and chronic musculoskeletal pain. Although the 
frequent coexistence of PTSD and chronic musculoskeletal pain, and the positive 
correlation between PTSD and chronic musculoskeletal  pain severity, have been 
widely reported and examined by various studies, there has been little consensus 
on the exact causes or influential factors of this relationship. As a result, various 
conceptual models have been proposed to explain the PTSD-pain relationship. In 
summary, our findings suggest there is most likely an indirect association 
between PTSD and chronic musculoskeletal pain severity, which may be 
explained by their shared, direct relationships with anxiety, depression, pain 
catastrophizing, and pain disability. Our findings also suggest a stronger 
relationship between PTSD and each component of chronic musculoskeletal pain 
(i.e. pain intensity and pain disability) than the composite pain severity variable 
which combined intensity and disability into 4 grades of chronic pain. While 
PTSD and the composite pain severity are indirectly related through anxiety, 
depression and pain catastrophizing (fifth and sixth findings), PTSD is found to 
be related to pain intensity directly (fifth finding), and pain disability is found to be 
related to PTSD directly (sixth finding).  
In addition, our findings provided additional empiric support for several 
theoretical models (see the next section: Theoretical and clinical implication), 
especially the Mutual Maintenance model, with data collected from 
Iraq/Afghanistan   war veterans in primary care setting.  
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Importantly, our study contributes to the medical literature by using various 
methodologies to examine the relationship between PTSD and chronic 
musculoskeletal pain. We are not aware of other studies that: 1) combine pain 
intensity and pain disability (classified into five pain grades) for model 
construction; 2) use decision tree techniques to identify risk factors for PTSD in 
patients with chronic pain; or 3) examine mediators or moderators of quality of 
life by various psychological factors in the complex, simultaneous model of PTSD 
and chronic pain. Furthermore, our study applied various statistical methods to 
test a comprehensive set of hypotheses informed by existing conceptual models 
and theories. A combination of all these tests gave us a more comprehensive 
picture of the direction and strength of the relationship between PTSD, chronic 
musculoskeletal pain and other variables. Finally, our study not only examined 
the relationship between the combined PTSD severity measure and chronic 
musculoskeletal pain, but also the relationship between individual PTSD 
symptom clusters and each chronic musculoskeletal pain dimension (pain 
intensity and pain disability). 
 
Theoretical and Clinical Implications of Findings 
Implications and application to mutual maintenance model 
 Our fifth and sixth findings from cross-sectional analyses are consistent 
with the mutual maintenance model. According to the mutual maintenance 
model, PTSD and chronic musculoskeletal pain have a mutual maintaining 
relationship through the mediation of seven identifiable mechanisms including 
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attentional and reasoning bias, anxiety sensitivity, reminders of the trauma, 
avoidance, depression and reduced activity levels, anxiety and pain perception, 
and cognitive demand from symptoms limiting use of adaptive strategies. In 
addition to their direct relationship with PTSD and chronic musculoskeletal pain, 
these seven mechanisms also influence PTSD and chronic musculoskeletal pain 
indirectly through patient distress and disability according to the mutual 
maintenance model. Our fifth finding supported the roles of depression and 
catastrophizing in mediating the relationships between PTSD and chronic 
musculoskeletal pain.  Our fifth finding also revealed a direct association 
between pain disability and PTSD. Although our seventh finding from the 
longitudinal, cross-lagged panel analyses found no significant,  direct relationship 
between  avoidance or re-experiencing and pain severity over a 9-months period 
or vice versa.  Our findings from both logistic regression and mixed model 
repeated measure analyses showed that baseline PTSD has a direct effect on 
pain disability at 9 months, and that both baseline pain intensity and pain 
disability predict PTSD at 9 months. These latter findings provided further 
support for the reciprocal and causal relationships posited by the mutual 
maintenance model. It is worth noting that our cross-lagged panel analysis has 
inherent limitations due to the lack of PTSD measurement in the ESCAPE trial at 
intermediate time points such as 3 and 6 months after the baseline visit, making 
it possible to only conduct a two-wave analysis. However, cross-lagged panel 
analysis has proved to be more powerful if more than two waves (panels) of data 
points are available (Finkel and NetLibrary Inc. 1995). 
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Implications and application to perpetual avoidance model 
 Our seventh finding (Hyperarousal and reexperiencing were indirectly 
related to pain disability and pain intensity through anxiety and pain 
catastrophizing) is consistent with part of the perpetual avoidance model. In the 
perpetual avoidance model, PTSD interacts with pain through hyperarousal to 
pain sensation and catastrophizing/fear-avoidance beliefs. Our sixth finding 
suggests that  hyperarousal and reexperiencing symptoms of PTSD may be the 
most important components because of their direct relationship with pain 
catastrophizing and their indirect relationship to pain intensity and disability.  
 
Implications and application to diathesis-stress model 
 Our seventh finding (Hyperarousal and reexperiencing were indirectly 
related to pain disability and pain intensity through anxiety and pain 
catastrophizing) is also consistent with part of the diathesis-stress model. In the 
diathesis-stress model, anxiety sensitivity results in catastrophizing and fear of 
pain/injury beliefs, which then leads to disability through avoidance behaviors. 
Our seventh finding suggests a direct effect of generalized anxiety symptom 
severity (as compared to anxiety sensitivity) on catastrophizing beliefs, and a 
direct effect of catastrophizing on the level of disability.  
 
Implications for clinical treatment 
 Because psychological factors often go unrecognized (Sherbourne, Asch 
et al. 2009), our first finding highlights the need for providers to be more vigilant 
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in their assessment of PTSD and other mental health problems in patients 
experiencing high pain levels (Sherbourne, Asch et al. 2009), especially for 
veterans seeking primary care treatment. Together, our second and fourth 
findings imply that effective treatment of traumatic pain to maximize pain relief 
may reduce the likelihood of PTSD as higher pain severity is associated with 
clinically significant PTSD symptoms. Treatment of PTSD with cognitive-behavior 
therapy alone proved to be insufficient in patients with severe pain (Taylor, 
Fedoroff et al. 2001). Although Tatrow et al. found pain reduction was weakly 
associated with PTSD symptoms improvement (Tatrow, Blanchard et al. 2003), 
treatment of acute burn pain with morphine may secondarily prevent PTSD 
(Saxe, Stoddard et al. 2001). 
 Our eighth finding indicates that patients with clinically significant PTSD 
symptoms may show  less improvement in pain disability from standard pain 
treatment; implying the need for assessment and possibly more aggressive 
treatment for chronic musculoskeletal pain patients with comorbid PTSD. In 
general, assessment should not only examine the presence and causes of 
musculoskeletal pain, but also the presence and causes of affective distress. And 
treatment should focus on both physical and emotional dysfunction (Thieme, 
Turk et al. 2004). As a result, multidisciplinary collaborative care models of 
treatment may be necessary to collectively address the full spectrum of postwar 
physical and neurocognitive health concerns (Wilk, Herrell et al. 2012).  
 Our fifth finding (PTSD was indirectly related to pain severity through 
depression or pain catastrophizing), sixth finding (Pain severity grade was related 
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to PTSD indirectly through pain catastrophizing), and seventh finding (Numbing 
and dysphoria were  indirectly related to pain disability mediated by depression, 
and hyperarousal and reexperiencing PTSD symptom domains were indirectly 
related to pain disability and pain intensity mediated by anxiety and pain 
catastrophizing) further imply that a comprehensive treatment approach of PTSD 
and pain in veteran populations should also include careful assessment and 
regular monitoring of depression (Poundja, Fikretoglu et al. 2006) as well as pain 
catastrophizing. These findings also point to the importance of unresolved PTSD 
symptoms in contributing to the level of depression, anxiety, pain, and disability 
seen in  chronic musculoskeletal pain patients and highlights the need to 
consider directed and primary treatment of PTSD in pain rehabilitation programs 
(Roth, Geisser et al. 2008).  
 In summary, the frequent co-occurrence of PTSD and chronic 
musculoskeletal pain and their mutual influence on each other through various 
mechanisms as shown in our study provided further support for the Mutual 
Maintenance model. Our study findings also suggest an integrated treatment 
approach targeting both physical symptoms including pain and psychological 
disorders including PTSD simultaneously might be more effective than traditional 
approach that targets either PTSD or chronic musculoskeletal pain separately, 
especially for patients with poor outcomes from traditional treatment. Similarly, 
any clinical trial targeting an intervention for chronic musculoskeletal pain also 
needs to consider PTSD and other psychological disorders, and vice versa.     
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Conclusions and Future Directions 
 Given our findings corresponding to each of our three research questions, 
we conclude that 
1) While our cross-lagged panel analyses did not show a mutual maintaining 
relationship between chronic musculoskeletal pain severity and any of the four 
PTSD symptom domains over 9 months, our logistic regression analysis and 
mixed model repeated measure analysis did show that baseline pain intensity 
and pain disability predicted PTSD at 9 months. Furthermore, the reciprocal 
relationship was seen; baseline PTSD predicted improvement of pain disability at 
9 months. Moreover, our SEM path analyses also demonstrated direct 
relationships between certain components of chronic musculoskeletal pain and 
PTSD, and indirect relationships mediated by depression and pain 
catastrophizing. Together these findings support a mutual maintaining 
relationship between chronic musculoskeletal pain and PTSD, as proposed by 
the mutual maintenance model. A longitudinal study which measures PTSD, 
chronic pain and other variables of interest at more than two points of time will be 
helpful in increasing our confidence in evaluating the mutual maintenance theory. 
2) Although our data identified depression, generalized anxiety, and 
catastrophizing as mediating factors between PTSD and chronic pain, they are 
by no means the only factors believed to be important. Due to constraints of the 
ESCAPE trial, other potentially important factors thought to mediate or moderate 
the relationship between PTSD and chronic pain were not included in our 
analyses. To increase our understanding of the complex relationship between 
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PTSD and chronic pain, future research needs to increase the number of 
variables measured that are hypothesized to influence this relationship.  
3) Our SEM path analyses with cross-sectional data revealed differential 
associations between different PTSD symptom domains and different pain 
outcomes (pain intensity and pain disability); some mediated by pain 
catastrophizing, depression, or generalized anxiety.  These associations suggest 
treatment approaches may need to target individual symptom domains to be 
effective in treating patients with chronic musculoskeletal pain and PTSD. For 
example, relaxation techniques can be used to treat hyperarousal and pain 
intensity, while biofeedback and physical activation may be used to treat pain 
catastrophizing, avoidance and pain disability.  
 Recognizing the role of depression and pain catastrophizing in mediating 
the relationship between PTSD and chronic musculoskeletal pain is important in 
optimizing care for both PTSD and chronic musculoskeletal pain.  The high 
frequency of co-occurring PTSD and chronic musculoskeletal pain and the 
various mechanisms (including cognitive, affective, behavioral, biological and 
social factors) through which these two conditions relate to and interact with each 
other present significant challenges to clinicians in a variety of clinical settings, 
especially in primary care setting where PTSD and other psychological disorders 
are often unrecognized. Improving awareness and understanding of these two 
conditions and their intersection may help clinicians find better treatment 
approaches for patients seeking treatment for either PTSD or chronic 
musculoskeletal pain alone. A thorough biopsychosocial history and assessment 
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for other medical and psychiatric illnesses including PTSD has been 
recommended to improve pain management (Gibson 2012). Effective 
management of pain often includes  an integrated and multidisciplinary approach 
involving a team of clinicians with varying expertise and clinical focus to address 
the physical, social, psychological, and spiritual components of pain in an 
individualized treatment plan that is specifically tailored to the patient and type of 
pain condition (Gibson 2012; Smeeding, Bradshaw et al. 2010). More research is 
needed to identify the most effective way of treating patients with chronic pain, 
PTSD and other psychological disorders, and to improve existing clinical practice 
guidelines (VA/DOD 2010) . 
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Appendices 
Appendix A 
DSM-IV Criteria for Posttraumatic Stress Disorder 
A. The person has been exposed to a traumatic event in which both of the 
following have been present:  
(1) the person experienced, witnessed, or was confronted with an event or 
events that involved actual or threatened death or serious injury, or a threat to 
the physical integrity of self or others (2) the person's response involved intense 
fear, helplessness, or horror. Note: In children, this may be expressed instead by 
disorganized or agitated behavior. 
B. The traumatic event is persistently reexperienced in one (or more) of the 
following ways:  
(1) recurrent and intrusive distressing recollections of the event, including 
images, thoughts, or perceptions. Note: In young children, repetitive play may 
occur in which themes or aspects of the trauma are expressed. 
(2) recurrent distressing dreams of the event. Note: In children, there may be 
frightening dreams without recognizable content. 
 
(3) acting or feeling as if the traumatic event were recurring (includes a sense of 
reliving the experience, illusions, hallucinations, and dissociative flashback 
episodes, including those that occur upon awakening or when intoxicated). Note: 
In young children, trauma-specific reenactment may occur. 
(4) intense psychological distress at exposure to internal or external cues that 
symbolize or resemble an aspect of the traumatic event. 
(5) physiological reactivity on exposure to internal or external cues that symbolize 
or resemble an aspect of the traumatic event. 
C. Persistent avoidance of stimuli associated with the trauma and numbing of 
general responsiveness (not present before the trauma), as indicated by three (or 
more) of the following:  
(1) efforts to avoid thoughts, feelings, or conversations associated with the 
trauma  
(2) efforts to avoid activities, places, or people that arouse recollections of the 
trauma  
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(3) inability to recall an important aspect of the trauma  
(4) markedly diminished interest or participation in significant activities  
(5) feeling of detachment or estrangement from others  
(6) restricted range of affect (e.g., unable to have loving feelings)  
(7) sense of a foreshortened future (e.g., does not expect to have a career, 
marriage, children, or a normal life span) 
D. Persistent symptoms of increased arousal (not present before the trauma), as 
indicated by two (or more) of the following:  
(1) difficulty falling or staying asleep  
(2) irritability or outbursts of anger  
(3) difficulty concentrating  
(4) hypervigilance  
(5) exaggerated startle response 
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 
one month. 
F. The disturbance causes clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. 
Specify if:  
Acute: if duration of symptoms is less than 3 months  
Chronic: if duration of symptoms is 3 months or more 
Specify if:  
With Delayed Onset: if onset of symptoms is at least 6 months after the stressor 
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Appendix B 
Table 2.1: Prevalence of PTSD in Pain Samples 
Author No. of 
Patients 
Study Setting Pain Type Patients with 
PTSD, % 
Muse 1985 64 Pain Clinic Chronic pain 
6-12m 
6/64 
Benedikt 1986 225 VA pain clinic Chronic pain 22 (10%) 
Amir, Kaplan et al. 
1997 
29 Psychiatric clinic Fibromyalgia 21% 
Asmundson, 
Norton et al. 1998 
139 rehabilitation 
program 
chronic pain 34.70% 
Sherman, Turk et 
al. 2000 
93 Pain Clinic Fibromyalgia 52(56%) 
Cohen, Neumann 
et al. 2002 
77 Rheumatology 
outpatient clinic 
Fibromyalgia 57% 
Roy-Byrne, Smith 
et al. 2004 
571 Referral clinic Fibromyalgia 20%PTSD;42
%MDD 
De Leeuw, Bertoli 
et al. 2005 
1478 tertiary care 
center 
chronic 
orofacial pain 
218, 15% 
de Leeuw, 
Schmidt et al. 
2005 
80 headache 
patients; 80 
muscle pain 
Orofacial Pain 
Center 
Headache; 
muscle pain 
51(64%); 
42(52%) 
Balasubramaniam, 
de Leeuw et al. 
2007 
32 Physical 
Medicine and 
Rehabilitation 
Clinic 
Fibromyalgia 41.30% 
Bertoli, de Leeuw 
et al. 2007 
445; muscle 
pain=242; 
joint pain= 
203 
    36,14.9%; 
20,9.9% 
Meltzer-Brody, 
Leserman et al. 
2007 
713 women referral-based 
pelvic pain clinic 
chronic 
pelvic pain 
31.30% 
Jenewein, 
Moergeli et al. 
2009 
40 Department of 
Traumatology 
accident-
related pain 
Chronic pain 
9(22.5%) 
subsyndramal 
PTSD 
Ifergane, Buskila 
et al. 2009 
92 Headache Clinic migraine 6(6.5%) 
Peterlin, Tietjen et 
al. 2009 
593 6 headache 
centers. 
Migraine; 
chronic daily 
headache 
22.4%;30.3% 
Jenewein, 
Moergeli et al. 
2009 
40 Department of 
Traumatology 
accident-
related pain 
Chronic pain 
4/40(10%) 
Williams, Newman 
et al. 2009 
106 Medical records hand-injured 
patients 
32/106 
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Appendix C 
Table 2.2: Rates of PTSD among Patients with and without Chronic Pain 
Author No. of 
Patients 
Study Setting Pain type With vs. Without 
Chronic Pain 
Bryant 1999 96 Interviews on 
patients 
admitted to a 
major brain 
injury 
rehabilitation 
unit 
chronic pain 
defined as pain 
that had existed 
for at least 6 
months and that 
occurred at least 
once a week 
Chi-square analyses 
indicated that more 
patients who 
reported chronic 
pain (37%) met 
criteria for PTSD 
than did those 
without pain (15%),  
(P < 0.05) 
Raphael 2004 1312 telephone 
survey of 
Community 
dwelling women 
fibromyalgia probable PTSD 
odds>3 (odds=5.18 
(2.99, 8.99)) among 
women with FM-like 
symptoms 
Johnson 2006 1,219 
female 
veterans 
Cross-sectional 
mailed survey  
mastalgia Compared to 
women without 
mastalgia, women 
reporting frequent 
mastalgia were 
more likely to screen 
positive for PTSD 
(odds ratio [OR] 5.2, 
95% confidence 
interval [CI] 3.2 to 
8.4), major 
depression (OR 4.2, 
2.6 to 6.9) 
McWilliams, 
Cox et al. 
2003 
5877 a sample 
representative 
of the general 
US civilian 
population 
chronic pain  Chronic pain was 
strongly associated 
with post-traumatic 
stress disorder 
(OR=3.69). The 
presence of one 
psychiatric disorder 
was not significantly 
associated with 
pain-related 
disability, but the 
presence of multiple 
psychiatric disorders 
was significantly 
associated with 
 134 
 
increased disability 
Liebschutz 
2007 
509 patients 
awaiting 
primary care 
appointments in 
an urban 
academic 
medical center 
chronic pain The prevalence of 
PTSD, adjusted for 
age, gender, race, 
and marital and 
socioeconomic 
statuses, was higher 
in participants with, 
compared to those 
without, chronic pain 
(23 vs. 12%, p = 
.003) 
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Appendix D 
Table 2.3: Effects of chronic pain on patients with PTSD 
Key Study Sample 
Size 
Sample Type Design Key Finding 
Jenewein, 
Moergeli et 
al. 2009 
90 Patients with 
sustained 
accidental injuries 
refereed to the 
intensive care unit 
prospective 
longitudinal 
cohort design 
Individuals with 
chronic pain showed 
significantly more 
symptoms of PTSD, 
depression, and 
anxiety, more 
disability, and more 
days off work. The 
development of 
chronic pain is more 
related to 
psychological factors, 
particularly PTSD 
symptoms 
Page, 
Kleiman et 
al. 2009) 
447 pain and pain-free 
patients scheduled 
for major surgery 
cross-sectional 
design 
In pain-free patients, 
PTSD symptoms were 
best expressed as 2 
symptom clusters (re-
experiencing/ 
avoidance; emotional 
numbing/hyperarousal
) accounting for 52.4% 
of the variance. In 
pain patients, PTSD 
symptoms were best 
expressed as a single 
symptom cluster 
accounting for 51.1% 
of the variance 
(Van Loey, 
Maas et al. 
2003) 
301 Patients with burn 
injury from six 
burn centers 
prospective 
longitudinal 
cohort design 
1) pain related anxiety 
correlated positively 
with PTSD symptom 
severity at 2 weeks 
and 12 months post 
burn; 2) pain-related 
anxiety predicted 
posttraumatic stress 
symptoms at 1-year 
after the burn injury 
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Liedl, 
O'Donnell et 
al. 2010 
824 Patients admitted 
to four hospitals 
following traumatic 
injuries 
longitudinal 
study 
SEM shows baseline 
and 12-month pain 
relationship mediated 
by 3-month arousal; 
Baseline and 12-
month arousal and re-
experiencing 
relationships mediated 
by 3-month pain 
Sullivan, 
Thibault et 
al. 2009) 
112 Individuals with 
whiplash injuries 
who had been 
admitted to a 
standardized 
multidisciplinary 
rehabilitation 
program 
prospective 
study 
1) pain and pain-
related psychological 
as indicators of injury 
severity were 
associated with more 
severe post-traumatic 
stress symptoms; 2) 
Contrary to 
expectations, 
indicators of pain 
severity did not 
contribute to the 
persistence of post-
traumatic stress 
symptoms; 3) pain 
catastrophizing were 
one of the significant 
determinants of the 
persistence of post-
traumatic stress 
symptoms 
Glynn, 
Shetty et al. 
2007 
336 patients treated for 
orofacial injury at a 
Level I trauma 
center 
prospective 
study 
Patient report of pain 
severity was one of 
the predictor of PTSD 
symptoms at 12 
months 
(Whitehead, 
Perkins-
Porras et al. 
2006) 
135 patients admitted 
to four coronary 
care units 
Two-phase 
prospective 
study 
Severity of chest pain 
and psychological 
factors during 
admission were 
predictive of PTSD 
severity 
Chossegros, 
Hours et al. 
2011 
541 patients 
hospitalized after a 
road traffic 
accident 
prospective 
cohort study 
persistent pain 6 
months after the 
accident is associated 
with PTSD 
Bonin, 
Norton et al. 
2000 
33+29 patients with 
comorbid PTSD 
and substance, or 
comorbid PTSD 
and chronic pain 
cross-sectional 
design 
Patients with chronic 
pain and PTSD 
reported greater 
severity scores for 
many indices (i.e., 9 of 
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17 PTSD symptoms), 
whereas patients 
with SA+PTSD had 
significantly greater 
frequency scores (i.e., 
8 of 17 PTSD 
symptoms). 
Humphreys, 
Cooper et 
al. 2010 
84 community-based 
sample of formerly 
abused women 
cross-sectional 
design 
Compared to women 
with mild pain, women 
with moderate to 
severe chronic pain 
had higher levels of 
depressive and PTSD 
symptoms  
Norman, 
Stein et al. 
2008 
115 patients admitted 
to a Level I 
surgical trauma 
center 
prospective 
observational 
study 
Peritraumatic pain 
was associated with 
an increased risk of 
PTSD 
Palyo and 
Beck 2005 
183 patients with a 
motor vehicle 
accident and 
reported pain due 
to accident-related 
injuries 
cross-sectional 
design 
more severe PTSD 
symptoms and greater 
pain complaints were 
related to 
psychosocial 
impairment, however, 
only pain was 
significantly related to 
impairment in physical 
functioning 
Ponsford, 
Hill et al. 
2008 
113+61 orthopedic trauma 
patients, recruited 
during 
rehabilitation, and 
demographically 
similar uninjured 
controls 
prospective 
longitudinal 
cohort study 
pain and PTSD 
symptoms predict 
ongoing disability after 
orthopedic trauma 
Amir, 
Kaplan et al. 
1997 
29 PTSD patients 
from a trauma 
clinic due to mixed 
types of trauma 
cross-sectional 
design 
PTSD subjects 
suffering from 
fibromyalgia syndrome 
were more tender, 
reported more pain, 
lower quality of life, 
higher functional 
impairment and 
suffered more 
psychological distress 
than the PTSD 
patients not having 
fibromyalgia syndrome 
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Appendix E 
SEM Fit Indices and their acceptable thresholds (Hooper 2008, Hoe 2008) 
 
  
Index (Range) Guidelines for interpretation Cutoff for the 
current study 
Chi Square (χ2) Nonsignificant χ2 suggests the model fits 
the data (i.e., differences are non-
significant). Usually significant in larger 
samples. 
 
> 0.05 
 
Relative χ2 (χ2/df)  
 
2:1 (Tabachnick 2007) 
3:1 (Kline 2005) 
 
Adjusted for 
sample size 
Root Mean Square Error 
of Approximation 
(RMSEA; 0 - ∞) 
 
Values less than 0.08 (Hoe 2008) 
 
<0.08;Values 
less than 0.05 
represent 
excellent fit.  
 
Comparative Fit Index  
(CFI; 0 – 1) 
 
 
Values closer to 1 indicate better fitting 
model; suggested cutoff is 0.95 (Hu 1999) 
 
≥ 0.90 was 
initially 
advanced ; 
> 0.95 good fit 
Non-Normed Fit Index 
(NNFI;TLI)  
 
An index that prefers simpler models; can 
go above 1.0 (Hu 1999) 
 
0.90 
acceptable fit; 
> 0.95 good fit 
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Table 2.4: Conceptual Models on PTSD and Chronic Pain Relationship 
# Model Name Key Points Model Classes Comments 
1 Mutual 
Maintenance 
Model 
(Sharp and 
Harvey 2001) 
PTSD and chronic pain maintain each other 
through increased distress and disability 
caused by: 
1) attentional and reasoning biases; 
2) anxiety sensitivity; 
3) reminders of the trauma; 
4) avoidance of activities and sensations 
associated with pain and trauma; 
5) depression and reduced activity 
levels; 
6) anxiety and pain perception; 
7) cognitive demand from symptoms 
limiting use of adaptive strategies 
Class #1: Mutual 
Maintenance 
1. Most widely cited model, 
validated partially by multiple 
studies.  
2. Unlike other models such as 
shared vulnerability model, this 
model focuses on the interaction 
rather than the cause of PTSD 
and pain, and offers a simplified 
view on the inherently complex 
relationship between PTSD, 
pain, distress and disability 
2 Shared 
Vulnerability 
Model 
(Asmundson, 
Coons et al. 
2002) 
People with high level of anxiety sensitivity 
are vulnerable to develop and maintain 
both PTSD and chronic pain. 
 
Class #2: Shared 
Vulnerability 
1. Focus on one of the common 
causes of PTSD and chronic 
Pain 
2. Simple, one-directional 
relationship 
3. Few citations. Not validated 
by any empirical study 
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3 Perpetual 
Avoidance 
Model 
(Liedl and 
Knaevelsrud 
2008) 
PTSD and chronic pain maintain each other 
through the interaction between the causal 
components of PTSD circle including 
1) dysfunctional cognition/intrusions, 
which causes 2) 
2) hyperarousal, which causes 3) and 4) 
3) avoidance/inactivity, which causes 1) 
, and the causal components of pain circle 
including 
4) pain sensation, which causes 5) 
5) catastrophizing/fear avoidance beliefs, 
which causes 3) 
3) avoidance/inactivity, which causes 1) 
and 4) 
Class #1: Mutual 
maintenance 
1. Involve interplay and mutual 
maintenance of chronic pain 
symptoms and PTSD symptoms  
2. Complex, one-directional 
model (except for avoidance<-
>pain sensation)  
3. No mention on the role of 
anxiety sensitivity and comorbid 
psychiatric disorders 
4 Triple 
Vulnerability 
Model 
(Otis, Keane et 
al. 2003) 
People with an integrated set of triple 
vulnerabilities are vulnerable to develop 
and maintain both PTSD and chronic pain: 
1) a generalized biological vulnerability,  
2) a generalized psychological 
vulnerability based on early 
experiences of control over salient 
events,  
3) a more specific psychological 
vulnerability in which one learns to 
focus anxiety on specific situations 
 
Class #2: Shared 
Vulnerability 
1. More general than shared 
vulnerability model but less than 
diathesis–stress model 
2. Lack of evidence to apply the 
full triple vulnerability model to 
the development of chronic pain 
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5 Fear Avoidance 
Model 
(Vlaeyen and 
Linton 2000; 
Otis, Keane et 
al. 2003) 
Fear can develop and maintain both PTSD 
and chronic pain through avoidance behavior: 
1) Fear of pain causes avoidance of 
painful movement or activities  
2) Fear of reexperiencing disturbing 
thoughts of events causes avoidance 
of reminders associated with the 
trauma  
3) Avoidance behavior causes the 
development and maintenance of 
PTSD and chronic pain symptoms 
Class #3: Shared 
pathway  
Extended from chronic pain 
model; Focuses on shared 
symptom (i.e. avoidance) 
between PTSD and chronic pain 
6 Stress System 
Dysregulation 
model 
(McLean, Clauw 
et al. 2005) 
Dysregulation of stress response system after 
trauma can develop and maintain both 
PTSD and chronic pain due to its interaction 
with cognitive-behavioral factors, such as 
avoidance learning. 
Class #3: Shared 
pathway 
1. Involve the interplay between 
psychological, behavioral and 
biological factors;  
2. Acute stress->stress system 
dysregulation->PTSD->chronic 
pain 
7 Diathesis-stress 
model 
(Dersh 
2002;Turk 
2002;Martin 
2010) 
1. People with pre-existing 
psychopathology vulnerability (i.e. 
diathesis) are vulnerable to develop 
PTSD or chronic pain due to acute 
or constant stress associated with 
trauma or pain. 
2. At the same time, and in a reciprocal 
manner, PTSD intensifies the pain or 
traumatic event experience, making it 
impossible to treat either condition 
independently of the other. 
Class #2: Shared 
Vulnerability  
1. Extended from chronic pain 
model; Involve the interplay 
between predisposing 
vulnerability factor, pain or 
traumatic event related stressor, 
and subsequent psychological 
factors; More comprehensive 
than shared vulnerability model 
and triple vulnerability model ;  
2. Trauma or pain ->stress 
3. Stress + diathesis  -> PTSD -
> pain 
 
  
  
142 
Appendix G 
Table 3.5: List of existing studies supporting our hypotheses 
Study Study population 
Sample 
size 
Analytic 
Methods 
Hypothesis 
Supported Results 
Geisser, 
Roth et al. 
1996 
patients with 
chronic pain 
referred to a 
multidisciplinary 
pain center 
241 
Used MANCOVA 
and ANCOVA to 
examine group 
differences 
#1 
Patients with accident-related pain and 
high PTSD symptoms displayed higher 
levels of self-reported pain compared to 
patients with accident-related pain and 
no or few PTSD symptoms, and to 
patients with pain that's not accident 
related and without PTSD  symptoms 
Beckham, 
Crawford et 
al. 1997 
combat veterans 
with PTSD who 
visited out-patient 
PTSD clinic  
103 
Used multiple 
regression 
analyses to 
examine 
relationship 
between pain and 
PTSD symptoms. 
#1 
 B PTSD symptoms (reexperiencing 
symptoms) were significantly related to 
pain disability, overall pain index, and 
depression scores were also significantly 
related to percent body pain 
Van Loey, 
Maas et al. 
2003 
Burn center 
patients 301 
Used hierachical 
linear regression 
model to analyze 
predictors of 
PTSD symptoms 
#7 Increase in pain is associated with increase in PTSD symptom severity 
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Glynn, 
Shetty et al. 
2007  
socioeconomicall
y disadvantaged 
adults treated for 
orofacial injury at 
a Level I trauma 
center 
336 
Used univariate 
analyses to test 
the predictores of 
PTSD symptoms 
#6 
Predictors of PTSD symptoms at 12 
months included current and lifetime 
mental health and social service needs, 
lifetime social service use, prior trauma 
exposure, sum of stressful life events in 
the year preceding injury, patient report 
of pain severity and inadequate social 
support at 10 days postdischarge, and 
PTSD scores at 1 month 
Norman, 
Stein et al. 
2008 
Level 1 Surgical 
Trauma Center 115 
Used logistic 
regression to 
compute 
unadjusted 
odds ratio for 
each of the 
previously 
identified risk 
factors measured 
in this study 
#7 
Peritraumatic pain was associated with 
an increased risk of PTSD, even after 
controlling for a number of other 
significant risk factors other than acute 
stress disorder symptoms. An increase 
of 0.5 s.d. from the mean in a 0-10 pain 
rating scale 24-48 h after injury was 
associated with an increased odds of 
PTSD at 4 months by more than fivefold, 
and at 8 months by almost sevenfold. A 
single item regarding amount of pain at 
the time of hospital admission correctly 
classified 65% of participants 
Humphreys
, Cooper et 
al. 2010 
community-based 
sample of 
formerly abused 
women 
84 
Used logistic 
regression 
analysis to 
compute odds 
ratio of PTSD and 
depression 
#2 
Women with moderate to severe chronic 
pain had equally high levels of 
depressive and PTSD symptoms and 
multiple trauma exposures 
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Whitehead, 
Perkins-
Porras et 
al. 2006  
Inpatient with 
acute cronary 
symdroms 
135 
Used chi-square 
(for categorical 
measures) and t 
tests (for 
continuous 
measures) to 
compared 
patients in PTSD 
and non-PTSD 
groups 
#6 
Severity of chest pain and psychological 
factors during admission were predictive 
of PTSD severity; Acute stress 
symptoms, depression, negative affect, 
hostility, and pain scores were 
independent predictors of three-month 
PTSD symptoms 
Jenewein, 
Wittmann 
et al. 2009  
sustained severe 
accidental injuries  90 
Group 
comparisons of 
dimensional 
variables were 
performed with 
independent 
samples Used t 
tests, one-way 
ANOVA, χ2, or 
Fisher's exact 
test, multivariate 
analysis of 
variance, and 
logistic regression 
for group 
comparisons and 
predictor 
assessing. 
#1, #6 
The prevalence of chronic pain in 
severely injured patients 3 years after 
the accident is considerably high. The 
development of chronic pain is more 
related to psychological factors, 
particularly PTSD symptoms, in the 
aftermath of the accident, as compared 
to sociodemographic and accident-
related variables at the time of the 
accident 
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Ramchand, 
Marshall et 
al. 2008  
hospitalized for 
injuries resulting 
from community 
violence 
413 
Structural 
equation 
modeling/cross-
lagged structural 
model 
#6 
Posttraumatic distress and physical 
functioning are reciprocally related. 
Individuals with high levels of 
psychological distress at 1 week 
posttrauma have worse physical 
functioning at 3 months. Psychological 
distress at 3 months was not significantly 
associated with subsequent change in 
physical functioning at 12 months. 
Individuals with poor physical functioning 
at 3 months had higher than expected 
levels of psychological distress at 12 
months. 
Zatzick, 
Jurkovich 
et al. 2008 
Combined 
pediatric-adult 
level I trauma 
center; 
adolescent injury 
survivors aged 12 
to 18 years  
108 Mixed-model regression #1, #6 
High baseline PTSD symptom levels 
were associated with significant 
impairments in CHQ-87 Role/Social 
Behavioral, Role/Social Physical, Bodily 
Pain, General Behavior, Mental Health, 
and General Health Perceptions 
subscales. High baseline depressive 
symptoms were associated with 
significant impairments in CHQ-87 
Physical Function, Role/Social 
Emotional, Bodily Pain, Mental Health, 
Self-esteem, and Family Cohesion 
subscales. 
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Cyders 
2010 
female patients 
with orofacial pain 411 
confirmatory 
factor analysis; 
structural 
equation 
modeling path 
analyses 
#5 
The hyperarousal symptom cluster 
exerted both 
direct effects and indirect effects on pain 
severity, through sleep quality. 
Additionally, the numbing symptom 
cluster was predictive of pain-related 
disability and pain severity through its 
effects on depression. Avoidance had a 
direct effect on pain-related disability and 
an indirect effect on pain-related 
disability through reduced general 
activity levels. Re-experiencing had 
direct effects on both hostility 
and anxiety. 
ESCAPE 
study 
War veterans  
from VA 
outpatient clinics 
242 
logistic 
regression; 
multiple 
regression; 
repeated 
measures; 
confirmatory 
factor analysis; 
structural 
equation 
modeling path 
analysis; 
structural 
equation 
modeling cross-
lagged panel 
analysis; CART 
analysis 
#1 -#7 See chapter 4 and 5 
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Table 4.2: Pearson correlations between baseline PTSD, pain, health-related quality of life, and psychological 
factors among 188 patients who screened positive for PTSD 
 
 PCL 
17 
GCPS 
pain 
intensity 
GCPS 
disability 
GCPS 
disability 
days 
PHQ-9  GAD-
7  
pain 
catastrophizing 
score 
PCS MCS 
PCL 17 1 0.26 0.38 0.3 0.74* 0.74* 0.42 -0.06 -0.71* 
GCPS pain 
intensity 
0.26 1 0.45 0.3 0.19 0.17 0.29 -0.4 -0.18 
GCPS disability 0.38 0.45 1 0.54 0.43 0.35 0.39 -0.6* -0.4 
GCPS disability 
days 
0.30 0.3 0.54 1 0.33 0.29 0.26 -0.38 -0.26 
PHQ-9 
depression 
0.74* 0.19 0.43 0.33 1 0.72* 0.45 -0.15 -0.77* 
GAD-7 Anxiety 0.74* 0.17 0.35 0.29 0.72* 1 0.52 -0.06 -0.69* 
pain 
catastrophizing 
score 
0.42 0.29 0.39 0.26 0.45 0.52 1 -0.27 -0.4 
PCS -0.06 -0.4 -0.6* -0.38 -0.15 -0.06 -0.27 1 -0.13 
MCS -0.71* -0.18 -0.4* -0.26 -0.77* -0.69* -0.4 -0.13 1 
Note: PCS= SF-36 physical component score; MCS= SF-36 mental component score; *strong correlation 0.6 ≥ r < 0.8 or -0.8<r≤-0.6. 
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Comparison of different SEM models examining the relationship of PTSD and pain at baseline. 
  Depression and anxiety  Pain  PTSD  
PTSD and pain 
relationships (*significant 
P-value<0.05) 
SF-36 Fit indices 
SEM Model 
A (Figure 
4.1) 
Anxiety and 
depression are 
separated 
Pain severity 
is included in 
the model, 
which is the 
combination 
of pain 
intensity and 
pain 
disability 
components 
measured by 
the GCPS. 
PTSD is 
defined 
as PCL 
17≥41. 
1) PTSD has a *direct 
effect on anxiety), and an 
*indirect effect on pain 
severity through 
depression . 
2) Pain severity has an 
*indirect effect on PTSD 
through pain 
catastrophizing. 
1) The mental 
health 
component 
score is 
*affected by 
depression or 
the 
combination 
of depression 
and anxiety.  
2) The physical 
health 
component 
score  is 
*affected by 
the severity of 
pain  
Model fit is 
acceptable:  
relative Chi-
square = 3.04, 
RMSEA 
=0.092, 
CFI=0.971, 
TLI=0.939 
SEM Model 
B (Figure 
4.2) 
Anxiety and 
depression are 
combined 
1) PTSD has an indirect 
effect on pain severity 
through pain 
catastrophizing or *through 
comorbid anxiety and 
depression. 
Model fit is 
good: relative 
Chi-square = 
1.40, RMSEA 
=0.041, 
CFI=0.992, 
TLI=0.98 
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SEM Model 
C (Figure 
4.3) 
Pain intensity 
and pain 
disability are 
included in 
the model 
separately, 
assuming 
pain 
disability has 
a *direct 
effect on 
pain 
intensity. 
1) PTSD has a *direct 
effect on pain intensity, 
and an *indirect effect on 
pain disability through 
comorbid anxiety and 
depression and pain 
catastrophizing.  
2) Pain disability has a 
*direct effect on PTSD.  
1) The mental 
health 
component 
score is 
*affected by 
the severity of 
PTSD, and the 
combination 
of depression 
and anxiety.  
2) The physical 
health 
component 
score is 
*affected by 
pain disability  
Model fit is 
good: relative 
Chi-square = 
1.36, RMSEA 
=0.038, 
CFI=0.992, 
TLI=0.98 
SEM Model 
D (Figure 
4.4) 
Pain intensity 
and pain 
disability are 
included in 
the model 
separately, 
assuming 
pain intensity 
has a *direct 
effect on 
pain 
disability. 
1) PTSD has an *indirect 
effect on pain intensity 
through comorbid anxiety 
and depression and pain 
catstrophizing.  
2) Pain disability has a 
*direct effect on PTSD.  
Model fit is 
good: relative 
Chi-square = 
1.92, RMSEA 
=0.062, 
CFI=0.973, 
TLI=0.949 
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SEM model 
based on 
factor model 
H (Figure 
4.8) 
Anxiety and 
depression are 
separated 
Pain intensity 
and pain 
disability are 
included in 
the model 
separately 
The 
following 
four 
PTSD 
factors 
are 
included 
in the 
model 
separatel
y as 
latent 
variables: 
Re-
experienc
ing, 
Avoidanc
e, 
Numbing, 
and 
Hyperaro
usal 
1) The re-experiencing 
latent variable is indirectly 
associated with pain 
intensity through anxiety 
and pain catastrophizing.  
2) The avoidance latent 
variable is directly 
associated with pain 
disability. 
3) The numbing latent 
variable is *indirectly 
associated with pain 
disability through its 
association with depression.  
4) The hyperarousal latent 
variable is *indirectly 
associated with pain 
intensity through anxiety 
and pain catastrophizing.  
Not included in 
the model 
Model fit is 
good: relative 
chi square = 
1.66, 
CFI=.917, 
TLI=.903, 
RMSEA=.072 
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SEM model 
based on 
factor model 
I (Figure 4.9) 
The 
following 
four 
PTSD 
factors 
are 
included 
in the 
model 
separatel
y as 
latent 
variables: 
: Re-
experienc
ing 
, 
Avoidanc
e, 
Dysphori
a and 
Hyperaro
usal  
1) The re-experiencing 
latent variable is *indirectly 
associated with pain 
intensity through anxiety 
and pain catastrophizing.   
2) The avoidance latent 
variable is directly 
associated with pain 
disability. 
3) The dysphoria latent 
variable is *indirectly 
associated with pain 
disability through 
depression.  
4)The hyperarousal latent 
variable is  directly 
associated and *indirectly  
associated with pain 
intensity through anxiety 
and pain catastrophizing. 
Model fit is 
slightly better: 
relative chi 
square = 1.58,  
CFI=.925, 
TLI=.913, 
RMSEA=0.069 
*Statistically significant relationship was defined as p-value<0.05. In all of the models above, anxiety was defined as GAD-7 total score>=10; 
depression was defined as PHQ-9 total score>=10.In SEM model based on factor model H, Re-experiencing was defined as (PCL-17 items 1–
5), Avoidance (PCL-17 items 6–7), Numbing (PCL-17 items 8–12), and Hyperarousal (PCL-17 items 13–17). In SEM model based on factor 
model I, Re-experiencing was defined as (PCL-17 items 1–5), Avoidance (PCL-17 items 6–7), Dysphoria (PCL-17 items 8–15), and 
Hyperarousal (PCL-17 items 16–17). 
  
152 
Appendix J 
 
Table 5.1: List of findings by each analysis method for each hypothesis and corresponding research question 
Research 
Question Hypothesis Analysis Finding 
1) How strong 
is the 
relationship 
between PTSD 
and chronic 
pain?  
1) Higher PTSD 
symptoms will be 
associated significantly 
with poorer pain-related 
and psychosocial 
outcomes 
univariate 
analysis 
PTSD was associated with greater pain severity, the 
coexistence of pain cognitions and psychological disorders 
including pain catastrophizing, anxiety, and depression, and 
poorer quality of life.  Hypothesis supported. 
Pearson 
correlation 
A strong correlation (r ≥ 0.6 or r≤-0.6) was found between PCL-
17 and depression, anxiety, and SF-36 mental component 
summary scores. A moderate correlation (0.4 ≤ r <0.6 or -
0.6<r≤-0.4) was found between PTSD symptoms (PCL17) and 
pain catastrophizing. Hypothesis supported. 
logistic 
regression 
 PTSD has no significant effect on pain severity. Hypothesis not 
supported. 
2) Higher pain severity 
will be associated with 
more severe PTSD and 
psychosocial outcomes 
univariate 
analysis 
The cohort with higher pain severity reported significantly higher 
pain catastophizing scores, and significantly higher rates of 
clinically significant PTSD, anxiety, and depression. Hypothesis 
supported. 
Pearson 
correlation 
A strong correlation (r ≥ 0.6 or r≤-0.6) was found between pain 
disability and SF-36 physical component scores; and between 
depression (PHQ-9), anxiety (GAD-7), and SF-36 mental 
component scores. A moderate correlation (0.4 ≤ r <0.6 or -
0.6<r≤-0.4) was found between 2) between pain intensity and 
pain disability, SF-36 physical component scores; 3) between 
pain disability and depression, SF-36 physical component 
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scores. Hypothesis supported. 
logistic 
regression 
Pain catastropizing, anxiety, and depression were significantly 
(p<0.05) associated with PTSD (PCL-17 ≥ 41) after adjustment 
for patient demographics, but the predictive association 
between pain severity and PTSD was not significant (PTSD did 
not have a direct relationship with pain severity). Hypothesis not 
supported. 
6) Baseline PTSD will 
predict pain severity at 
9 months, and baseline 
chronic pain severity 
will predict PTSD at 9 
months 
cross-lagged 
panel 
analysis 
The data did not fit the model well (TLI and CFI <0.9). No 
support was found for the hypothesis that any PTSD symptom 
domain was a significant predictor of any other PTSD factor or 
pain severity over  9-months. Hypothesis not supported. 
7) The longitudinal 
change in pain severity 
will be predicted by 
PTSD at baseline. The 
PTSD at 9 month will 
be predicted by pain 
intensity and disability 
at baseline 
 
repeated 
measure 
analysis 
Baseline PTSD symptom severity was not significantly related to 
pain intensity over time. However, patients with clinically 
significant PTSD symptoms did show significant negative 
relationship with pain disability score improvement after 9 
months. Hypothesis partially supported. 
Logistic 
regression 
After adjusting for covariates, both baseline pain intensity and 
baseline disability score were significantly associated s with 
clinically significant PTSD (PCL-17>=41). Hypothesis 
supported. 
2) Which 
factors mediate 
the relationship 
between PTSD 
and chronic 
3) Besides pain 
severity, there are other 
key factors that are 
associated with PTSD 
 
CART 
analysis 
Patients with higher pain severity or with coexisting depression 
and anxiety were more likely to have clinically significant PTSD. 
Hypothesis supported. 
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pain? 4) The relationship 
between PTSD and 
chronic pain severity 
will be mediated 
through depression, 
anxiety, or pain 
catastrophizing. And 
moreover, PTSD and 
pain severity will 
adversely affect quality 
of life (SF-36, 
MCS/PCS components) 
independently; and 
chronic pain patients 
with PTSD will have 
worse quality of life 
than those with one or 
neither of the conditions  
. 
SEM 
analysis 
PTSD was indirectly related to pain severity mediated by 
depression, and pain severity was indirectly related to PTSD 
mediated by catastrophizing. There was no direct association 
between PTSD and pain severity. Moreover, PTSD was directly 
related to pain intensity, and pain disability was directly related 
to PTSD. A combination of both anxiety and depression 
mediates the effect of PTSD on pain catastrophizing, which has 
a direct relationship with pain disability.  Finally, pain disability 
was directly related to SF-36 PCS and PTSD was directly 
related to SF-36 MCS component. Hypothesis supported. 
ANCOVA 
analysis 
Patients with more severe pain and PTSD symptoms were 
associated with worse SF-36 PCS and MCS scores. Hypothesis 
partially supported. 
3) Do specific 
PTSD symptom 
domains affect 
chronic pain 
outcomes 
differently? 
5) Different PTSD 
symptom domains will 
have differential effects 
on chronic pain 
outcomes, either 
directly, or through 
mediating factors such 
as depression or 
general anxiety 
disorder. 
confirmatory 
factor 
analysis 
The two four-factor models (reexperiencing, avoidance, 
numbing/dysphoria and hyperarousal) provided the best fit for 
our data. The four factors/symptom clusters of PTSD were 
classified as re-experiencing, avoidance, numbing/dysphoria 
and hyperarousal. Hypothesis supported. 
SEM 
analysis with 
latent 
variables 
None of the four factors of PTSD (reexperiencing, avoidance, 
numbing/dysphoria and hyperarousal) directly related to pain 
intensity or pain disability. However, numbing and dysphoria 
were indirectly related to pain disability mediated by depression, 
and hyperarousal and reexperiencing were indirectly related to 
pain disability and pain intensity mediated by anxiety and pain 
catastrophizing. Hypothesis partially supported. 
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Appendix K 
Table 5.2: Comparison between Cyders et al study and our present study in 
evaluating the relationship of pain outcomes and the four symptom 
clusters of PTSD. 
 
  Cyders study Present study 
Methods 
Study type cross-sectional, retrospective baseline, prospective 
Care setting orofacial pain center primary care 
Population 
female patients with orofacial 
pain and PTSD 
veteran patients with 
musculoskeletal pain and PTSD 
Sample size 411 188 
PTSD measure PCL-17 PCL-17 
Pain intensity 
measure 
Multidimensional pain 
inventory (MPI) 
Graded Chronic Pain Scale 
(GCPS)  
Pain disability 
measure 
Multidimensional pain 
inventory (MPI) 
Graded Chronic Pain Scale 
(GCPS)  
General activity 
level measure 
Multidimensional pain 
inventory (MPI)   
Depression 
measure 
Sympton Checklist-90-Revised 
(SCL-90-R) Health Questionnaire (PHQ-9) 
Anxiety measure 
Sympton Checklist-90-Revised 
(SCL-90-R) GAD-7  
Hostility measure 
Sympton Checklist-90-Revised 
(SCL-90-R) 
 Sleep quality 
measure 
Pittsburgh Sleep Quality Index 
(PSQI) 
 Pain 
catastrophizing 
measure 
 
Pain Catastrophizing Scale  
Results 
Hyperarousal  
had both direct and indirect 
effects on pain intensity, as 
partially mediated by sleep 
quality. 
had indirect effects on pain 
intensity and disability as mediated 
by anxiety and pain 
catastrophizing. 
Re-experiencing  
did not predict pain intensity 
at all, whether through direct 
or indirect means. 
had indirect relationship with 
both pain intensity and pain 
disability 
Avoidance 
predicted pain-related 
disability through general 
activity levels and through 
direct effect on pain-related 
disability.  
did not have a significant 
relationship with either pain 
intensity or pain disability. 
Numbing/dysphoria  
predicted pain-related 
disability and pain intensity 
through depression. 
had indirect effects on pain-
related disability through 
depression. 
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